WO2022129579A1 - Modulating plant responses to activities of pathogen virulence factors - Google Patents
Modulating plant responses to activities of pathogen virulence factors Download PDFInfo
- Publication number
- WO2022129579A1 WO2022129579A1 PCT/EP2021/086603 EP2021086603W WO2022129579A1 WO 2022129579 A1 WO2022129579 A1 WO 2022129579A1 EP 2021086603 W EP2021086603 W EP 2021086603W WO 2022129579 A1 WO2022129579 A1 WO 2022129579A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- mutation
- rpn10
- vector
- sequence
- Prior art date
Links
- 244000052769 pathogen Species 0.000 title claims abstract description 80
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 69
- 230000000694 effects Effects 0.000 title description 8
- 230000007923 virulence factor Effects 0.000 title description 4
- 239000000304 virulence factor Substances 0.000 title description 4
- 230000004044 response Effects 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 109
- 241001468265 Candidatus Phytoplasma Species 0.000 claims abstract description 69
- 241000196324 Embryophyta Species 0.000 claims description 286
- 230000035772 mutation Effects 0.000 claims description 91
- 108090000623 proteins and genes Proteins 0.000 claims description 88
- 102000004169 proteins and genes Human genes 0.000 claims description 81
- 150000007523 nucleic acids Chemical group 0.000 claims description 69
- 239000013598 vector Substances 0.000 claims description 65
- 239000012636 effector Substances 0.000 claims description 53
- 102000039446 nucleic acids Human genes 0.000 claims description 48
- 108020004707 nucleic acids Proteins 0.000 claims description 48
- 101150006293 Rpn10 gene Proteins 0.000 claims description 30
- 230000001965 increasing effect Effects 0.000 claims description 23
- 238000006467 substitution reaction Methods 0.000 claims description 20
- 241000894006 Bacteria Species 0.000 claims description 16
- 108091005461 Nucleic proteins Chemical group 0.000 claims description 16
- 230000027455 binding Effects 0.000 claims description 14
- 238000010362 genome editing Methods 0.000 claims description 11
- 208000015181 infectious disease Diseases 0.000 claims description 11
- 108010047303 von Willebrand Factor Proteins 0.000 claims description 11
- 102100036537 von Willebrand factor Human genes 0.000 claims description 11
- 229960001134 von willebrand factor Drugs 0.000 claims description 11
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 10
- 244000061456 Solanum tuberosum Species 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- 240000003768 Solanum lycopersicum Species 0.000 claims description 9
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 8
- 235000011430 Malus pumila Nutrition 0.000 claims description 8
- 244000098338 Triticum aestivum Species 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000021307 Triticum Nutrition 0.000 claims description 7
- 240000006365 Vitis vinifera Species 0.000 claims description 7
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 7
- 240000008042 Zea mays Species 0.000 claims description 7
- 240000007124 Brassica oleracea Species 0.000 claims description 6
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 6
- 244000000626 Daucus carota Species 0.000 claims description 6
- 235000002767 Daucus carota Nutrition 0.000 claims description 6
- 240000002791 Brassica napus Species 0.000 claims description 5
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 5
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 5
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 5
- 244000060011 Cocos nucifera Species 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 5
- 235000015103 Malus silvestris Nutrition 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 230000004777 loss-of-function mutation Effects 0.000 claims description 5
- 235000009973 maize Nutrition 0.000 claims description 5
- 102100033458 26S proteasome non-ATPase regulatory subunit 4 Human genes 0.000 claims description 4
- 235000011293 Brassica napus Nutrition 0.000 claims description 4
- 241000207199 Citrus Species 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 4
- 101001135231 Homo sapiens 26S proteasome non-ATPase regulatory subunit 4 Proteins 0.000 claims description 4
- 241000209510 Liliopsida Species 0.000 claims description 4
- 241000220225 Malus Species 0.000 claims description 4
- 240000000111 Saccharum officinarum Species 0.000 claims description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 241001233957 eudicotyledons Species 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 235000011331 Brassica Nutrition 0.000 claims description 3
- 241000219198 Brassica Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 3
- 235000021028 berry Nutrition 0.000 claims description 3
- 241000219146 Gossypium Species 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 235000021374 legumes Nutrition 0.000 claims description 2
- 235000014571 nuts Nutrition 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 241000132092 Aster Species 0.000 claims 1
- 240000006394 Sorghum bicolor Species 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 66
- 108091033409 CRISPR Proteins 0.000 description 46
- 150000001413 amino acids Chemical group 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 30
- 102100036646 Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Human genes 0.000 description 29
- 101001072655 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Proteins 0.000 description 29
- 241000238631 Hexapoda Species 0.000 description 28
- 108020004414 DNA Proteins 0.000 description 26
- 108091028043 Nucleic acid sequence Proteins 0.000 description 22
- 101710162083 26S proteasome non-ATPase regulatory subunit 4 homolog Proteins 0.000 description 19
- 238000010354 CRISPR gene editing Methods 0.000 description 19
- 235000001014 amino acid Nutrition 0.000 description 18
- 210000001938 protoplast Anatomy 0.000 description 18
- 229940024606 amino acid Drugs 0.000 description 17
- 241001481828 Glyptocephalus cynoglossus Species 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- 230000015556 catabolic process Effects 0.000 description 15
- 238000006731 degradation reaction Methods 0.000 description 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
- 241001414662 Macrosteles fascifrons Species 0.000 description 14
- 230000001404 mediated effect Effects 0.000 description 14
- 238000001086 yeast two-hybrid system Methods 0.000 description 14
- 239000005090 green fluorescent protein Substances 0.000 description 13
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 12
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 12
- 101710097688 Probable sphingosine-1-phosphate lyase Proteins 0.000 description 12
- 101710105985 Sphingosine-1-phosphate lyase Proteins 0.000 description 12
- 101710122496 Sphingosine-1-phosphate lyase 1 Proteins 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 238000000263 scanning probe lithography Methods 0.000 description 12
- 108091079001 CRISPR RNA Proteins 0.000 description 11
- 108091023040 Transcription factor Proteins 0.000 description 11
- 102000040945 Transcription factor Human genes 0.000 description 11
- 102000044159 Ubiquitin Human genes 0.000 description 11
- 108090000848 Ubiquitin Proteins 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 11
- 241001414720 Cicadellidae Species 0.000 description 10
- 108091028113 Trans-activating crRNA Proteins 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000009466 transformation Effects 0.000 description 10
- 241001416183 Ginglymostomatidae Species 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 238000010566 fecundity assay Methods 0.000 description 9
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 8
- 244000007853 Sarothamnus scoparius Species 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 7
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 230000009261 transgenic effect Effects 0.000 description 7
- 101000590234 Arabidopsis thaliana 26S proteasome non-ATPase regulatory subunit 4 homolog Proteins 0.000 description 6
- 241000208822 Lactuca Species 0.000 description 6
- 241000209140 Triticum Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 238000012217 deletion Methods 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 230000002018 overexpression Effects 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- 108700028369 Alleles Proteins 0.000 description 5
- 108010088742 GATA Transcription Factors Proteins 0.000 description 5
- 102000009041 GATA Transcription Factors Human genes 0.000 description 5
- 244000299507 Gossypium hirsutum Species 0.000 description 5
- 241001478324 Liberibacter Species 0.000 description 5
- 108010029485 Protein Isoforms Proteins 0.000 description 5
- 102000001708 Protein Isoforms Human genes 0.000 description 5
- 101150071816 SAP11 gene Proteins 0.000 description 5
- 244000078534 Vaccinium myrtillus Species 0.000 description 5
- 210000004899 c-terminal region Anatomy 0.000 description 5
- 230000005782 double-strand break Effects 0.000 description 5
- 235000018977 lysine Nutrition 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 244000000003 plant pathogen Species 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 244000075850 Avena orientalis Species 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 101100084999 Caenorhabditis elegans rpn-10 gene Proteins 0.000 description 4
- 244000105627 Cajanus indicus Species 0.000 description 4
- 235000010773 Cajanus indicus Nutrition 0.000 description 4
- 244000052363 Cynodon dactylon Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 101150081329 GATA18 gene Proteins 0.000 description 4
- 108020005004 Guide RNA Proteins 0.000 description 4
- 101710154606 Hemagglutinin Proteins 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 244000302544 Luffa aegyptiaca Species 0.000 description 4
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 4
- 244000081841 Malus domestica Species 0.000 description 4
- 240000004658 Medicago sativa Species 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 4
- 235000005043 Oryza sativa Japonica Group Nutrition 0.000 description 4
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 4
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 4
- 101710176177 Protein A56 Proteins 0.000 description 4
- 235000017848 Rubus fruticosus Nutrition 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 4
- 108091027544 Subgenomic mRNA Proteins 0.000 description 4
- 230000004790 biotic stress Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000185 hemagglutinin Substances 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 108700003117 plant sucrose transport Proteins 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 230000017854 proteolysis Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000034512 ubiquitination Effects 0.000 description 4
- 238000010798 ubiquitination Methods 0.000 description 4
- 238000012762 unpaired Student’s t-test Methods 0.000 description 4
- 108091006112 ATPases Proteins 0.000 description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
- 240000002234 Allium sativum Species 0.000 description 3
- 241000219195 Arabidopsis thaliana Species 0.000 description 3
- 241000238421 Arthropoda Species 0.000 description 3
- 241000722913 Callistephus chinensis Species 0.000 description 3
- 235000009467 Carica papaya Nutrition 0.000 description 3
- 240000006432 Carica papaya Species 0.000 description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 240000007571 Consolida ajacis Species 0.000 description 3
- 240000007582 Corylus avellana Species 0.000 description 3
- 235000007466 Corylus avellana Nutrition 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 241000255925 Diptera Species 0.000 description 3
- 240000003133 Elaeis guineensis Species 0.000 description 3
- 235000001950 Elaeis guineensis Nutrition 0.000 description 3
- 240000009088 Fragaria x ananassa Species 0.000 description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 244000267823 Hydrangea macrophylla Species 0.000 description 3
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 240000003183 Manihot esculenta Species 0.000 description 3
- 240000005561 Musa balbisiana Species 0.000 description 3
- 240000002834 Paulownia tomentosa Species 0.000 description 3
- 235000010659 Phoenix dactylifera Nutrition 0.000 description 3
- 244000104275 Phoenix dactylifera Species 0.000 description 3
- 241000219000 Populus Species 0.000 description 3
- 241001466030 Psylloidea Species 0.000 description 3
- 244000088415 Raphanus sativus Species 0.000 description 3
- -1 SAP60 Proteins 0.000 description 3
- 241000124033 Salix Species 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 244000061458 Solanum melongena Species 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- 241000204362 Xylella fastidiosa Species 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 235000021029 blackberry Nutrition 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 235000004611 garlic Nutrition 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 235000002532 grape seed extract Nutrition 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000011426 transformation method Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 244000046151 Acer negundo Species 0.000 description 2
- 240000005748 Achyranthes aspera Species 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 241000556614 Alstroemeria aurea Species 0.000 description 2
- 244000036975 Ambrosia artemisiifolia Species 0.000 description 2
- 244000160914 Ammi majus Species 0.000 description 2
- 235000005750 Ammi majus Nutrition 0.000 description 2
- 241000776115 Ampelopsis glandulosa var. brevipedunculata Species 0.000 description 2
- 241000410488 Anemone coronaria Species 0.000 description 2
- 240000000662 Anethum graveolens Species 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 101100533902 Arabidopsis thaliana SPL13A gene Proteins 0.000 description 2
- 101100533904 Arabidopsis thaliana SPL13B gene Proteins 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- 244000003416 Asparagus officinalis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 108091032955 Bacterial small RNA Proteins 0.000 description 2
- 241000589969 Borreliella burgdorferi Species 0.000 description 2
- 241001316288 Bougainvillea spectabilis Species 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
- 244000308180 Brassica oleracea var. italica Species 0.000 description 2
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 2
- 241000743756 Bromus inermis Species 0.000 description 2
- 235000013050 Bunias orientalis Nutrition 0.000 description 2
- 240000002668 Bunias orientalis Species 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 241001522082 Candidatus Phytoplasma mali Species 0.000 description 2
- 241000985905 Candidatus Phytoplasma solani Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 240000001829 Catharanthus roseus Species 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 244000281762 Chenopodium ambrosioides Species 0.000 description 2
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000067456 Chrysanthemum coronarium Species 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 241000132536 Cirsium Species 0.000 description 2
- 235000005918 Cirsium arvense Nutrition 0.000 description 2
- 240000001579 Cirsium arvense Species 0.000 description 2
- 241001673112 Citrus clementina Species 0.000 description 2
- 244000175448 Citrus madurensis Species 0.000 description 2
- 235000001759 Citrus maxima Nutrition 0.000 description 2
- 244000276331 Citrus maxima Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 235000005976 Citrus sinensis Nutrition 0.000 description 2
- 240000002319 Citrus sinensis Species 0.000 description 2
- 244000242024 Conyza bonariensis Species 0.000 description 2
- 244000074881 Conyza canadensis Species 0.000 description 2
- 235000004385 Conyza canadensis Nutrition 0.000 description 2
- 235000002787 Coriandrum sativum Nutrition 0.000 description 2
- 244000018436 Coriandrum sativum Species 0.000 description 2
- 241000209023 Cornus racemosa Species 0.000 description 2
- 235000001543 Corylus americana Nutrition 0.000 description 2
- 240000003023 Cosmos bipinnatus Species 0.000 description 2
- 241000729892 Crotalaria spectabilis Species 0.000 description 2
- 235000014260 Cryptotaenia canadensis Nutrition 0.000 description 2
- 240000004467 Cryptotaenia canadensis Species 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 241000612153 Cyclamen Species 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 241001598128 Dicentra formosa subsp. formosa Species 0.000 description 2
- 240000001879 Digitalis lutea Species 0.000 description 2
- 240000004530 Echinacea purpurea Species 0.000 description 2
- 244000286838 Eclipta prostrata Species 0.000 description 2
- 235000017643 Elaeagnus angustifolia Nutrition 0.000 description 2
- 244000307545 Elaeagnus angustifolia Species 0.000 description 2
- 240000000279 Emilia sonchifolia Species 0.000 description 2
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 2
- 244000061508 Eriobotrya japonica Species 0.000 description 2
- 244000001381 Eschscholzia californica Species 0.000 description 2
- 244000041517 Etlingera elatior Species 0.000 description 2
- 241000490229 Eucephalus Species 0.000 description 2
- 240000002395 Euphorbia pulcherrima Species 0.000 description 2
- 241000234643 Festuca arundinacea Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 235000017316 Fortunella japonica Nutrition 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 241000549548 Fraxinus uhdei Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 101150015462 GATA19 gene Proteins 0.000 description 2
- 244000225256 Gaillardia pulchella Species 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- 240000000208 Gerbera jamesonii Species 0.000 description 2
- 241000245654 Gladiolus Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000070990 Gomphocarpus physocarpus Species 0.000 description 2
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 2
- 108060003760 HNH nuclease Proteins 0.000 description 2
- 102000029812 HNH nuclease Human genes 0.000 description 2
- 241000258937 Hemiptera Species 0.000 description 2
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 2
- 235000000100 Hibiscus rosa sinensis Nutrition 0.000 description 2
- 244000025221 Humulus lupulus Species 0.000 description 2
- 241000218092 Hylotelephium spectabile Species 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 244000018716 Impatiens biflora Species 0.000 description 2
- 235000015912 Impatiens biflora Nutrition 0.000 description 2
- 241000721662 Juniperus Species 0.000 description 2
- 241000167847 Koelreuteria paniculata Species 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 235000003127 Lactuca serriola Nutrition 0.000 description 2
- 240000006137 Lactuca serriola Species 0.000 description 2
- 241000218652 Larix Species 0.000 description 2
- 240000000486 Lepidium draba Species 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- 240000001585 Limonium sinuatum Species 0.000 description 2
- 244000100545 Lolium multiflorum Species 0.000 description 2
- 241000215452 Lotus corniculatus Species 0.000 description 2
- 241000219745 Lupinus Species 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000007575 Macadamia integrifolia Species 0.000 description 2
- 241001166593 Maize bushy stunt phytoplasma Species 0.000 description 2
- 240000000982 Malva neglecta Species 0.000 description 2
- 235000000060 Malva neglecta Nutrition 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 235000010624 Medicago sativa Nutrition 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 240000000233 Melia azedarach Species 0.000 description 2
- 240000006959 Melochia corchorifolia Species 0.000 description 2
- 235000016462 Mimosa pudica Nutrition 0.000 description 2
- 240000001140 Mimosa pudica Species 0.000 description 2
- 241001430197 Mollicutes Species 0.000 description 2
- 244000302512 Momordica charantia Species 0.000 description 2
- 235000009811 Momordica charantia Nutrition 0.000 description 2
- 244000293610 Morus bombycis Species 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 244000204970 Myriophyllum brasiliense Species 0.000 description 2
- 235000004234 Myriophyllum brasiliense Nutrition 0.000 description 2
- 240000005125 Myrtus communis Species 0.000 description 2
- 235000013418 Myrtus communis Nutrition 0.000 description 2
- 235000017879 Nasturtium officinale Nutrition 0.000 description 2
- 240000005407 Nasturtium officinale Species 0.000 description 2
- 235000018806 Nicolaia elatior Nutrition 0.000 description 2
- 240000005912 Nigella damascena Species 0.000 description 2
- 235000008750 Nigella damascena Nutrition 0.000 description 2
- 108020004485 Nonsense Codon Proteins 0.000 description 2
- 235000010676 Ocimum basilicum Nutrition 0.000 description 2
- 240000007926 Ocimum gratissimum Species 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 240000001439 Opuntia Species 0.000 description 2
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 101100043227 Oryza sativa subsp. japonica SPL13 gene Proteins 0.000 description 2
- 241001279838 Pachysandra terminalis Species 0.000 description 2
- 235000007846 Papaver rhoeas Nutrition 0.000 description 2
- 240000004674 Papaver rhoeas Species 0.000 description 2
- 241001077924 Parthenium hysterophorus Species 0.000 description 2
- 235000000370 Passiflora edulis Nutrition 0.000 description 2
- 244000288157 Passiflora edulis Species 0.000 description 2
- 241001495381 Peanut witches'-broom phytoplasma Species 0.000 description 2
- 241000208181 Pelargonium Species 0.000 description 2
- 235000007195 Pennisetum typhoides Nutrition 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 241000255129 Phlebotominae Species 0.000 description 2
- 244000304321 Phlox drummondii Species 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 241001092086 Pittosporum undulatum Species 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- 241000209049 Poa pratensis Species 0.000 description 2
- 241000218982 Populus nigra Species 0.000 description 2
- 244000234609 Portulaca oleracea Species 0.000 description 2
- 235000001855 Portulaca oleracea Nutrition 0.000 description 2
- 229940079156 Proteasome inhibitor Drugs 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 244000007021 Prunus avium Species 0.000 description 2
- 235000010401 Prunus avium Nutrition 0.000 description 2
- 235000005805 Prunus cerasus Nutrition 0.000 description 2
- 240000002878 Prunus cerasus Species 0.000 description 2
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 description 2
- 244000017714 Prunus persica var. nucipersica Species 0.000 description 2
- 240000005049 Prunus salicina Species 0.000 description 2
- 241000305548 Pterocarya stenoptera Species 0.000 description 2
- 240000001987 Pyrus communis Species 0.000 description 2
- 235000014443 Pyrus communis Nutrition 0.000 description 2
- 240000009089 Quercus robur Species 0.000 description 2
- 102000014450 RNA Polymerase III Human genes 0.000 description 2
- 241001120635 Ranunculus asiaticus Species 0.000 description 2
- 235000011380 Raphanus sativus Nutrition 0.000 description 2
- 241000219100 Rhamnaceae Species 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 235000001466 Ribes nigrum Nutrition 0.000 description 2
- 244000281247 Ribes rubrum Species 0.000 description 2
- 235000016911 Ribes sativum Nutrition 0.000 description 2
- 235000002355 Ribes spicatum Nutrition 0.000 description 2
- 235000016785 Rosa della China Nutrition 0.000 description 2
- 235000000656 Rosa multiflora Nutrition 0.000 description 2
- 244000050053 Rosa multiflora Species 0.000 description 2
- 235000000659 Rosa rugosa Nutrition 0.000 description 2
- 240000006066 Rosa rugosa Species 0.000 description 2
- 235000006595 Roystonea elata Nutrition 0.000 description 2
- 240000007186 Roystonea regia Species 0.000 description 2
- 101150073907 SPL11 gene Proteins 0.000 description 2
- 101150096142 SPL5 gene Proteins 0.000 description 2
- 235000002493 Salix babylonica Nutrition 0.000 description 2
- 244000020191 Salix babylonica Species 0.000 description 2
- 240000000513 Santalum album Species 0.000 description 2
- 240000003946 Saponaria officinalis Species 0.000 description 2
- 240000000136 Scabiosa atropurpurea Species 0.000 description 2
- 235000019095 Sechium edule Nutrition 0.000 description 2
- 240000007660 Sechium edule Species 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- 244000111146 Sonchus arvensis Species 0.000 description 2
- 244000113423 Sonchus asper Species 0.000 description 2
- 244000113428 Sonchus oleraceus Species 0.000 description 2
- 235000006745 Sonchus oleraceus Nutrition 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 241000202917 Spiroplasma Species 0.000 description 2
- 240000006694 Stellaria media Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 241001104043 Syringa Species 0.000 description 2
- 235000004338 Syringa vulgaris Nutrition 0.000 description 2
- 244000297179 Syringa vulgaris Species 0.000 description 2
- 240000000785 Tagetes erecta Species 0.000 description 2
- 235000012311 Tagetes erecta Nutrition 0.000 description 2
- 235000004452 Tagetes patula Nutrition 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 2
- 241000949477 Toona ciliata Species 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 241000219793 Trifolium Species 0.000 description 2
- 235000000598 Trifolium hybridum Nutrition 0.000 description 2
- 240000006345 Trifolium hybridum Species 0.000 description 2
- 235000015724 Trifolium pratense Nutrition 0.000 description 2
- 244000042324 Trifolium repens Species 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 102100020779 UV excision repair protein RAD23 homolog B Human genes 0.000 description 2
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 2
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 description 2
- 244000126014 Valeriana officinalis Species 0.000 description 2
- 208000011312 Vector Borne disease Diseases 0.000 description 2
- 240000004482 Withania somnifera Species 0.000 description 2
- 241001330791 Wodyetia bifurcata Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 240000003307 Zinnia violacea Species 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000001264 anethum graveolens Substances 0.000 description 2
- 150000001484 arginines Chemical class 0.000 description 2
- 239000012639 bacterial effector Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 210000000081 body of the sternum Anatomy 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229930186364 cyclamen Natural products 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 2
- 235000014134 echinacea Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 231100000221 frame shift mutation induction Toxicity 0.000 description 2
- 230000037433 frameshift Effects 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000442 meristematic effect Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 244000000045 multihost pathogen Species 0.000 description 2
- 108091027963 non-coding RNA Proteins 0.000 description 2
- 102000042567 non-coding RNA Human genes 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000005305 organ development Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 238000013081 phylogenetic analysis Methods 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 239000003207 proteasome inhibitor Substances 0.000 description 2
- 230000004063 proteosomal degradation Effects 0.000 description 2
- 241000816786 rapeseed phytoplasma Species 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 235000013526 red clover Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 230000004572 zinc-binding Effects 0.000 description 2
- BZSALXKCVOJCJJ-IPEMHBBOSA-N (4s)-4-[[(2s)-2-acetamido-3-methylbutanoyl]amino]-5-[[(2s)-1-[[(2s)-1-[[(2s,3r)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy Chemical compound CC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CCCC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](C(N)=O)CC1=CC=CC=C1 BZSALXKCVOJCJJ-IPEMHBBOSA-N 0.000 description 1
- 101710091326 26S proteasome non-ATPase regulatory subunit 4 Proteins 0.000 description 1
- 101710189849 26S proteasome regulatory subunit RPN10 Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- 235000004422 Acer negundo Nutrition 0.000 description 1
- 235000012092 Acer negundo ssp. interius Nutrition 0.000 description 1
- 235000009231 Acer negundo var texanum Nutrition 0.000 description 1
- 235000012089 Acer negundo var. negundo Nutrition 0.000 description 1
- 235000005517 Achyranthes aspera Nutrition 0.000 description 1
- 235000009212 Achyranthes aspera var aspera Nutrition 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 241000983387 Adenium obesum Species 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 235000007237 Aegopodium podagraria Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241001466033 Aleyrodoidea Species 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000005255 Allium cepa Nutrition 0.000 description 1
- 240000000966 Allium tricoccum Species 0.000 description 1
- 235000006905 Allium tricoccum Nutrition 0.000 description 1
- 241001135756 Alphaproteobacteria Species 0.000 description 1
- 241000219318 Amaranthus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000011746 Amaranthus hypochondriacus Nutrition 0.000 description 1
- 240000003147 Amaranthus hypochondriacus Species 0.000 description 1
- 235000003133 Ambrosia artemisiifolia Nutrition 0.000 description 1
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 241001083548 Anemone Species 0.000 description 1
- 235000007227 Anethum graveolens Nutrition 0.000 description 1
- 235000017311 Anethum sowa Nutrition 0.000 description 1
- 244000251090 Anthemis cotula Species 0.000 description 1
- 235000007639 Anthemis cotula Nutrition 0.000 description 1
- 241001465983 Aphidoidea Species 0.000 description 1
- 235000002764 Apium graveolens Nutrition 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 101100084997 Arabidopsis thaliana RPN10 gene Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000404047 Argyranthemum frutescens Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 208000034309 Bacterial disease carrier Diseases 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 241000132023 Bellis perennis Species 0.000 description 1
- 241000254127 Bemisia tabaci Species 0.000 description 1
- 235000021533 Beta vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 240000004183 Bongardia chrysogonum Species 0.000 description 1
- 101000742951 Bos taurus Retinol dehydrogenase 5 Proteins 0.000 description 1
- 241000204786 Brachyscome Species 0.000 description 1
- 235000011303 Brassica alboglabra Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 241000202722 Bupleurum falcatum Species 0.000 description 1
- 108010040467 CRISPR-Associated Proteins Proteins 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- 238000010453 CRISPR/Cas method Methods 0.000 description 1
- 241000964586 Cacopsylla crataegi Species 0.000 description 1
- 241000776777 Cacopsylla mali Species 0.000 description 1
- 241000883203 Cacopsylla pruni Species 0.000 description 1
- 241000526200 Cacopsylla pyri Species 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000217446 Calystegia sepium Species 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- 235000014595 Camelina sativa Nutrition 0.000 description 1
- 241000948845 Candidatus Phytoplasma hispanicum Species 0.000 description 1
- 241001182423 Candidatus Phytoplasma oryzae Species 0.000 description 1
- 241000217224 Candidatus Phytoplasma pyri Species 0.000 description 1
- 241000900200 Candidatus Phytoplasma vitis Species 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007034 Carum copticum Nutrition 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000201841 Celosia Species 0.000 description 1
- 240000008365 Celosia argentea Species 0.000 description 1
- 235000000722 Celosia argentea Nutrition 0.000 description 1
- 235000017926 Celtis australis Nutrition 0.000 description 1
- 244000256534 Celtis australis Species 0.000 description 1
- 241001414824 Cercopidae Species 0.000 description 1
- 241000747028 Cestrum yellow leaf curling virus Species 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 235000008302 Chamaenerion angustifolium Nutrition 0.000 description 1
- 244000103926 Chamaenerion angustifolium Species 0.000 description 1
- 201000009182 Chikungunya Diseases 0.000 description 1
- 208000004293 Chikungunya Fever Diseases 0.000 description 1
- 241000256135 Chironomus thummi Species 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- 235000007871 Chrysanthemum coronarium Nutrition 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 241001466037 Cicadoidea Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241001498622 Cixius wagneri Species 0.000 description 1
- 241000219930 Clarkia Species 0.000 description 1
- 241001465977 Coccoidea Species 0.000 description 1
- 241001466016 Coleorrhyncha Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 244000225789 Cordyline australis Species 0.000 description 1
- 235000016071 Cordyline australis Nutrition 0.000 description 1
- 241000723366 Coreopsis Species 0.000 description 1
- 244000128583 Coreopsis cardaminifolia Species 0.000 description 1
- 235000005912 Coreopsis cardaminifolia Nutrition 0.000 description 1
- 241000209020 Cornus Species 0.000 description 1
- 241001480079 Corymbia calophylla Species 0.000 description 1
- 244000028595 Crotalaria tetragona Species 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 235000004035 Cryptotaenia japonica Nutrition 0.000 description 1
- 244000146493 Cryptotaenia japonica Species 0.000 description 1
- 241000526129 Ctenarytaina eucalypti Species 0.000 description 1
- 241000526131 Ctenarytaina spatulata Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000207901 Cuscuta Species 0.000 description 1
- 240000007371 Cuscuta campestris Species 0.000 description 1
- 240000009034 Cyclamen persicum Species 0.000 description 1
- 244000126759 Cyrtostachys renda Species 0.000 description 1
- 102100026846 Cytidine deaminase Human genes 0.000 description 1
- 108010031325 Cytidine deaminase Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 244000033273 Dahlia variabilis Species 0.000 description 1
- 241001260003 Dalbulus Species 0.000 description 1
- 241000202296 Delphinium Species 0.000 description 1
- 241000220210 Diplotaxis erucoides Species 0.000 description 1
- 101100245782 Drosophila melanogaster Rpn10 gene Proteins 0.000 description 1
- 101100476652 Drosophila melanogaster Sap47 gene Proteins 0.000 description 1
- 235000002139 Emilia sonchifolia Nutrition 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000721098 Epilobium Species 0.000 description 1
- 241000293484 Eryngium alpinum Species 0.000 description 1
- 241000742671 Erysimum linifolium Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 244000151703 Eucalyptus rostrata Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241001473319 Eupatorium capillifolium Species 0.000 description 1
- 235000016869 European olive Nutrition 0.000 description 1
- 244000048738 European olive Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 241000597000 Freesia Species 0.000 description 1
- 241000865492 Frutilla phytoplasma Species 0.000 description 1
- 241001489612 Fulgoroidea Species 0.000 description 1
- 241000192128 Gammaproteobacteria Species 0.000 description 1
- 235000002145 Geum coccineum Nutrition 0.000 description 1
- 235000009977 Gladiolus dalenii Nutrition 0.000 description 1
- 240000008905 Gladiolus dalenii Species 0.000 description 1
- 241001502121 Glossina brevipalpis Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000009438 Gossypium Nutrition 0.000 description 1
- 241000302934 Grapevine yellows phytoplasma Species 0.000 description 1
- 235000003239 Guizotia abyssinica Nutrition 0.000 description 1
- 240000002795 Guizotia abyssinica Species 0.000 description 1
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
- 241000552065 Haplaxius crudus Species 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000255763 Helianthus debilis Species 0.000 description 1
- 241001466007 Heteroptera Species 0.000 description 1
- 102100023358 Histone deacetylase complex subunit SAP25 Human genes 0.000 description 1
- 102100023357 Histone deacetylase complex subunit SAP30 Human genes 0.000 description 1
- 101000685994 Homo sapiens Histone deacetylase complex subunit SAP25 Proteins 0.000 description 1
- 101000686001 Homo sapiens Histone deacetylase complex subunit SAP30 Proteins 0.000 description 1
- 101000864786 Homo sapiens Secreted frizzled-related protein 2 Proteins 0.000 description 1
- 101000874241 Homo sapiens Sin3 histone deacetylase corepressor complex component SDS3 Proteins 0.000 description 1
- 101000707561 Homo sapiens Splicing factor 3A subunit 2 Proteins 0.000 description 1
- 101000616167 Homo sapiens Splicing factor 3B subunit 4 Proteins 0.000 description 1
- 101000717424 Homo sapiens UV excision repair protein RAD23 homolog B Proteins 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 241001632576 Hyacinthus Species 0.000 description 1
- 241001632578 Hyacinthus orientalis Species 0.000 description 1
- 241001502185 Hyalesthes obsoletus Species 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 244000053214 Ipomoea obscura Species 0.000 description 1
- 241000038248 Isopyrum thalictroides Species 0.000 description 1
- 241000410039 Jacobaea vulgaris Species 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 241000221089 Jatropha Species 0.000 description 1
- 241001048891 Jatropha curcas Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000531434 Lamprocapnos spectabilis Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 208000004554 Leishmaniasis Diseases 0.000 description 1
- 235000000391 Lepidium draba Nutrition 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 241000219138 Luffa Species 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 241001414659 Macrosteles Species 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 235000013939 Malva Nutrition 0.000 description 1
- 235000004456 Manihot esculenta Nutrition 0.000 description 1
- 108091027974 Mature messenger RNA Proteins 0.000 description 1
- 238000007476 Maximum Likelihood Methods 0.000 description 1
- 241001466038 Membracoidea Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000006721 Morus bombycis Nutrition 0.000 description 1
- 101000607569 Mus musculus Unknown protein from 2D-PAGE of fibroblasts Proteins 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 244000291473 Musa acuminata Species 0.000 description 1
- 241000026126 Muscari armeniacum Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241000721621 Myzus persicae Species 0.000 description 1
- 108700010674 N-acetylVal-Nle(7,8)- allatotropin (5-13) Proteins 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241001490843 Neoaliturus haematoceps Species 0.000 description 1
- 241001472103 Neoaliturus tenellus Species 0.000 description 1
- 235000016698 Nigella sativa Nutrition 0.000 description 1
- 235000007642 Olea europaea subsp europaea Nutrition 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 235000004727 Opuntia ficus indica Nutrition 0.000 description 1
- 240000009297 Opuntia ficus-indica Species 0.000 description 1
- 244000192701 Opuntia sp Species 0.000 description 1
- 101000982427 Orgyia pseudotsugata multicapsid polyhedrosis virus OPEP-3 protein Proteins 0.000 description 1
- 101001136705 Oryza sativa subsp. japonica 26S proteasome non-ATPase regulatory subunit 4 homolog Proteins 0.000 description 1
- 101100256132 Oryza sativa subsp. japonica SAP15 gene Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 241001520808 Panicum virgatum Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 241000479842 Pella Species 0.000 description 1
- 244000038248 Pennisetum spicatum Species 0.000 description 1
- 244000115721 Pennisetum typhoides Species 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 235000002770 Petroselinum crispum Nutrition 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 208000016012 Phenotypic abnormality Diseases 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 240000009134 Physalis philadelphica Species 0.000 description 1
- 235000002489 Physalis philadelphica Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 241001127637 Plantago Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 235000008930 Primula sp Nutrition 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000009226 Prunus puddum Nutrition 0.000 description 1
- 235000012904 Prunus salicina Nutrition 0.000 description 1
- 235000003681 Prunus ussuriensis Nutrition 0.000 description 1
- 241001290145 Psylliostachys suworowii Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000011471 Quercus robur Nutrition 0.000 description 1
- 108010078067 RNA Polymerase III Proteins 0.000 description 1
- 235000019057 Raphanus caudatus Nutrition 0.000 description 1
- 244000286177 Raphanus raphanistrum Species 0.000 description 1
- 235000000241 Raphanus raphanistrum Nutrition 0.000 description 1
- 235000000245 Raphanus raphanistrum subsp raphanistrum Nutrition 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241001498624 Reptalus Species 0.000 description 1
- 241000553985 Reptalus panzeri Species 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 241001312569 Ribes nigrum Species 0.000 description 1
- 235000016897 Ribes triste Nutrition 0.000 description 1
- 241001313103 Rice orange leaf phytoplasma Species 0.000 description 1
- 235000000664 Rosa chinensis Nutrition 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 244000172730 Rubus fruticosus Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000510450 Rudbeckia hirta Species 0.000 description 1
- 101150066201 SAP13 gene Proteins 0.000 description 1
- 108091078740 SPL family Proteins 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000170989 Scaphoideus titanus Species 0.000 description 1
- 240000002252 Schizanthus pinnatus Species 0.000 description 1
- 102100030054 Secreted frizzled-related protein 2 Human genes 0.000 description 1
- 235000008515 Setaria glauca Nutrition 0.000 description 1
- 102100035738 Sin3 histone deacetylase corepressor complex component SDS3 Human genes 0.000 description 1
- 241000258242 Siphonaptera Species 0.000 description 1
- 241000607059 Solidago Species 0.000 description 1
- 235000000914 Solidago virgaurea Nutrition 0.000 description 1
- 235000008950 Sommerlauch Nutrition 0.000 description 1
- 235000006731 Sonchus arvensis Nutrition 0.000 description 1
- 235000008135 Sonchus arvensis ssp. arvensis Nutrition 0.000 description 1
- 235000008132 Sonchus arvensis ssp. uliginosus Nutrition 0.000 description 1
- 235000006744 Sonchus asper Nutrition 0.000 description 1
- 235000000113 Sonchus asper subsp glaucescens Nutrition 0.000 description 1
- 241000246048 Spartium Species 0.000 description 1
- 244000187976 Spiraea japonica Species 0.000 description 1
- 241001516543 Spiraea tomentosa Species 0.000 description 1
- 102100031712 Splicing factor 3A subunit 2 Human genes 0.000 description 1
- 102100031710 Splicing factor 3A subunit 3 Human genes 0.000 description 1
- 102100021815 Splicing factor 3B subunit 4 Human genes 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 108700035472 Squamosa promoter-binding proteins Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000366369 Stone fruit phytoplasma Species 0.000 description 1
- 235000018459 Streblus asper Nutrition 0.000 description 1
- 244000229023 Streblus asper Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 240000002670 Tagetes lucida Species 0.000 description 1
- 235000003595 Tagetes minuta Nutrition 0.000 description 1
- 240000005285 Tagetes patula Species 0.000 description 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 description 1
- 241000250966 Tanacetum cinerariifolium Species 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 235000006754 Taraxacum officinale Nutrition 0.000 description 1
- 108091046869 Telomeric non-coding RNA Proteins 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 208000004006 Tick-borne encephalitis Diseases 0.000 description 1
- 241000592342 Tracheophyta Species 0.000 description 1
- 241000589892 Treponema denticola Species 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 240000002913 Trifolium pratense Species 0.000 description 1
- 235000010729 Trifolium repens Nutrition 0.000 description 1
- 235000013540 Trifolium repens var repens Nutrition 0.000 description 1
- 241000647292 Tripleurospermum maritimum Species 0.000 description 1
- 241000404538 Tripleurospermum maritimum subsp. inodorum Species 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 241000722921 Tulipa gesneriana Species 0.000 description 1
- 108010005705 Ubiquitinated Proteins Proteins 0.000 description 1
- 241000218220 Ulmaceae Species 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 101800000864 VP58 Proteins 0.000 description 1
- 235000012511 Vaccinium Nutrition 0.000 description 1
- 241000736767 Vaccinium Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241001530097 Verbascum Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 206010057293 West Nile viral infection Diseases 0.000 description 1
- 235000001978 Withania somnifera Nutrition 0.000 description 1
- 235000009240 Xanthoceras sorbifolium Nutrition 0.000 description 1
- 244000248162 Xanthoceras sorbifolium Species 0.000 description 1
- 108010027199 Xylosidases Proteins 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 241000180524 Yucca constricta Species 0.000 description 1
- 241001079064 Zanthoxylum schinifolium Species 0.000 description 1
- 241000907316 Zika virus Species 0.000 description 1
- 102000038627 Zinc finger transcription factors Human genes 0.000 description 1
- 108091007916 Zinc finger transcription factors Proteins 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 208000035472 Zoonoses Diseases 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 244000037640 animal pathogen Species 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 235000003484 annual ragweed Nutrition 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 239000001387 apium graveolens Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 201000006824 bubonic plague Diseases 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012761 co-transfection Methods 0.000 description 1
- 235000003488 common ragweed Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 238000012272 crop production Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 235000012280 devils horsewhip Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- RUZYUOTYCVRMRZ-UHFFFAOYSA-N doxazosin Chemical compound C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 RUZYUOTYCVRMRZ-UHFFFAOYSA-N 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000006645 dysphania ambrosioides Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000015134 garland chrysanthemum Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000009643 growth defect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 235000002741 hibiscus rosa-sinensis Nutrition 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 235000010414 hoary cress Nutrition 0.000 description 1
- 235000011671 hortensia Nutrition 0.000 description 1
- 244000220389 hortensia Species 0.000 description 1
- 230000005745 host immune response Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000011890 leaf development Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 235000009018 li Nutrition 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 244000000181 phytoplasma pathogen Species 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 201000009430 pneumonic plague Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000002005 protein protein interaction detection Methods 0.000 description 1
- 238000002762 protein-protein interaction assay Methods 0.000 description 1
- 238000011865 proteolysis targeting chimera technique Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- 235000008954 quail grass Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 108010080909 spiralin Proteins 0.000 description 1
- 108010022412 splicing factor 3a Proteins 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 235000013706 tagetes lucida Nutrition 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000009105 vegetative growth Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- SASUFNRGCZMRFD-JCUIILOWSA-N withanolide D Chemical compound C1C(C)=C(C)C(=O)O[C@H]1[C@](C)(O)[C@@H]1[C@@]2(C)CC[C@@H]3[C@@]4(C)C(=O)C=C[C@H](O)[C@@]54O[C@@H]5C[C@H]3[C@@H]2CC1 SASUFNRGCZMRFD-JCUIILOWSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/12—Processes for modifying agronomic input traits, e.g. crop yield
- A01H1/122—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- A01H1/1245—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance
- A01H1/125—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
Definitions
- the invention relates to methods of engineering a host to become resistant or increase the resistance of a host to a vector-borne pathogen.
- a method of engineering a plant to become resistant to phytoplasma there is provided a method of engineering a plant to become resistant to phytoplasma.
- Vector-borne diseases account for more than 17% of all infectious diseases and cause more than 700,000 deaths annually. They can be caused by parasites, bacteria or viruses. In humans, ticks and fleas are responsible for the spread of Borrelia burgdorferi, the agent of Lyme disease, and Yersinia pestis, the agent of bubonic and pneumonic plague, respectively. Other notable examples include malaria, which is a parasitic infection transmitted by Anopheline mosquitoes, which causes an estimated 219 million cases globally, and results in more than 400,000 deaths every year.
- viral diseases transmitted by vectors include chikungunya fever, Zika virus fever, yellow fever, West Nile fever, Japanese encephalitis (all transmitted by mosquitoes), tick-borne encephalitis (transmitted by ticks).
- Vector-borne diseases also include Chagas disease (transmitted by triatomine bugs), leishmaniasis (sandflies) and schistosomiasis (snails) affect hundreds of millions of people worldwide.
- sap-feeding insects that feed from the plant vasculature, such as leafhoppers, froghoppers and psyllids, transmit a plethora of plant viruses and the plant pathogenic bacteria Xylella fastidiosa, Liberibacter species and phytoplasmas that have destroyed major crop productions and spread worldwide. These bacteria produce effectors, which are translocated to hosts to modulate specific host processes, such as immune responses, and promote bacterial colonisation. Bacterial effectors that influence processes within humans, vertebrate animals and plants have been functionally described. However, no mechanisms of host resistance to these vector-borne pathogens are known.
- Phytoplasmas are obligate insect-vectored plant pathogens that are invasive colonisers of both plants (Kingdom Plantae) and insect vectors (Kingdom Animalia). These bacteria belong to a large group in the class Mollicutes that also includes human and animal mycoplasma pathogens and that are characterised by small cells enveloped in a single membrane, the absence of cell walls and small genomes. Phytoplasmas often replicate intracellularly and colonise most tissues of their insect vectors with colonisation of salivary glands being required for pathogen inoculation into the plant vasculature.
- phytoplasmas migrate throughout the plant within the phloem sieve cells of the vascular system and often induce massive changes in plant architecture, such as the retrograde development of flowers into leaf-like organs (phyllody) and excessive proliferation of axillary shoots (witches’ brooms).
- Multiple candidate phytoplasma effectors have been identified in the genomes of phytoplasma, but to date the plant targets of only a few of these effectors have been functionally characterised. These include SAP11 and homologous effectors that bind and destabilise plant transcription factors of the TCP family, resulting in changes in stem proliferation and leaf shape, and SAP54/phyllogens that bind and degrade MADS-box transcription factors, leading to the induction of leaf-like flowers.
- SAP11 and SAP54 also promote plant susceptibility to phytoplasma insect vectors, a phenotype that likely aids phytoplasma dispersal.
- SAP11 and SAP54 target plant-specific proteins, and hence are unlikely to modulate similar processes in both plant and insect vectors.
- a method of providing resistance or increasing resistance of a host to a vector-borne pathogen comprising: a. identifying at least one host protein that is the target of at least one pathogen effector; b.
- identifying at least one homologue of the host target protein in the vector c. comparing the nucleic acid or protein sequence of the host target and vector homologue and identifying one or more differences in the nucleic acid or protein sequence between the host and vector nucleic acid or protein sequence; and d. introducing said one or more differences in nucleic acid or protein sequence into the host target protein; wherein introduction of one or more of the differences increases resistance to the vector-borne pathogen.
- a genetically altered plant, part thereof or plant cell wherein the plant comprises at least one mutation in at least one RPN10 gene.
- the mutation is a loss of function mutation. More preferably, the mutation is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof.
- vWA von Willebrand factor type A
- the mutation is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence.
- the mutation is a substitution.
- a method of increasing resistance of a plant to vector-borne pathogen comprising introducing at least one mutation into at least one RPN10 gene.
- the method comprises increasing the resistance of a plant.
- a method of producing a plant with increased resistance to a vector borne pathogen comprising introducing at least one mutation into at least one RPN10 gene.
- the vector-borne pathogen is a bacteria, preferably a phytoplasma.
- the mutation is a loss of function mutation.
- the mutation is a mutation is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof. More preferably, the mutation is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence.
- the mutation is a substitution.
- the mutation is introduced using targeted genome editing.
- the genetically altered plant is a monocot or dicot.
- the plant is selected from rice, maize, wheat, barley, sorghum, potato, tomato, cotton, soybean, Brassica napus, cabbage, lettuce, carrot, asters, coconut, grape, apple, oranges and sugarcane.
- the plant part is a seed.
- a method for identifying and/or selecting a plant that will have increased resistance to phytoplasma infection comprising detecting in the plant or plant germplasm at least one polymorphism in the RPN10 gene.
- the polymorphism prevents binding of a phytoplasma effector protein, wherein preferably the phytoplasma effector protein is SAP05.
- the polymorphism is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof.
- the polymorphism is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence.
- Figure 1 shows that the phytoplasma effector SAP05 induces developmental changes in A. thaliana.
- a-c Representative phenotypes of plants stably producing SAP05 or GFP (control). Plants were grown under short-day (SD) conditions, and images were obtained at 4 weeks (a), 7 weeks (b) and 10 weeks (c) after germination. Arrowheads in a indicate leaf serrations of GFP plants as opposed to the smoother leaf edges of SAP05 plants. Scale bars, 1 cm.
- Insets in c show enlarged images of mature flowers with the same magnification
- d-g Statistic analyses of phenotypes shown in a-c: numbers of rosette leaves of 4-week-old plants (d) and time of shoot emergence from rosettes (bolting time; e), number of shoots emerging from rosettes (lateral shoot number; f) and plant height (g) of 10-week-old plants.
- Each data point black or red dots
- DAG day after germination. *, P ⁇ 0.05, two-tailed unpaired Student’s t-tests.
- h Percentage of M.
- FIG. 2 shows SAP05 degrades plant GATA and SPL transcription factors via the plant 26S proteasomal ubiquitin receptor RPN10.
- a Locations of the zinc-finger (ZnF) domains in representative proteins of the A. thaliana (At) GATA and SPL transcription factor families.
- SBP SQUAMOSA promoter-binding protein. Red and yellow dots indicate cysteine and histidine residues, respectively.
- b SAP05 interacts with AtGATAs and SPLs via their ZnF domains in yeast.
- EV empty vector control.
- AD GAL4-activation domain.
- BD GAL4-DNA binding domain.
- Yeast transformed with AD and BD constructs grew on medium lacking leucine and tryptophan (-L-W) and growth on medium lacking leucine, tryptophan, histidine and alanine (-L-W-H-A) indicates positive interactions
- c Western blot analysis of SAP05-mediated degradation of GATA and SPL proteins in A. thaliana protoplasts.
- GFP control;
- HA hemagglutinin tag;
- rSPL miR156-resistant form. Numbers at left indicate markers in kilodaltons, d, Domain localisation of A. thaliana RPN10.
- vWA von Willebrand factor type A domain
- UIM ubiquitin-interacting motifs
- e SAP05 interacts with AtRPNIO via its vWA domain in yeast.
- N-ter and C-ter refer to the N and C termini, respectively, f-k, Western blot analysis of SAP05 degradation assays in either rpn10-2 (f) or wild type (g-k) A. thaliana protoplasts.
- SAP05-mediated degradation of targets is dependent on AtRPNIO (f) and independent of the presence of lysines in targets (g).
- K->R all lysines replaced by arginines (g).
- ‘tail’ represents an unstructured region that serves as an initiation site for proteasomal degradation.
- Fig. 3 shows SAP05 degrades SPL and GATA transcription factors in whole plants, a- d, SAP05 suppresses plant phenotypes caused by the overexpression of various SPL or GATA members; shown are plant phenotypes (a) and quantitative analyses of leaf serrations (b), rosette leaf numbers (c) and shoot lengths (d).
- OE overexpression; x, cross of two lines; rSPL, miR156-resistant form.
- arrowheads indicate leaf serrations, and arrow a flowering stem; scale bars, 1 cm.
- Each data point black or red dot) represents one transgenic line, and the columns show means ⁇ s.d. of these data points.
- FIG. 4 shows insect-directed engineering of A. thaliana RPN10 confers SAP05 resistance, a, Domain organisation of A. thaliana and M. quadrilineatus RPN10 proteins and alignment of the first 70 residues of plant and animal RPN10 vWA domains. Highly divergent residues are highlighted below.
- SAP05 does not interact with RPN10 of the phytoplasma leafhopper vector (Mq) or with the specific AtRPNIO mutants hRPN10, RPN10 ml and m2 (see a) in yeast, whereas AtRAD23 (control) does, c, Western blot analysis of SAP05-mediated AtGATA18 degradation upon the expression of various RPN10 variants in A.
- thaliana rpn10-2 protoplasts GFP, control.
- the UIM domains were mutated in hRPN10 uim. d,e, SAP05 induces witches’-broom-like phenotypes in rpn10-2 plants complemented with wild-type AtRPNIO, but not with AtRPNIO ml .
- Data are mean ⁇ s.d. f, Percentage of M. quadrilineatus nymphs produced in choice fecundity assays.
- Data are mean ⁇ s.d. from 3 independent experiments, g, Representative images of control or eRPN10 plants in AY-WB phytoplasma infection assays. The lateral shoots are circled.
- AtRPNIO Arabidopsis thaliana RPN10 (Uniprot ID: P55034); SIRPN10, Solanum lycopersicum RPN10 (A0A3Q7F6N7); OsRPNIO, Oryza sativa RPN10 (082143); ZmRPNIO, Zea mays RPN10 (B6TK61); DmRPNIO, Drosophila melanogaster RPN10 (P55035); HsRPNIO, Homo sapiens RPN10 (Q5VWC4); BtRPNIO, Bemisia tabaci RPN10 (XP_018915695); MqRPNIO, Macrosteles quadrilineatus RPN10; MpRPNIO, Myzus persicae RPN10 (XP_022181722.1).
- b Sequence alignment of the A. thaliana RPN10 and the M. quadrilineatus RPN10 proteins. The vWA domains and UIM domains are highlighted in red
- Figure 6 shows an engineered RPN10 allele rescues the developmental defects of the rpn10-2 mutant.
- the rpn10-2 mutant was complemented by either a wild-type AtRPNIO allele (cRPNIO) or an engineered RPN10 allele (AtRPNIO ml, eRPNIO) under the control of the native RPN10 promoter. At least two independent lines for each complementation were obtained, with consistent plant phenotype.
- Figure 7 shows an alignment of SAP05 homologs from various phytoplasmas.
- Figure 8 shows the alignment of the conserved vWA domain from representative plant species. The first 118 residues of the vWA domain is shown. The position corresponding to the engineered sites in AtvWA domain are highlighted.
- Figure 9 shows target sequences around substitution sites of AtRPNIO gene that can be used for CRISPR. The substitution sites are highlighted in red box.
- Figure 10 shows an alignment of RPN10 sequences.
- nucleic acid As used herein, the words “nucleic acid”, “nucleic acid sequence”, “nucleotide”, “nucleic acid molecule” or “polynucleotide” are intended to include DNA molecules (e.g., cDNA or genomic DNA), RNA molecules (e.g., mRNA), natural occurring, mutated, synthetic DNA or RNA molecules, and analogs of the DNA or RNA generated using nucleotide analogs. It can be single-stranded or double-stranded. Such nucleic acids or polynucleotides include, but are not limited to, coding sequences of structural genes, anti-sense sequences, and non-coding regulatory sequences that do not encode mRNAs or protein products.
- genes may include introns and exons as in the genomic sequence, or may comprise only a coding sequence as in cDNAs, and/or may include cDNAs in combination with regulatory sequences.
- polypeptide and “protein” are used interchangeably herein and refer to amino acids in a polymeric form of any length, linked together by peptide bonds.
- a “genetically altered plant” or “mutant plant” is a plant that has been genetically altered compared to the naturally occurring wild type (WT) plant.
- a mutant plant is a plant that has been altered compared to the naturally occurring wild type (WT) plant using a mutagenesis method, such as any of the mutagenesis methods described herein.
- the mutagenesis method is targeted genome modification or genome editing.
- the plant genome has been altered compared to wild type sequences using a mutagenesis method.
- Such plants have an altered phenotype as described herein, such as an increased resistance to a vector-borne pathogen.
- increased resistance to a vector-borne pathogen is conferred by the presence of an altered plant genome, for example, a mutated endogenous RPN10 gene.
- the endogenous gene is specifically targeted using targeted genome modification and the presence of a mutated gene is not conferred by the presence of transgenes expressed in the plant.
- the genetically altered plant can be described as transgene- free.
- the aspects of the invention involve recombination DNA technology and exclude embodiments that are solely based on generating plants by traditional breeding methods.
- a method of providing resistance or increasing resistance of a host to a vector-borne pathogen comprising: a. identifying at least one host target that is the target of at least one pathogen effector; b. identifying at least one homologue of the host target in the vector; c. comparing the nucleic acid or protein sequence of the host target and vector homologue and identifying one or more sequence differences in the nucleic acid or protein sequence between the host and vector nucleic acid or protein sequence; and d. introducing said one or more differences in nucleic acid or protein sequence of the vector into the host target; wherein introduction of one or more of the differences provides resistance or increases resistance to the vector-borne pathogen.
- the pathogen may be any animal pathogen, such as a human, animal or plant pathogen.
- the pathogen is a plant pathogen.
- the pathogen may be a virus, parasite or bacteria.
- the bacteria may be a xylem-limited vector borne bacteria or a phloem-limited vector borne bacteria.
- xylem-limited vector borne bacteria include bacteria from the class Gammaproteobacteria, such as X.fastidiosa.
- Examples of phloem-limited vector borne bacteria include Spiroplasmas, Phytoplasmas (from the class Mollicutes) and Liberibacters (from the class Alphaproteobacteria).
- the pathogen is bacteria, preferably phytoplasma.
- the phytoplasma is selected from Aster yellows, including Aster Yellow strain Witches Broom (AY-WB) and other yellows diseases caused by andidatus Phytoplasma asteris; Peanut witches’-broom; X-disease group; Coconut-lethal yellows; Elm yellows; Clover proliferation group; Ash yellows; Loofah witches’-broom; Pigeon pea witches’-broom; Apple proliferation group; Rice yellow dwarf; Stolbur group; Mexican periwinkle virescence; Bermuda grass white leaf; Italian bindweed stolbur group; Buckthorn witches’; Spartium witches’-broom; Italian alfalfa witches’ broom and Cirsium phyllody.
- Aster Yellow strain Witches Broom AY-WB
- Peanut witches’-broom X-
- Further examples include, pine witches’-broom, Lethal yellowing (LY); grapevine yellows phytoplasmas; bois noir phytoplasm, flavescence doree phytoplasma, Candidatus phytoplasma solani that infect tomato, potato and other solanaceous crops and Maize redness disease phytoplasma, clover and strawberry phytoplasmas, rice yellow dwarf phytoplasma, rice orange leaf phytoplasma, maize bushy stunt phytoplasma, lettuce phyllody phytoplasma, Peanut witches’ broom phytoplasma, Witches broom disease of lime phytoplasma, Rapeseed phytoplasma, pear decline phytoplasma, European stonefruit phytoplasma, and the Apple proliferation phytoplasma.
- pathogen effector is meant the or one of the proteins secreted by the pathogen into the cells of the host.
- the function of the pathogen effector is to help the pathogen invade host tissue, modulate host processes, supress the host immune system (or host immune response to the pathogen and its arthropod vectors) or otherwise help the pathogen to survive.
- These effector molecules may be small proteins that typically function through the manipulation of plant immune responses, pathogen self-defence or liberation of nutrients from host tissues.
- the effectors may also comprise other types of microbially secreted molecules, such as secondary metabolites, small RNAs, messenger RNAs and long non-coding RNAs.
- an effector protein can be predicted based on protein sequence similarities. Examples of pathogen effectors include but are not limited to the below examples. In one example, where the pathogen is X.fastidiosa, the effector molecule is selected from RpfC, FimA, FimF, HxfA,
- the effector molecule is a secreted AY-WB protein, such as, but not limited to SAP21 , SAP05, SAP06, SAP19,
- SAP68 SAP11 , SAP09, SAP08, SAP30, SAP50, SAP69, SAP70, SAP34, SAP71 ,
- SAP35 SAP15, SAP13, SAP20, SAP72, SAP37, SAP01 , SAP02, SAP73, SAP74,
- SAP67 and SAP76 or a homologous effector molecule in another phytoplasma.
- the effector molecule is Amp, TENGLI, Phyllogen, P38, HfIB and VmpA.
- the effector molecule is P58, SARP1 , Spiralin and P32.
- the effector molecule is SC2_gpO95.
- RNA targets any molecule that interacts with or binds to the pathogen effector.
- the target may be any host protein or nucleic acid, such as DNA or RNA.
- RNA targets are small RNAs, mRNA transcripts and IncRNAs.
- DNA targets include genes and promoters.
- the host target of the pathogen effector can be easily identified using routine methods in the art, such as protein-protein interaction assays, including yeast two-hybrid screens.
- Other methods of identifying a host target include analysing effector structure, in vivo expression patterns and/or localisation patterns and/or the target’s biochemical activities.
- the host may be an animal or plant. “Providing resistance or increasing resistance” of the host to the vector-borne pathogen” can be determined by measuring pathogen growth on the host. For example, a host may be considered resistant or the resistance of a host may be considered increased if the growth of the pathogen on the host is abolished or reduced compared to growth on a control or wild-type host. Alternatively, resistance may be measured by determining a reduction or abolition of a symptom or phenotype associated with the pathogen infection. Again, such a reduction or abolition may be in comparison to the symptom or phenotype of a control or wild-type host.
- the vector is meant any vector for a pathogen.
- the vector may be an arthropod, such as an insect or other invertebrate vector.
- the vector may be a mosquito, aquatic snail, lice, midge, sandfly, tick, fly, flea, triatomine bug, louse, mite or tsetse fly.
- the vector is a hemipteran insect. More preferably, the insect is selected from Psylloidea, Aleyrodoidea, Coccoidea, Aphidoidea, Fulgoroidea, Cicadoidea, Cercopodidea, Membracoidea, Coleorrhyncha and Heteroptera.
- the vector is a microbial vector, a fungi or plasmodia.
- the one or more difference is a difference in the nucleic acid sequence and/or the amino acid sequence of the vector and host.
- the vector may contain one or more additional or different nucleic acids or amino acids compared to the host.
- the vector may lack one or more nucleic acids or amino acids compared to the host.
- introducing the one or more differences preferably means introducing one or more mutations into the host nucleic acid or amino acid sequence such that the host contains the same nucleic acid or amino acid sequence or part of the same sequence as the vector homologue.
- the mutation may be introduced using any mutagenesis technique.
- CRISPR may be used to introduce the one or more mutation.
- the method may comprise identifying one or more domains in the host target protein that binds the pathogen effector and identifying one or more difference in nucleic acid and/or amino acid sequence between the host and vector in this domain.
- the method may further comprise introducing only the difference between the host and vector in this domain into the host.
- the method may comprise selectively mutating only the domain in the host target protein that binds the pathogen effector.
- sequence homologues can be used based on their sequence homology to the host sequence. There are predictors in the art that can be used to identify such sequences. Topology of the sequences and the characteristic domains structure can also be considered when identifying and isolating homologs. Sequences may be isolated based on their sequence identity to the entire sequence or to fragments thereof. In hybridization techniques, all or part of a known nucleotide sequence is used as a probe that selectively hybridizes to other corresponding nucleotide sequences present in a population of cloned genomic DNA fragments or cDNA fragments (i.e. , genomic or cDNA libraries) from a chosen plant.
- the hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labelled with a detectable group, or any other detectable marker.
- Methods for preparation of probes for hybridization and for construction of cDNA and genomic libraries are generally known in the art and are disclosed in Sambrook, et al., (1989) Molecular Cloning: A Library Manual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, New York).
- a method of producing an organism that has resistance or increased resistance to a vector-borne pathogen comprising a. identifying at least one host protein that is the target of at least one pathogen effector; b. identifying at least one homologue of the host target protein in the vector; c. comparing the nucleic acid or protein sequence of the host target and vector homologue and identifying one or more sequence differences in the nucleic acid or protein sequence between the host and vector nucleic acid or protein sequence; and d. introducing said one or more differences in nucleic acid or protein sequence of the vector into at least one cell of the organism; wherein introduction of one or more of the differences provides resistance or increases resistance to the vector-borne pathogen; and e. regenerating at least one organism from the cell or cells.
- the organism may be a plant or animal. Where the organism is an animal it may not be a human. There is also provided the organism obtained or obtainable from the abovedescribed method. In a further aspect of the invention, there is provided a method of providing or increasing biotic stress tolerance or resistance (such terms may be used interchangeably) in a plant, the method comprising introducing at least one mutation into at least one RPN10 gene.
- biotic stress refers to harmful effects caused by another (living) organism.
- the organism is a plant pathogen, and in a more preferable embodiment, the pathogen is a vector-borne pathogen.
- the pathogen is bacteria, preferably phytoplasma, as defined above.
- the phytoplasma is Aster Yellow strain Witches Broom (AY-WB) .
- the method also provides or increases resistance to the vector.
- the method provides or increases biotic stress resistance, where the biotic stress is caused by both a vector and the vector-borne pathogen.
- the vector is an insect.
- the vector can be another invertebrate or microbe. More preferably the vector is a leafhopper, planthopper or psyllid.
- the insect is preferably M. quadrilineatus or another Macrosteles species.
- the insect may be selected from Dalbulus species, Scaphoideus titanus, Hishimonas phycitis, Circulifer tenellus, Circulifer haematoceps, Cacopsylla crataegi, Cacopsylla mali, Ctenarytaina spatulata, Ctenarytaina eucalypti, Cacopsylla pyri, Cacopsylla pruni, Hyalesthes obsoletus, Reptalus noahi, Reptalus panzeri and Myndus crudus.
- “By at least one mutation” is meant that where the RPN10 gene is present as more than one copy or homoeologue (with the same or slightly different sequence) there is at least one mutation in at least one gene. Preferably all genes are mutated.
- an “increase” in resistance or tolerance to the vector-borne pathogen, such as phytoplasma may be characterised by a reversal or reduction in the developmental effects of infection, such as the phyllody and/or the excessive proliferation of axillary shoots. Any of the above can be determined using standard techniques in the art. As such, an increase in resistance may be determined by a qualitative improvement in phenotype. Alternatively, an effect on plant development may be quantified by measuring one or more of leaf number, bolting, number of lateral shoots, plant height, level of chlorosis or other discolorations of the plant/leaves, timing of onset of developmental stages, seed and fruit production and/or level of viable progeny.
- an increase in resistance may be quantified as an increase in one or more of these characteristics, for example, an increase of at least 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 30%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% in comparison to a control plant.
- RPN10 is a subunit of the 26S proteasome that recognises polyubiquitinated proteins.
- RPN10 may also be known as 26S proteasome non-ATPase regulatory subunit 4 homolog, 26S proteasome regulatory subunit RPN10, 26S proteasome regulatory subunit S5A homolog and Multiubiquitin chain-binding protein 1.
- RPN10 is characterised by an N-terminal von Willebrand factor type A domain (vWA) and a C-terminal domain containing Ubiquitin-interacting motifs (UM).
- vWA von Willebrand factor type A domain
- UM Ubiquitin-interacting motifs
- SAP05 is highly conserved among different phytoplasma.
- mutation of the vWA domain prevents the interaction with SAP05 and consequent degradation of the SAP05 targets, GATAs and SPLs.
- the method comprises introducing at least one mutation into at least one endogenous RPN10 gene.
- the mutation abolishes or reduces the binding of SAP05 to RPN10.
- the method may involve introducing more two or three mutations into the RPN10 gene.
- an ’endogenous’ nucleic acid or gene may refer to the native or natural sequence in the plant genome.
- the endogenous nucleic acid sequence encodes a RPN10 amino acid sequence as defined in SEQ ID NO: 18 or a functional variant or homologue thereof.
- the nucleic acid sequence comprises or consists of a nucleic acid sequence selected from SEQ ID NO: 1 or a functional variant or homologue thereof.
- variant refers to a variant gene sequence or part of the gene sequence which retains the biological function of the full non-variant sequence.
- a functional variant also comprises a variant of the gene of interest, which has sequence alterations that do not affect function, for example in non-conserved residues.
- variant that is substantially identical, i.e. has only some sequence variations, for example in non-conserved residues, compared to the wild type sequences as shown herein and is biologically active.
- a codon for the amino acid alanine, a hydrophobic amino acid may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine.
- a codon encoding another less hydrophobic residue such as glycine
- a more hydrophobic residue such as valine, leucine, or isoleucine.
- changes which result in substitution of one negatively charged residue for another such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product.
- a “variant” or a “functional variant” has at least 25%, 26%, 27%, 28%, 29%, 30%, 31 %, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41 %, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51 %,
- homolog also designates a RPN10 gene orthologue from other plant species.
- a homolog may have, in increasing order of preference, at least 50%,
- the homolog has an amino acid sequence selected from SEQ ID Nos 19 to 34 or a variant thereof. In a further embodiment, the homolog has a nucleic acid sequence selected from SEQ ID Nos 2 to 17 or a variant thereof.
- the RPN10 protein is characterised by an N-terminal von Willebrand factor type A domain (vWA).
- vWA domain comprises or consists of the following amino acid sequence:
- the RPN10 homologue comprises a vWA domain as defined in SEQ ID NO:47 or a variant thereof as defined above. As shown in Figure 8, the vWA domain is highly conserved in different plants.
- Suitable homologues can be identified by sequence comparisons and identifications of conserved domains as described above. There are predictors in the art that can be used to identify such sequences. The function of the homologue can be identified as described herein and a skilled person would thus be able to confirm the function, for example when overexpressed in a plant.
- Hybridization of such sequences may be carried out under stringent conditions.
- stringent conditions or “stringent hybridization conditions” is intended conditions.
- stringent conditions will be those in which the salt concentration is less than about 1.5 M Na ion, typically about 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30°C for short probes (e.g., 10 to 50 nucleotides) and at least about 60°C for long probes (e.g., greater than 50 nucleotides).
- Duration of hybridization is generally less than about 24 hours, usually about 4 to 12 hours.
- Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide.
- a method of increasing resistance of a host to a vector-borne pathogen comprising introducing at least one mutation into a RPN10 gene, wherein the RPN10 gene comprises or consists of a. a nucleic acid sequence encoding a polypeptide comprising at least one vWA domain as defined in SEQ ID NO: 47 or a variant thereof; b. a nucleic acid sequence encoding a polypeptide as defined in one of SEQ ID Nos 18 to 34; or c. a nucleic acid sequence as defined in one of SEQ ID Nos 1 to 17; or d.
- nucleic acid sequence with at least 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or at least 99% overall sequence identity to either (a) or (c); or e. a nucleic acid sequence encoding a RPN10 polypeptide as defined herein that is capable of hybridising under stringent conditions as defined herein to the nucleic acid sequence of any of (a) to (d).
- the mutation that is introduced into the endogenous RPN10 gene thereof may be selected from the following mutation types
- a "missense mutation” which is a change in the nucleic acid sequence that results in the substitution of an amino acid for another amino acid
- a "nonsense mutation” or "STOP codon mutation” which is a change in the nucleic acid sequence that results in the introduction of a premature STOP codon and, thus, the termination of translation (resulting in a truncated protein); plant genes contain the translation stop codons "TGA” (UGA in RNA), "TAA” (UAA in RNA) and “TAG” (UAG in RNA); thus any nucleotide substitution, insertion, deletion which results in one of these codons to be in the mature mRNA being translated (in the reading frame) will terminate translation.
- a "frameshift mutation” resulting in the nucleic acid sequence being translated in a different frame downstream of the mutation.
- a frameshift mutation can have various causes, such as the insertion, deletion or duplication of one or more nucleotides.
- a “splice site” mutation which is a mutation that results in the insertion, deletion or substitution of a nucleotide at the site of splicing.
- the mutation is a loss of function mutation. In a further preferred embodiment, the mutation is a substitution and/or deletion.
- the mutation may be introduced into the N-terminal vWA (von Willebrand factor type A) domain of RPN10.
- N-terminal vWA von Willebrand factor type A domain of RPN10.
- at least one mutation may be introduced into the N-terminal vWA domain as defined in SEQ ID NO:47.
- the mutation is selected from one or both of the following mutations: a substitution at positions 38 and 39 of SEQ ID NO: 18 or a homologous position thereof; and/or a substitution at positions 56 to 58 of SEQ ID NO: 18 or a homologous position thereof.
- the mutation is selected from a GA to HS substitution at positions 38 and 39 of SEQ ID NO: 18 or a homologous position thereof; and/or a GKG to K substitution at positions 56 to 58 of SEQ ID NO: 18 or a homologous position thereof.
- the mutation is a GA to HS substitution at positions 38 and 39 of SEQ ID NO: 18 or a homologous position thereof.
- Homologous positions can be easily determined using techniques in the art.
- to identify the homologous positions shown in SEQ ID NO: 19 to 34 and 2 to 17 we first downloaded the homologous nucleotide and aa sequences from NCBI by BLAST using the sequence of AtRPNIO CDNA or aa as the query. Then we used the online too Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) to align either the nucleotide or aa sequences and to identify the homologous positions.
- the mutation is at the following homologous position is selected from
- the mutation is introduced using targeted genome editing. That is, in one embodiment, the invention relates to a method and plant that has been generated by genetic engineering methods as described above, and does not encompass naturally occurring varieties or generating plants by traditional breeding methods.
- Targeted genome modification or targeted genome editing is a genome engineering technique that uses targeted DNA double-strand breaks (DSBs) to stimulate genome editing through homologous recombination (HR)-mediated recombination events.
- DSBs targeted DNA double-strand breaks
- HR homologous recombination
- the genome editing method that is used according to the various aspects of the invention is CRISPR.
- Type II CRISPR is one of the most well characterized systems and carries out targeted DNA double-strand breaks in four sequential steps.
- the mature crRNA:tracrRNA complex directs Cas9 to the target DNA via Watson-Crick base-pairing between the spacer on the crRNA and the protospacer on the target DNA next to the protospacer adjacent motif (PAM), an additional requirement for target recognition.
- Cas9 mediates cleavage of target DNA to create a double-stranded break within the protospacer.
- CRISPR-Cas9 compared to conventional gene targeting and other programmable endonucleases is the ease of multiplexing, where multiple genes can be mutated simultaneously simply by using multiple sgRNAs each targeting a different gene.
- the intervening section can be deleted or inverted (Wiles et al., 2015).
- Cas9 is thus the hallmark protein of the type II CRISPR-Cas system, and is a large monomeric DNA nuclease guided to a DNA target sequence adjacent to the PAM (protospacer adjacent motif) sequence motif by a complex of two noncoding RNAs: CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA).
- the Cas9 protein contains two nuclease domains homologous to RuvC and HNH nucleases.
- the HNH nuclease domain cleaves the complementary DNA strand whereas the RuvC-like domain cleaves the non-complementary strand and, as a result, a blunt cut is introduced in the target DNA.
- sgRNA can introduce site-specific double strand breaks (DSBs) into genomic DNA of live cells from various organisms.
- DSBs site-specific double strand breaks
- codon optimized versions of Cas9 which is originally from the bacterium Streptococcus pyogenes, have been used.
- the single guide RNA is the second component of the CRISPR/Cas system that forms a complex with the Cas9 nuclease.
- sgRNA is a synthetic RNA chimera created by fusing crRNA with tracrRNA.
- the sgRNA guide sequence located at its 5’ end confers DNA target specificity. Therefore, by modifying the guide sequence, it is possible to create sgRNAs with different target specificities.
- the canonical length of the guide sequence is 20 bp.
- sgRNAs have been expressed using plant RNA polymerase III promoters, such as U6 and U3. Accordingly, using techniques known in the art, such as http://chopchop.cbu.uib.no/ it is possible to design sgRNA molecules that targets a RPN10 gene sequence as described herein.
- Figure 9 shows 6 possible CRISPR target sites that can be used for CRISPR followed by homology directed repair to introduce one or more mutations into AtRPNIO.
- nucleic acid construct comprising a nucleic acid sequence encoding a sgRNA molecule, wherein the sgRNA molecule targets a nucleic acid sequence in RPN10 selected from SEQ ID NO: 35, 37, 39, 41 , 43 or 45 or a variant thereof.
- nucleic acid sequence comprises or consists of SEQ ID NO: 36, 38, 40, 42, 44 or 46 or a variant thereof.
- sgRNA single-guide RNA
- sgRNA single-guide RNA
- sgRNA single-guide RNA
- gRNA single-guide RNA
- the sgRNA or gRNA provide both targeting specificity and scaffolding/binding ability for a Cas nuclease.
- a gRNA may refer to a dual RNA molecule comprising a crRNA molecule and a tracrRNA molecule.
- the nucleic acid sequence encoding a sgRNA molecule is operable linked to a regulatory sequence, such as a plant promoter.
- a suitable plant promoter may be a constitutive or strong promoter or may be a tissue-specific promoter.
- suitable plant promoters are selected from, but not limited to, oestrum yellow leaf curling virus (CmYLCV) promoter or switchgrass ubiquitin 1 promoter (Pvllbil), wheat U6 RNA polymerase III (Tall6), CaMV35S, wheat U6 or maize ubiquitin (e.g. Ubi1) promoters.
- the nucleic acid construct of the present invention may also further comprise a nucleic acid sequence that encodes a CRISPR enzyme.
- CRISPR enzyme is meant an RNA- guided DNA endonuclease that can associate with the CRISPR system. Specifically, such an enzyme binds to the tracrRNA sequence.
- the CRIPSR enzyme is a Cas protein (“CRISPR associated protein), preferably Cas 9 or Cpf1 , more preferably Cas9.
- the Cas9 enzyme may be modified as described below. In a specific embodiment Cas9 is codon-optimised Cas9.
- the CRISPR enzyme is a protein from the family of Class 2 candidate x proteins, such as C2c1 , C2C2 and/or C2c3.
- the Cas protein is from Streptococcus pyogenes.
- the Cas protein may be from any one of Staphylococcus aureus, Neisseria meningitides, Streptococcus thermophiles or Treponema denticola.
- the CRISPR enzyme is operably linked to a regulatory sequence - either the same or a different regulatory sequence as for the sgRNA sequence. Again, suitable regulatory sequences are described above.
- Cas9 and sgRNA may be combined or in separate expression vectors (or nucleic acid constructs, such terms are used interchangeably).
- an isolated plant cell is transfected with a single nucleic acid construct comprising both sgRNA and a CRISPR enzyme as described in detail above.
- an isolated plant cell is transfected with two nucleic acid constructs, a first nucleic acid construct comprising at least one sgRNA as defined above and a second nucleic acid construct comprising a CRISPR enzyme or a functional variant or homolog thereof.
- the second nucleic acid construct may be transfected below, after or concurrently with the first nucleic acid construct.
- the advantage of a separate, second construct comprising a CRISPR enzyme is that the nucleic acid construct encoding at least one sgRNA can be paired with any type of CRISPR enzyme, as described herein, and therefore is not limited to a single CRISPR enzyme function (as would be the case when both the CRISPR enzyme and sgRNA are encoded on the same nucleic acid construct).
- the nucleic acid construct comprising a CRISPR enzyme is transfected first and is stably incorporated into the genome, before the second transfection with a nucleic acid construct comprising at least one sgRNA nucleic acid.
- a plant or part thereof or at least one isolated plant cell is transfected with mRNA encoding a CRISPR enzyme and co-transfected with at least one nucleic acid construct as defined herein.
- sgRNA molecule expressed from the nucleic acid construct described above.
- sgRNA can be used with a modified Cas9 protein, such as nickase Cas9 or nCas9 or a “dead” Cas9 (dCas9) fused to a “Base Editor” - such as an enzyme, for example a deaminase such as cytidine deaminase, or TadA (tRNA adenosine deaminase) or ADAR or APOBEC. These enzymes are able to substitute one base for another. As a result no DNA is deleted, but a single substitution is made (Kim et al., 2017; Gaudelli et al. 2017).
- the method may use sgRNA together with a template or donor DNA constructs, to introduce a targeted SNP or mutation, in particular one of the substitutions described herein, into a RPN10 gene.
- introduction of a template DNA strand following a sgRNA-mediated snip in the double-stranded DNA, can be used to produce a specific targeted mutation (i.e. a SNP) in the gene using homology directed repair.
- GGAGCC coding amino acids G and A at positions 112 to 117 of SEQ ID NO:1
- Plants obtained or obtainable and seeds obtained or obtainable from such plants by such method which carry a functional mutation in the endogenous RPN10 gene are also within the scope of the invention.
- the progeny plant is stably transformed with the CRISPR constructs, and comprises the exogenous polynucleotide which is heritably maintained in the plant cell.
- the method may include steps to verify that the construct is stably integrated.
- the method may also comprise the additional step of collecting seeds from the selected progeny plant.
- the method may further comprise at least one or more of the steps of assessing the phenotype of the genetically altered plant, specifically, measuring or assessing an increase in resistance to a vector-borne pathogen (such as a bacteria), wherein preferably said increase is relative to a control or wild-type plant.
- CRISPR constructs nucleic acid constructs
- the CRISPR constructs may be used to introduce at least one mutation into the vWA domain, wherein the mutation prevents or reduces binding of SAP05 to RPN10.
- a method of preventing binding of a pathogen effector molecule to its host target comprising introducing and expressing a CRISPR construct as described above or introducing a sgRNA molecule expressed by the construct into a plant.
- a genetically altered plant, part thereof or plant cell characterised in that the plant has increased resistance to at least one vector-borne pathogen.
- the plant comprises at least one mutation in the RPN10 gene.
- the mutation is a substitution and/or deletion, and even more preferably, the mutation is the N-terminal vWA domain as described above.
- the mutation has been introduced using targeted genome editing, again as described above.
- a method of making a genetically altered plant wherein the plant is characterised by increased resistance to a vector borne pathogen, the method comprising introducing at least one mutation into at least one RPN10 gene.
- the method comprises a. selecting a part of the plant; b. transfecting at least one cell of the part of the plant of paragraph (a) with at least one CRISPR construct or sgRNA molecule, wherein the CRISPR construct or sgRNA molecule targets the RPN 10 gene and introduces at least one mutation into the RPN 10 gene as described above; c. regenerating at least one plant derived from the transfected cell or cells; d. selecting one or more plants obtained according to paragraph (c) that show at least one mutation in the RPN10 gene, preferably in the N-terminal vWA domain of the RPN10 gene .
- the method may comprises obtaining a DNA sample from a transformed plant and carrying out DNA amplification to detect the at least one mutation in the RPN10 gene.
- the method may further comprise at least one or more of the steps of assessing the phenotype of the genetically altered plant, measuring at least one of resistance or increased resistance to a vector-borne pathogen, such as phytoplasma.
- the method may involve the step of screening the plants for the desired phenotype.
- Transformation methods for generating a genetically altered plant of the invention are known in the art.
- a CRISPR construct as defined herein is introduced into a plant and expressed as a transgene.
- the construct is introduced into said plant through a process called transformation.
- transformation or transformation as referred to herein encompass the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer.
- Plant tissue capable of subsequent clonal propagation, whether by organogenesis or embryogenesis may be transformed with a genetic construct of the present invention and a whole plant regenerated therefrom.
- tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem).
- the CRISPR construct may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host genome.
- the resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art.
- Transformation of plants is now a routine technique in many species.
- any of several transformation methods may be used to introduce a CRISPR construct into a suitable ancestor cell.
- the methods described for the transformation and regeneration of plants from plant tissues or plant cells may be utilized for transient or for stable transformation. Transformation methods include the use of liposomes, electroporation, chemicals that increase free DNA uptake, injection of the DNA directly into the plant, particle gun bombardment, transformation using viruses or pollen and microinjection. Methods may be selected from the calcium/polyethylene glycol method for protoplasts, electroporation of protoplasts, microinjection into plant material, DNA or RNA-coated particle bombardment, infection with (non-integrative) viruses and the like.
- Transgenic plants, including transgenic crop plants are preferably produced via Agrobacterium tumefaciens mediated transformation.
- the plant material obtained in the transformation is subjected to selective conditions so that transformed plants can be distinguished from untransformed plants.
- the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying.
- a further possibility is growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants.
- the transformed plants are screened for the presence of a selectable marker.
- the generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques.
- a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques.
- the generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion).
- the method may further comprise regenerating a genetically altered plant from the plant or plant cell wherein the genetically altered plant comprises in its genome at least one mutation in a RPN10 gene as described above, and obtaining a progeny plant derived from the transgenic plant, wherein said progeny exhibits at least one mutation in a RPN10 gene as described and shows an increase in resistance to vector-borne pathogens, such as phytoplasma.
- the methods comprise generating stable T2 plants preferably homozygous for the mutation (that is a mutation in at least one RPN10 gene sequence).
- a genetically altered plant of the present invention may also be obtained by transference of any of the sequences of the invention by crossing, e.g., using pollen of the genetically altered plant described herein to pollinate a wild-type or control plant, or pollinating the gynoecia of plants described herein with other pollen that is not genetically altered as described herein.
- the methods for obtaining the plant of the invention are not exclusively limited to those described in this paragraph; for example, genetic transformation of germ cells from the ear of wheat could also be carried out as mentioned, but without having to regenerate a plant afterwards.
- a plant according to all aspects of the invention described herein may be a monocot or a dicot plant.
- the plant is a crop plant.
- crop plant is meant any plant which is grown on a commercial scale for human or animal consumption or use.
- the plant is Arabidopsis.
- the plant is a vascular plant.
- the plant is a crop plant.
- the plant is any plant infected or capable of being infected by phytoplasma.
- the plant may be selected from a brassicas, legumes, cereals, citrus, root vegetables, tuber and rhizome crops, fruits including berries and soft fruits and fruit, nut and seed bearing trees.
- the plant may be selected from Acer negundo (box elder), Achyranthes aspera (devil's horsewhip), Aconitum napellus (aconite monkshood), Adenium obesum, Allium ampeloprasum (wild leek), Allium cepa (onion), Allium sativum (garlic), Alstroemeria (Inca lily), Amaranthus (amaranth), Amaranthus hypochondriacus, Ambrosia artemisiifolia (common ragweed), Ammi majus (Bishop's-weed), Ampelopsis brevipedunculata (Amur amelopsis), Anemone coronaria (Poppy anemone), Anethum graveolens (dill), Apium graveolens (celery), Asparagus officinalis (asparagus), Avena sativa (oats), Bellis perennis (com
- Brassica oleracea napus (rape), Brassica oleracea (cabbages, cauliflowers), Brassica oleracea var. capitata (cabbage), Brassica oleracea var. italica (broccoli), Brassica rapa subsp.
- rapa (turnip), Bromus inermis (Awnless brome), Bunias orientalis (Turkish warty-cabbage), Bupleurum falcatum, Cajanus cajan (pigeon pea), Calendula officinalis (Pot marigold), Callistephus chinensis (China aster), Camelina sativa, Cannabis sativa (hemp), Capsicum annuum (bell pepper), Carica papaya (pawpaw), Carthamus tinctorius (safflower), Catharanthus roseus (Madagascar periwinkle), Celosia argentea (celosia), Celtis australis (European nettle wood), Chrysanthemum coronarium (garland chrysanthemum), Chrysanthemum frutescens (marguerite), Chrysanthemum morifolium (chrysanthemum (florists')), Cirsium arven
- the plant is selected from rice, maize, wheat, barley, sorghum, potato, tomato, cotton, soybean, Brassicas, such as B.napus, cabbage, lettuce, carrot, coconut, papaya, oil palms, grape, apple, oranges, sugarcane, citrus (such as lime, citrus, orange, grapefruit), egg plant, elm, ash, willow, elm, Dogwood, hydrangea, cyclamen, mulberry, poplar, cactus, anemone, olive, Paulownia species, pecan, walnut, alder, jujube, pigeon pea, hazel, sugar cane, bermuda grass, oat, buckthorn, cirsium, sesame, alfalfa, pea, plantain, birch, cassava, peanut, loofah, cocoa, date or date palm, sweet potato, lettuce, chrysanthemum, pointsettia, sunflower, flox, hort
- plant as used herein encompasses whole plants, ancestors and progeny of the plants and plant parts, including seeds, fruit, shoots, stems, leaves, roots (including tubers), flowers, tissues and organs, wherein each of the aforementioned carry at least one of the herein described mutations.
- plant also encompasses plant cells, suspension cultures, callus tissue, embryos, meristematic regions, gametophytes, sporophytes, pollen and microspores, again wherein each of the aforementioned comprises the mutations as described herein.
- the invention also extends to harvestable parts of a plant of the invention as described herein, but not limited to seeds, leaves, fruits, flowers, stems, roots, rhizomes, tubers and bulbs.
- the aspects of the invention also extend to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins.
- products derived preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins.
- the plant part or harvestable product is a seed or grain. Therefore, in a further aspect of the invention, there is provided a seed or grain produced from a genetically altered plant as described herein. Accordingly, in one aspect of the invention there is provided seed, wherein the seed contains one more of the genetic alterations described herein - specifically, the seed comprises one or more mutations in RPN10. Also provided is progeny plant obtained from the seed as well as seed obtained from that progeny.
- the plant part is pollen, a propagule or progeny of the genetically altered plant described herein. Accordingly, in a further aspect of the invention there is provided pollen, a propagule or progeny produced from a genetically altered plant as described herein.
- a control plant as used herein according to all of the aspects of the invention is a plant which has not been modified according to the methods of the invention. Accordingly, in one embodiment, the control plant does not have one of the mutations in RPN10 described herein. In one embodiment, the control plant is a wild type plant. The control plant is typically of the same plant species, preferably having the same genetic background as the modified plant.
- Phytoplasmas often depend on insect vectors for transmission and spread. In addition to inducing developmental phenotypes, phytoplasma virulence factors increase plant susceptibility to their insect vectors.
- SAP05 affects A. thaliana susceptibility to the most important insect vector of AY-WB phytoplasma, the leafhopper Macrosteles quadrilineatus.
- SAP05 interacted with several A. thaliana zinc-finger transcription factors, specifically GATAs and SPLs, in a yeast two-hybrid (Y2H) screen against an A. thaliana seedling library (Fig. 2a).
- GATAs and SPLs were successfully cloned and shown to interact with SAP05 in Y2H assays (Fig 2b), indicating that SAP05 most likely binds all members of both families.
- SPLs regulate plant developmental phase transitions, and most are developmentally regulated by microRNA156 (miR156), whereas GATA proteins regulate photosynthetic processes, leaf development and flower organ development.
- miR156 microRNA156
- GATA proteins regulate photosynthetic processes, leaf development and flower organ development.
- thaliana 26S proteasome subunit RPN10 was identified as a potential SAP05 interactor in the Y2H screen. RPN10 is located within the 19S regulatory particle of the proteasome and serves as one of the main ubiquitin receptors recruiting ubiquitinated proteins for proteasomal degradation.
- the GATA and SPL transcription factor families evolved independently, though both have zinc-finger (ZnF) DNA-binding domains.
- ZnF domain of the GATA family contains one C4-type zinc-binding site of approximately 50 residues and is conserved among plants, animals and fungi, whereas that of SPL proteins is approximately 80 amino acids, contains two zinc-binding sites of the C2HC and the C3H types and is specific to plants (Fig. 2a). Nevertheless, the ZnF domains of SPLs and GATAs are both sufficient to mediate SAP05 binding in Y2H experiments (Fig. 2b).
- RPN10 is one of the primary ubiquitin receptor proteins in eukaryotes.
- RPN10 has two main domains, an N-terminal vWA (von Willebrand factor type A) domain required for RPN10 docking to the proteasome and a C-terminal half with ubiquitin-interacting motifs (UIM) involved in binding to ubiquitin chains that are attached to lysine residues of proteins directed to the proteasome for degradation (Fig. 2d).
- UIM ubiquitin-interacting motifs
- SAP05 interacted with the vWA domain but not the UIM domain of A. thaliana RPN10 (Fig. 2e).
- GATA18 and GATA19 proteins in which all lysines were replaced by arginines were also degraded in an SAP05-dependent manner (Fig. 2g).
- Example III SAP05 degrades GATAs and SPLs in planta
- thaliana SPL5 under the control of the 35S promoter; and (iii) miR156-resistant forms of SPL11 and SPL13 (rSPL11 and rSPI13, respectively) fused with a p-glucuronidase (GUS) under the control of their native promoter.
- GUS p-glucuronidase
- Example IV Insect-guided plant resistance to SAP05
- GATA transcription factors have multiple roles in humans and animals, including the regulation of processes related to immunity.
- SAP05 expression has been detected in phytoplasma-colonised insects.
- M. quadrilineatus RPN10 which is highly similar in sequence to A. thaliana RPN10 (AtRPNIO) (Fig. 4a and Fig. 6).
- SAP05 did not bind MqRPNIO, its vWA domain or a hybrid RPN10 (hRPNIO) consisting of the M. quadrilineatus vWA domain and the A. thaliana C-terminal (UIM) domain (Fig. 4b).
- hRPNIO hybrid RPN10
- UAM A. thaliana C-terminal
- thaliana rpn10-2 protoplasts showed that GATA18 was less degraded in the presence of MqRPNIO, hRPNIO and RPN10 ml compared to AtRPNIO (Fig. 4c), indicating that the AtRPNIO vWA domain, and particularly the GA residues that are unique to plant versus animal RPN10 proteins, are involved in the SAP05-mediated degradation of plant GATA18. Therefore, by replacing those residues with those in the same locations in the animal proteins, we were able to engineer A. thaliana RPN10 to become more resistant to SAP05 binding and degradation.
- Plant resistance to pathogens may be achieved by knocking out effector targets or susceptibility genes. Knocking out multiple GATA and SPL proteins in plants is tedious and can cause pleiotropic phenotypes.
- RPN10 has an essential function in A. thaliana, and rpn10 null mutants have pleotropic phenotypes, including severe growth defects.
- eRPNIO transforming the A. thaliana RPN10 mutant rpn10-2 with the SAP05 non-interacting allele AtRPNIO ml under the control of the native RPN10 promoter to create rpn10-2 AtRPN10::AtRPN10 ml plants, hereafter called eRPNIO (A.
- thaliana engineered RPN10 for short, rescued the developmental defects of the rpn10-2 plants, producing a phenotype similar to that erf rpn10-2 complemented with wild-type A.
- thaliana RPN10 rpn10-2 AtRPN10::AtRPN10, hereafter cRPNIO, for RPN10 complementation
- cRPNIO for RPN10 complementation
- the RPN10_39GA40->HS mutation confers resistance to phytoplasma-SAP05-mediated developmental changes in A. thaliana.
- the phytoplasma insect vector M. quadrilineatus did not show a reproduction preference for 35S::SAP05 eRPNIO versus eRPNIO plants, unlike for 35S::SAP05 cRPNIO versus cRPNIO plants (Fig. 4f) and 35S::SAP05 versus GFP plants (Fig. 1 h), indicating that RPN10_39GA40->HS also confers resistance to SAP05-mediated plant susceptibility to the phytoplasma insect vector M. quadrilineatus.
- the AY-WB phytoplasma secretes an arsenal of virulence factors, among which only TENGLI, SAP11 , SAP54, and herein SAP05, have been functionally investigated.
- SAP05 To investigate the contribution of SAP05 to symptom development due to AY-WB phytoplasma infection in A. thaliana, we infected wild-type, cRPNIO and eRPNIO plants with AY-WB phytoplasma.
- the infected wild-type and cRPNIO plants produced large quantities of small, deformed leaves and more lateral shoots compared to plants of similar age not infected with phytoplasma (Fig. 4g, h).
- the symptoms of these infected plants resembled the phenotypes of 35S::SAP05 plants (Fig.
- eRPNIO A. thaliana infected with phytoplasma did not produce severely deformed leaves or more lateral shoots as compared to the non-infected plants (Fig. 4g, h).
- All AY-WB-infected A. thaliana genotypes produced leaflike flowers that resemble the phyllody symptoms of AY-WB-infected plants, indicating that the engineered RPN10 allele does not interfere with the leaf-like flower phenotype induced by the AY-WB phytoplasma effector SAP54.
- SAP05 protein levels may be altered by gene knockout and RNA silencing
- some systems require the direct targeting of proteins for degradation.
- targeted protein degradation has become one of the most promising approaches for drug discovery in targeted therapies.
- Current approaches to changing protein abundance in cells rely on substrate ubiquitination: for example, the proteolysis-targeting chimera (PROTAC) technique uses small-molecule ligands that create complexes between E3 ligases and targets, a process that can be challenging.
- PROTAC proteolysis-targeting chimera
- Our study of phytoplasma effectors has revealed an alternative approach whereby bridging targets directly onto proteasome subunits, such as RPN10, results in efficient protein degradation.
- This strategy of engineering targets to become resistant to effector modulation may be used to engineer resistance to the effectors of other pathogens.
- effectors of more specialised pathogens may not have evolved to avoid modulation of targets within organisms that they do not colonise.
- Insect-transmitted pathogens have mechanisms to differentially modulate primary host versus insect vector processes: for instance, liberibacters and phytoplasmas differentially regulate effector gene expression depending whether they colonise plants or insect vectors.
- liberibacters and phytoplasmas differentially regulate effector gene expression depending whether they colonise plants or insect vectors.
- effectors appear to avoid binding targets in certain hosts.
- Such effectors may also be present in other multihost pathogen systems, including insect-transmitted pathogens, such as B. burgdorferi, Y. pestis and Liberibacter spp., exposing an Achilles heel of multi-host pathogens that can be exploited to achieve resistance.
- A. thaliana Columbia-0 ecotype (Col-0) plants were grown in the greenhouse under either long-day (16 h light/8 h dark) or short-day conditions (10 h light/8 h dark) at 22°C.
- To generate 35S::SAP05 or AtSUC2::SAP05 plants a codon-optimised SAP05 coding sequence without the secretory signal peptide was used.
- Transgenic plants were generated as previously described.
- the initial Y2H screen of SAP05 against the A. thaliana seedling library was performed by Hybrigenics Services SAS (Paris, France).
- the coding sequence of SAP05 without the secretory signal peptide was cloned into a pB27 bait plasmid as a C-terminal fusion to the LexA domain).
- the prey library was constructed from an A. thaliana seedling cDNA library, with pP6 as the prey plasmid.
- the same SAP05 sequence was cloned into the pDEST32 plasmid and screened against an A. thaliana transcription factor library (pDEST22-TF). The identified interactions were further confirmed using the Matchmaker Gold yeast two-hybrid system (Clontech) or the DUALhybrid system (Dualsystems Biotech).
- A. thaliana (Col-0) mesophyll protoplast isolation and transformation were carried out according to the methods of Yoo et al.. Briefly, mesophyll protoplasts were isolated from leaves of 4-5-week-old A. thaliana plants grown under short-day conditions. For transfection, 300 pl of fresh protoplast solution (120,000 protoplasts) was transformed with 24 pg of high-quality plasmids (12 pg each for co-transfection) using the PEG- calcium method. Transfected protoplasts were incubated at room temperature (22-25 °C) for 16 h in the dark before harvest. For MG132 treatment, a final concentration of 20 pM was used during the 16-h incubation period.
- Antibody to SAP05 from AY-WB phytoplasma were raised to the mature part of the SAP05 protein (residues 33-135), which was produced with a 6XHis-tag into Escherichia coli and purified.
- the purified protein was used for raising polyclonal antibodies in rabbits (Genscript).
- Optimal detection of SAP05 in phytoplasma-infected plants occured at a 1 :2,000 dilution of the antibody, and this dilution was used in all western blot experiments for detection of SAP05.
- the OptimAb HA.11 monoclonal antibody (Eurogentec) was used to detect hemagglutinin (HA)-fusion proteins at the concentration of 0.5 pg/ml.
- Rabbit polyclonal anti-GFP antibody (Santa Cruz Biotechnology) was used at a 1 :10,000 dilution. Protein loading was visualised using Amido black staining solution (Sigma).
- the aster leafhopper M. quadrilineatus was reared on oats under long-day conditions at 22 °C.
- A. thaliana plants used for insect fecundity assays were grown on insecticide-free F2 compost soil (Levington) in 8 x 8 cm pots under short-day conditions for 4 weeks.
- For choice fecundity assay three control plants and three experiment plants, placed in an alternating manner, were bagged together in a perforated bag. Twenty leafhoppers (10 females and 10 males) were released into the bag for 5 d and removed. The plants were then bagged individually and the nymphs that developed on each plant were scored 2-3 weeks after leafhopper removal. The experiments were repeated at least three times.
- no-choice fecundity assays For no-choice fecundity assays, the plants were bagged individually from the beginning. Ten leafhoppers (six females and four males) were kept on each plant for 5 d and removed. The number of nymphs produced on each plant was scored 2-3 weeks after leafhopper removal. For each genotype, at least three plants were used in no-choice fecundity assays.
- M. quadrilineatus colonies carrying the AY-WB phytoplasma were reared on infected lettuce and china aster under long-day conditions at 24 °C.
- A. thaliana inoculation one leaf from a 4-week-old plant grown under short-day conditions was exposed to two or three leafhoppers from this colony in a clip cage for 2 d. The leaf and the clip cage were then removed to get rid of the insects. The plants were then transfer to either short- day or long-day conditions for recording of disease symptoms.
- the RAD23 family provides an essential connection between the 26S proteasome and ubiquitylated proteins in Arabidopsis.
- Underlined bases are mutation/substitution positions in the cDNA sequence that lead to a 39-40 GA to HS mutation in the amino acid sequence of AtRPNIO or a homologous mutation at a homologous position in a homologous sequence (homologous mutations are underlined).
- SEQ ID NO: 8 >XM_015776829.2 Oryza sativa Japonica Group 26S proteasome non- ATPase regulatory subunit 4 homolog (LOC4332222) ATGGTGCTCGAGGCGACGATGATCTGCATAGACAACTCGGAGTGGATGCGGAAC
- SEQ ID NO: 17 >TraesCS4D02G2279004D [Triticum aestivum]
- Underlined bases are mutation/substitution positions in the amino acid sequence that lead to a 38-39 GA to HS mutation in the amino acid sequence of AtRPNIO or a homologous mutation at a homologous position in a homologous sequence.
- SEQ ID NO: 26 >XP_025876377.1 26S proteasome non-ATPase regulatory subunit 4 homolog [Oryza sativa Japonica Group] MVLELEATVICVDDSEWMRNGDYPPTRLQAQEDAANLWGTKMTSNPENTVGVLAM AGDRVRVLLAPTSDPVKFLACMHGLEASGEANLTATLNIAELVLKNRPDKRLSQRIVVF
- SEQ ID NO: 34 >TraesCS4D02G2279004D [Triticum aestivum]
- Target_2 CGAATCCGGAGAATACGGTGGGG
- SEQ ID NO: 36 Protospacer sequence: CGAATCCGGAGAATACGGTG
- Target_4 TATGTATCGACAACTCCGAGTGG
- SEQ ID NO: 38 Protospacer sequence: TATGTATCGACAACTCCGAG
- Target_9 TATCGACACGATGGTTCTCGAGG
- SEQ ID NO: 40 Protospacer sequence: TATCGACACGATGGTTCTCG
- SEQ ID NO: 42 Protospacer sequence: CTGGGCGATCTGGATAGCTG
- SEQ ID NO: 44 Protospacer sequence: ATCTCCGTTTCGCATCCACT
- Target_21 TTTTCAGGCCTTGATGTGGGAGG
- SEQ ID NO: 46 Protospacer sequence: TTTTCAGGCCTTGATGTGGG
- SEQ ID NO: 48 SAP05 amino acid sequence >SAP05_AYWB MFKIKNNLLKSKIFVFILLGLFVIINNHQAMAAPNEEFVGDMRIVNVNLSNIDILKKHETFK KYFDFTLTGPRYNGNIAEFAMIWKIKNPPLNLLGVFFDDGTRDDEDDKYILEELKQIGN GAKNMYIFWQYEQK SEQ ID NO: 49 SAP05 cDNA sequence >SAP05_AYWB
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Environmental Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The invention relates to methods of engineering a host to become resistant or increase the resistance of a host to a vector-borne pathogen. In one example, there is a provided a method of engineering a plant to become resistant to phytoplasma.
Description
Modulating plant responses to activities of pathogen virulence factors
FIELD OF THE INVENTION
The invention relates to methods of engineering a host to become resistant or increase the resistance of a host to a vector-borne pathogen. In one example, there is provided a method of engineering a plant to become resistant to phytoplasma.
BACKGROUND OF THE INVENTION
Vector-borne diseases account for more than 17% of all infectious diseases and cause more than 700,000 deaths annually. They can be caused by parasites, bacteria or viruses. In humans, ticks and fleas are responsible for the spread of Borrelia burgdorferi, the agent of Lyme disease, and Yersinia pestis, the agent of bubonic and pneumonic plague, respectively. Other notable examples include malaria, which is a parasitic infection transmitted by Anopheline mosquitoes, which causes an estimated 219 million cases globally, and results in more than 400,000 deaths every year. Other viral diseases transmitted by vectors include chikungunya fever, Zika virus fever, yellow fever, West Nile fever, Japanese encephalitis (all transmitted by mosquitoes), tick-borne encephalitis (transmitted by ticks). Vector-borne diseases also include Chagas disease (transmitted by triatomine bugs), leishmaniasis (sandflies) and schistosomiasis (snails) affect hundreds of millions of people worldwide.
In plants, sap-feeding insects that feed from the plant vasculature, such as leafhoppers, froghoppers and psyllids, transmit a plethora of plant viruses and the plant pathogenic bacteria Xylella fastidiosa, Liberibacter species and phytoplasmas that have destroyed major crop productions and spread worldwide. These bacteria produce effectors, which are translocated to hosts to modulate specific host processes, such as immune responses, and promote bacterial colonisation. Bacterial effectors that influence processes within humans, vertebrate animals and plants have been functionally described. However, no mechanisms of host resistance to these vector-borne pathogens are known.
Phytoplasmas are obligate insect-vectored plant pathogens that are invasive colonisers of both plants (Kingdom Plantae) and insect vectors (Kingdom Animalia). These bacteria
belong to a large group in the class Mollicutes that also includes human and animal mycoplasma pathogens and that are characterised by small cells enveloped in a single membrane, the absence of cell walls and small genomes. Phytoplasmas often replicate intracellularly and colonise most tissues of their insect vectors with colonisation of salivary glands being required for pathogen inoculation into the plant vasculature. In plants, phytoplasmas migrate throughout the plant within the phloem sieve cells of the vascular system and often induce massive changes in plant architecture, such as the retrograde development of flowers into leaf-like organs (phyllody) and excessive proliferation of axillary shoots (witches’ brooms). Multiple candidate phytoplasma effectors have been identified in the genomes of phytoplasma, but to date the plant targets of only a few of these effectors have been functionally characterised. These include SAP11 and homologous effectors that bind and destabilise plant transcription factors of the TCP family, resulting in changes in stem proliferation and leaf shape, and SAP54/phyllogens that bind and degrade MADS-box transcription factors, leading to the induction of leaf-like flowers. SAP11 and SAP54 also promote plant susceptibility to phytoplasma insect vectors, a phenotype that likely aids phytoplasma dispersal. SAP11 and SAP54 target plant-specific proteins, and hence are unlikely to modulate similar processes in both plant and insect vectors.
There is a need therefore to increase the resistance of a host, such as a plant or animal to a vector-borne pathogen. In a specific example, there is the need to increase resistance of plants to phytoplasma pathogens. The present invention addresses these needs.
SUMMARY OF THE INVENTION
We have functionally characterised the phytoplasma effector SAP05. This effector interacted with plant proteins that are highly conserved among organisms, including arthropods, and induced extensive architectural changes in plants, but did not interact with homologous targets of insects. Using insect-guided engineering, we modified the plant to become resistant to manipulation by the bacterial effector and become less susceptible to the insect vector. Our work reveals a new strategy for engineering resistance against insect-vectored plant diseases that is applicable to other vector-borne or multi-host vector-borne pathogen systems.
In one aspect of the invention there is provided a method of providing resistance or increasing resistance of a host to a vector-borne pathogen, the method comprising: a. identifying at least one host protein that is the target of at least one pathogen effector; b. identifying at least one homologue of the host target protein in the vector; c. comparing the nucleic acid or protein sequence of the host target and vector homologue and identifying one or more differences in the nucleic acid or protein sequence between the host and vector nucleic acid or protein sequence; and d. introducing said one or more differences in nucleic acid or protein sequence into the host target protein; wherein introduction of one or more of the differences increases resistance to the vector-borne pathogen.
In another aspect of the invention, there is provided a genetically altered plant, part thereof or plant cell, wherein the plant comprises at least one mutation in at least one RPN10 gene.
Preferably, the mutation is a loss of function mutation. More preferably, the mutation is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof.
In one embodiment, the mutation is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence. Preferably, the mutation is a substitution.
In another aspect of the invention, there is provided a seed obtained or obtainable from the plant of the invention.
In another aspect of the invention, there is provided a method of increasing resistance of a plant to vector-borne pathogen, the method comprising introducing at least one mutation into at least one RPN10 gene. Preferably, the method comprises increasing the resistance of a plant.
In another aspect of the invention, there is provided a method of producing a plant with increased resistance to a vector borne pathogen, the method comprising introducing at least one mutation into at least one RPN10 gene.
In one embodiment, the vector-borne pathogen is a bacteria, preferably a phytoplasma.
In one embodiment, the mutation is a loss of function mutation. Preferably, the mutation is a mutation is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof. More preferably, the mutation is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence. Preferably, the mutation is a substitution.
In one embodiment, the mutation is introduced using targeted genome editing.
In one embodiment, the genetically altered plant is a monocot or dicot. Preferably, the plant is selected from rice, maize, wheat, barley, sorghum, potato, tomato, cotton, soybean, Brassica napus, cabbage, lettuce, carrot, asters, coconut, grape, apple, oranges and sugarcane. Preferably, the plant part is a seed.
In another aspect of the invention, there is provided a method for identifying and/or selecting a plant that will have increased resistance to phytoplasma infection, the method comprising detecting in the plant or plant germplasm at least one polymorphism in the RPN10 gene. Preferably, the polymorphism prevents binding of a phytoplasma effector protein, wherein preferably the phytoplasma effector protein is SAP05. More preferably, the polymorphism is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof.
In one embodiment, the polymorphism is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence.
DESCRIPTION OF THE FIGURES
The invention is further described in the following non-limiting figures:
Figure 1 shows that the phytoplasma effector SAP05 induces developmental changes in A. thaliana. a-c, Representative phenotypes of plants stably producing SAP05 or GFP (control). Plants were grown under short-day (SD) conditions, and images were obtained at 4 weeks (a), 7 weeks (b) and 10 weeks (c) after germination. Arrowheads in a indicate leaf serrations of GFP plants as opposed to the smoother leaf edges of SAP05 plants. Scale bars, 1 cm. Insets in c show enlarged images of mature flowers with the same magnification, d-g, Statistic analyses of phenotypes shown in a-c: numbers of rosette leaves of 4-week-old plants (d) and time of shoot emergence from rosettes (bolting time; e), number of shoots emerging from rosettes (lateral shoot number; f) and plant height (g) of 10-week-old plants. Each data point (black or red dots) represents one transgenic line and the columns showing the means ± s.d. of these data points. DAG, day after germination. *, P < 0.05, two-tailed unpaired Student’s t-tests. h, Percentage of M. quadrilineatus nymphs produced in choice fecundity assays between GFP- and SAP05- expressing plants (two independent lines of the latter were tested). Data are mean ± s.d. from three independent biological replicates; *, P < 0.05, /2 test.
Figure 2 shows SAP05 degrades plant GATA and SPL transcription factors via the plant 26S proteasomal ubiquitin receptor RPN10. a, Locations of the zinc-finger (ZnF) domains in representative proteins of the A. thaliana (At) GATA and SPL transcription factor families. SBP, SQUAMOSA promoter-binding protein. Red and yellow dots indicate cysteine and histidine residues, respectively, b, SAP05 interacts with AtGATAs and SPLs via their ZnF domains in yeast. EV, empty vector control. AD, GAL4-activation domain. BD, GAL4-DNA binding domain. Yeast transformed with AD and BD constructs grew on medium lacking leucine and tryptophan (-L-W) and growth on medium lacking leucine, tryptophan, histidine and alanine (-L-W-H-A) indicates positive interactions, c, Western blot analysis of SAP05-mediated degradation of GATA and SPL proteins in A. thaliana protoplasts. GFP, control; HA, hemagglutinin tag; rSPL, miR156-resistant form. Numbers at left indicate markers in kilodaltons, d, Domain localisation of A. thaliana RPN10. vWA, von Willebrand factor type A domain; UIM, ubiquitin-interacting motifs, e, SAP05 interacts with AtRPNIO via its vWA domain in yeast. N-ter and C-ter refer to the N and C termini, respectively, f-k, Western blot analysis of SAP05 degradation assays in either rpn10-2 (f) or wild type (g-k) A. thaliana protoplasts. SAP05-mediated degradation of targets is dependent on AtRPNIO (f) and independent of the presence of lysines in targets (g). K->R, all lysines replaced by arginines (g). In h-k, ‘tail’ represents
an unstructured region that serves as an initiation site for proteasomal degradation. (a,d) Numbers below indicate amino acid positions. (c,f-k) Red dots at left of bands indicate expected protein sizes. (I) shows that the 26S proteasome inhibitor MG132 suppresses SAP05-mediated protein destabilisation. Western blot analysis of protein degradation assays with or without 20 pM MG132 in A. thaliana protoplasts. Dots indicate protein bands of correct size.
Fig. 3 shows SAP05 degrades SPL and GATA transcription factors in whole plants, a- d, SAP05 suppresses plant phenotypes caused by the overexpression of various SPL or GATA members; shown are plant phenotypes (a) and quantitative analyses of leaf serrations (b), rosette leaf numbers (c) and shoot lengths (d). OE, overexpression; x, cross of two lines; rSPL, miR156-resistant form. In a, arrowheads indicate leaf serrations, and arrow a flowering stem; scale bars, 1 cm. Each data point (black or red dot) represents one transgenic line, and the columns show means ± s.d. of these data points. *, P < 0.05, two-tailed unpaired Student’s t-tests. e-f, SPLs (SPL11, e, and SPL13, f) are degraded in plants infected with AY-WB phytoplasma. Black arrows indicate blue GUS staining of non-infected plants that is strongly reduced in AY-WB- infected plants.
Figure 4 shows insect-directed engineering of A. thaliana RPN10 confers SAP05 resistance, a, Domain organisation of A. thaliana and M. quadrilineatus RPN10 proteins and alignment of the first 70 residues of plant and animal RPN10 vWA domains. Highly divergent residues are highlighted below. For full-length alignments of RPN10, see Fig. 6. b, SAP05 does not interact with RPN10 of the phytoplasma leafhopper vector (Mq) or with the specific AtRPNIO mutants hRPN10, RPN10 ml and m2 (see a) in yeast, whereas AtRAD23 (control) does, c, Western blot analysis of SAP05-mediated AtGATA18 degradation upon the expression of various RPN10 variants in A. thaliana rpn10-2 protoplasts. GFP, control. The UIM domains were mutated in hRPN10 uim. d,e, SAP05 induces witches’-broom-like phenotypes in rpn10-2 plants complemented with wild-type AtRPNIO, but not with AtRPNIO ml . Data are mean ± s.d. f, Percentage of M. quadrilineatus nymphs produced in choice fecundity assays. Data are mean ± s.d. from 3 independent experiments, g, Representative images of control or eRPN10 plants in AY-WB phytoplasma infection assays. The lateral shoots are circled. Scale bars, 1 cm. h, Statistical analysis of lateral shoot formation during AY-WB phytoplasma infection. Data are mean ± s.d. from 2 independent experiments. *, P < 0.05, two-tailed unpaired Student’s t-tests (e,h) and /2 test (f).
Figure 5 shows that RPN10 homologues are conserved among plants and animals, a, Phylogenetic analysis of RPN10 proteins from various organisms. The presence of vWA and UIM domains were predicted by PFAM. AtRPNIO, Arabidopsis thaliana RPN10 (Uniprot ID: P55034); SIRPN10, Solanum lycopersicum RPN10 (A0A3Q7F6N7); OsRPNIO, Oryza sativa RPN10 (082143); ZmRPNIO, Zea mays RPN10 (B6TK61); DmRPNIO, Drosophila melanogaster RPN10 (P55035); HsRPNIO, Homo sapiens RPN10 (Q5VWC4); BtRPNIO, Bemisia tabaci RPN10 (XP_018915695); MqRPNIO, Macrosteles quadrilineatus RPN10; MpRPNIO, Myzus persicae RPN10 (XP_022181722.1). b, Sequence alignment of the A. thaliana RPN10 and the M. quadrilineatus RPN10 proteins. The vWA domains and UIM domains are highlighted in red and blue, respectively.
Figure 6 shows an engineered RPN10 allele rescues the developmental defects of the rpn10-2 mutant. The rpn10-2 mutant was complemented by either a wild-type AtRPNIO allele (cRPNIO) or an engineered RPN10 allele (AtRPNIO ml, eRPNIO) under the control of the native RPN10 promoter. At least two independent lines for each complementation were obtained, with consistent plant phenotype.
Figure 7 shows an alignment of SAP05 homologs from various phytoplasmas.
Figure 8 shows the alignment of the conserved vWA domain from representative plant species. The first 118 residues of the vWA domain is shown. The position corresponding to the engineered sites in AtvWA domain are highlighted.
Figure 9 shows target sequences around substitution sites of AtRPNIO gene that can be used for CRISPR. The substitution sites are highlighted in red box.
Figure 10 shows an alignment of RPN10 sequences.
DETAILED DESCRIPTION OF THE INVENTION
The present invention will now be further described. In the following passages, different aspects of the invention are defined in more detail. Each aspect so defined may be combined with any other aspect or aspects unless clearly indicated to the contrary. In
particular, any feature indicated as being preferred or advantageous may be combined with any other feature or features indicated as being preferred or advantageous.
The practice of the present invention will employ, unless otherwise indicated, conventional techniques of botany, microbiology, tissue culture, molecular biology, chemistry, biochemistry and recombinant DNA technology, bioinformatics, which are within the skill of the art. Such techniques are explained fully in the literature.
As used herein, the words "nucleic acid", "nucleic acid sequence", "nucleotide", "nucleic acid molecule" or "polynucleotide" are intended to include DNA molecules (e.g., cDNA or genomic DNA), RNA molecules (e.g., mRNA), natural occurring, mutated, synthetic DNA or RNA molecules, and analogs of the DNA or RNA generated using nucleotide analogs. It can be single-stranded or double-stranded. Such nucleic acids or polynucleotides include, but are not limited to, coding sequences of structural genes, anti-sense sequences, and non-coding regulatory sequences that do not encode mRNAs or protein products. These terms also encompass a gene. The term "gene" or “gene sequence" is used broadly to refer to a DNA nucleic acid associated with a biological function. Thus, genes may include introns and exons as in the genomic sequence, or may comprise only a coding sequence as in cDNAs, and/or may include cDNAs in combination with regulatory sequences.
The terms "polypeptide" and "protein" are used interchangeably herein and refer to amino acids in a polymeric form of any length, linked together by peptide bonds.
For the purposes of the invention, a “genetically altered plant" or “mutant plant” is a plant that has been genetically altered compared to the naturally occurring wild type (WT) plant. In one embodiment, a mutant plant is a plant that has been altered compared to the naturally occurring wild type (WT) plant using a mutagenesis method, such as any of the mutagenesis methods described herein. In one embodiment, the mutagenesis method is targeted genome modification or genome editing. In one embodiment, the plant genome has been altered compared to wild type sequences using a mutagenesis method. Such plants have an altered phenotype as described herein, such as an increased resistance to a vector-borne pathogen. Therefore, in this example, increased resistance to a vector-borne pathogen is conferred by the presence of an altered plant genome, for example, a mutated endogenous RPN10 gene. In one embodiment, the
endogenous gene is specifically targeted using targeted genome modification and the presence of a mutated gene is not conferred by the presence of transgenes expressed in the plant. In other words, the genetically altered plant can be described as transgene- free.
The aspects of the invention involve recombination DNA technology and exclude embodiments that are solely based on generating plants by traditional breeding methods.
It is well documented that pathogens produce effectors that modify specific processes in the host. Here we have identified that the phytoplasma effector protein, SAP05, interacts with plant proteins to cause developmental defects. Interestingly we have further found that the same effector did not interact with the homologous protein in the phytoplasma- colonised insects (i.e. the vector for phytoplasma). Analysis of the amino acid sequence between the insect vector and plant host revealed a number of amino acid differences, and that these differences in amino acid sequence prevented binding of SAP05 to the insect homologue. The ability of phytoplasma to selectively target only its host is key to its successful vector-mediated transmission. As such, our work reveals a new strategy by which vector-borne pathogens selectively target hosts without causing pathology to its vector. This strategy can thus be used to engineer hosts - or the host targets - and confer resistance of the host to the vector-borne pathogen.
Accordingly, in one aspect of the invention, there is provided a method of providing resistance or increasing resistance of a host to a vector-borne pathogen, the method comprising: a. identifying at least one host target that is the target of at least one pathogen effector; b. identifying at least one homologue of the host target in the vector; c. comparing the nucleic acid or protein sequence of the host target and vector homologue and identifying one or more sequence differences in the nucleic acid or protein sequence between the host and vector nucleic acid or protein sequence; and d. introducing said one or more differences in nucleic acid or protein sequence of the vector into the host target; wherein introduction of one or more of the differences provides resistance or increases resistance to the vector-borne pathogen.
The pathogen may be any animal pathogen, such as a human, animal or plant pathogen. Preferably, the pathogen is a plant pathogen. In one embodiment, the pathogen may be a virus, parasite or bacteria. Where the plant pathogen is a bacteria, the bacteria may be a xylem-limited vector borne bacteria or a phloem-limited vector borne bacteria. Examples of xylem-limited vector borne bacteria include bacteria from the class Gammaproteobacteria, such as X.fastidiosa. Examples of phloem-limited vector borne bacteria include Spiroplasmas, Phytoplasmas (from the class Mollicutes) and Liberibacters (from the class Alphaproteobacteria).
Most preferably, the pathogen is bacteria, preferably phytoplasma. In one example, the phytoplasma is selected from Aster yellows, including Aster Yellow strain Witches Broom (AY-WB) and other yellows diseases caused by andidatus Phytoplasma asteris; Peanut witches’-broom; X-disease group; Coconut-lethal yellows; Elm yellows; Clover proliferation group; Ash yellows; Loofah witches’-broom; Pigeon pea witches’-broom; Apple proliferation group; Rice yellow dwarf; Stolbur group; Mexican periwinkle virescence; Bermuda grass white leaf; Italian bindweed stolbur group; Buckthorn witches’; Spartium witches’-broom; Italian alfalfa witches’ broom and Cirsium phyllody.
Further examples include, pine witches’-broom, Lethal yellowing (LY); grapevine yellows phytoplasmas; bois noir phytoplasm, flavescence doree phytoplasma, Candidatus phytoplasma solani that infect tomato, potato and other solanaceous crops and Maize redness disease phytoplasma, clover and strawberry phytoplasmas, rice yellow dwarf phytoplasma, rice orange leaf phytoplasma, maize bushy stunt phytoplasma, lettuce phyllody phytoplasma, Peanut witches’ broom phytoplasma, Witches broom disease of lime phytoplasma, Rapeseed phytoplasma, pear decline phytoplasma, European stonefruit phytoplasma, and the Apple proliferation phytoplasma.
By “pathogen effector” is meant the or one of the proteins secreted by the pathogen into the cells of the host. The function of the pathogen effector is to help the pathogen invade host tissue, modulate host processes, supress the host immune system (or host immune response to the pathogen and its arthropod vectors) or otherwise help the pathogen to survive. These effector molecules may be small proteins that typically function through the manipulation of plant immune responses, pathogen self-defence or liberation of nutrients from host tissues. The effectors may also comprise other types of microbially
secreted molecules, such as secondary metabolites, small RNAs, messenger RNAs and long non-coding RNAs. Once a pathogen genome has been sequenced, an effector protein can be predicted based on protein sequence similarities. Examples of pathogen effectors include but are not limited to the below examples. In one example, where the pathogen is X.fastidiosa, the effector molecule is selected from RpfC, FimA, FimF, HxfA,
HxfB, PglA, -1 ,4 endoglucanases, Xylanases, Xylosidases, LesA and O-antigen in LPS. In another embodiment, where the pathogen is a Phytoplasma, the effector molecule is a secreted AY-WB protein, such as, but not limited to SAP21 , SAP05, SAP06, SAP19,
SAP27, SAP59, SAP26, SAP25, SAP60, SAP61 , SAP36, SAP55, SAP39, SAP54,
SAP53, SAP62, SAP40, SAP41 , SAP63, SAP42, SAP43, SAP52, SAP64, SAP22,
SAP44, SAP45, SAP51 , SAP65, SAP49, SAP48, SAP47, SAP66, SAP56, SAP67,
SAP68, SAP11 , SAP09, SAP08, SAP30, SAP50, SAP69, SAP70, SAP34, SAP71 ,
SAP35, SAP15, SAP13, SAP20, SAP72, SAP37, SAP01 , SAP02, SAP73, SAP74,
SAP67 and SAP76 or a homologous effector molecule in another phytoplasma.
Alternatively, the effector molecule is Amp, TENGLI, Phyllogen, P38, HfIB and VmpA. In another embodiment, where the pathogen is a Spiroplasma, the effector molecule is P58, SARP1 , Spiralin and P32. In another embodiment, where the pathogen is a Liberibacter, the effector molecule is SC2_gpO95.
By “host target” is meant any molecule that interacts with or binds to the pathogen effector. The target may be any host protein or nucleic acid, such as DNA or RNA. Examples of RNA targets are small RNAs, mRNA transcripts and IncRNAs. Examples of DNA targets include genes and promoters.
Once a pathogen effector has been identified, the host target of the pathogen effector can be easily identified using routine methods in the art, such as protein-protein interaction assays, including yeast two-hybrid screens. Other methods of identifying a host target include analysing effector structure, in vivo expression patterns and/or localisation patterns and/or the target’s biochemical activities.
The host may be an animal or plant. “Providing resistance or increasing resistance” of the host to the vector-borne pathogen can be determined by measuring pathogen growth on the host. For example, a host may be considered resistant or the resistance of a host may be considered increased if the growth of the pathogen on the host is abolished or
reduced compared to growth on a control or wild-type host. Alternatively, resistance may be measured by determining a reduction or abolition of a symptom or phenotype associated with the pathogen infection. Again, such a reduction or abolition may be in comparison to the symptom or phenotype of a control or wild-type host.
By “vector” is meant any vector for a pathogen. In one embodiment, the vector may be an arthropod, such as an insect or other invertebrate vector. For example, the vector may be a mosquito, aquatic snail, lice, midge, sandfly, tick, fly, flea, triatomine bug, louse, mite or tsetse fly. In one embodiment, the vector is a hemipteran insect. More preferably, the insect is selected from Psylloidea, Aleyrodoidea, Coccoidea, Aphidoidea, Fulgoroidea, Cicadoidea, Cercopodidea, Membracoidea, Coleorrhyncha and Heteroptera. In another embodiment, the vector is a microbial vector, a fungi or plasmodia.
In one embodiment, the one or more difference is a difference in the nucleic acid sequence and/or the amino acid sequence of the vector and host. For example, the vector may contain one or more additional or different nucleic acids or amino acids compared to the host. Alternatively, the vector may lack one or more nucleic acids or amino acids compared to the host. By introducing the one or more differences preferably means introducing one or more mutations into the host nucleic acid or amino acid sequence such that the host contains the same nucleic acid or amino acid sequence or part of the same sequence as the vector homologue. The mutation may be introduced using any mutagenesis technique. In a preferred embodiment, CRISPR may be used to introduce the one or more mutation.
In one embodiment, the method may comprise identifying one or more domains in the host target protein that binds the pathogen effector and identifying one or more difference in nucleic acid and/or amino acid sequence between the host and vector in this domain. The method may further comprise introducing only the difference between the host and vector in this domain into the host. In other words, the method may comprise selectively mutating only the domain in the host target protein that binds the pathogen effector.
To identify a vector homologue, methods such as PCR, hybridization, and the like can be used based on their sequence homology to the host sequence. There are predictors in the art that can be used to identify such sequences. Topology of the sequences and
the characteristic domains structure can also be considered when identifying and isolating homologs. Sequences may be isolated based on their sequence identity to the entire sequence or to fragments thereof. In hybridization techniques, all or part of a known nucleotide sequence is used as a probe that selectively hybridizes to other corresponding nucleotide sequences present in a population of cloned genomic DNA fragments or cDNA fragments (i.e. , genomic or cDNA libraries) from a chosen plant. The hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labelled with a detectable group, or any other detectable marker. Methods for preparation of probes for hybridization and for construction of cDNA and genomic libraries are generally known in the art and are disclosed in Sambrook, et al., (1989) Molecular Cloning: A Library Manual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, New York).
In another aspect of the invention, there is provided a method of producing an organism that has resistance or increased resistance to a vector-borne pathogen, the method comprising a. identifying at least one host protein that is the target of at least one pathogen effector; b. identifying at least one homologue of the host target protein in the vector; c. comparing the nucleic acid or protein sequence of the host target and vector homologue and identifying one or more sequence differences in the nucleic acid or protein sequence between the host and vector nucleic acid or protein sequence; and d. introducing said one or more differences in nucleic acid or protein sequence of the vector into at least one cell of the organism; wherein introduction of one or more of the differences provides resistance or increases resistance to the vector-borne pathogen; and e. regenerating at least one organism from the cell or cells.
The organism may be a plant or animal. Where the organism is an animal it may not be a human. There is also provided the organism obtained or obtainable from the abovedescribed method.
In a further aspect of the invention, there is provided a method of providing or increasing biotic stress tolerance or resistance (such terms may be used interchangeably) in a plant, the method comprising introducing at least one mutation into at least one RPN10 gene.
As used herein, “biotic stress" refers to harmful effects caused by another (living) organism. In one embodiment, the organism is a plant pathogen, and in a more preferable embodiment, the pathogen is a vector-borne pathogen. Most preferably, the pathogen is bacteria, preferably phytoplasma, as defined above. In one example, the phytoplasma is Aster Yellow strain Witches Broom (AY-WB) .In a further embodiment, where the pathogen is a vector-borne pathogen, the method also provides or increases resistance to the vector. In other words, the method provides or increases biotic stress resistance, where the biotic stress is caused by both a vector and the vector-borne pathogen. Preferably, the vector is an insect. Alternatively, the vector can be another invertebrate or microbe. More preferably the vector is a leafhopper, planthopper or psyllid. In one example the insect is preferably M. quadrilineatus or another Macrosteles species. In a further example, the insect may be selected from Dalbulus species, Scaphoideus titanus, Hishimonas phycitis, Circulifer tenellus, Circulifer haematoceps, Cacopsylla crataegi, Cacopsylla mali, Ctenarytaina spatulata, Ctenarytaina eucalypti, Cacopsylla pyri, Cacopsylla pruni, Hyalesthes obsoletus, Reptalus noahi, Reptalus panzeri and Myndus crudus.
“By at least one mutation” is meant that where the RPN10 gene is present as more than one copy or homoeologue (with the same or slightly different sequence) there is at least one mutation in at least one gene. Preferably all genes are mutated.
In one embodiment, an “increase" in resistance or tolerance to the vector-borne pathogen, such as phytoplasma, may be characterised by a reversal or reduction in the developmental effects of infection, such as the phyllody and/or the excessive proliferation of axillary shoots. Any of the above can be determined using standard techniques in the art. As such, an increase in resistance may be determined by a qualitative improvement in phenotype. Alternatively, an effect on plant development may be quantified by measuring one or more of leaf number, bolting, number of lateral shoots, plant height, level of chlorosis or other discolorations of the plant/leaves, timing of onset of developmental stages, seed and fruit production and/or level of viable progeny. In this embodiment, an increase in resistance may be quantified as an increase in one or more
of these characteristics, for example, an increase of at least 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 30%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% in comparison to a control plant.
RPN10 is a subunit of the 26S proteasome that recognises polyubiquitinated proteins. RPN10 may also be known as 26S proteasome non-ATPase regulatory subunit 4 homolog, 26S proteasome regulatory subunit RPN10, 26S proteasome regulatory subunit S5A homolog and Multiubiquitin chain-binding protein 1. RPN10 is characterised by an N-terminal von Willebrand factor type A domain (vWA) and a C-terminal domain containing Ubiquitin-interacting motifs (UM). We have found that the Phytoplasma protein SAP05 protein interacts specifically with the vWA domain of RPN10. SAP05 and homologs of SAP05 are widespread in different phytoplasmas. Examples include AY- WB, Peanut witches’ broom phytoplasma, Witches broom disease of lime phytoplasma, Rapeseed phytoplasma and the Apple proliferation phytoplasma, as discussed above. As shown in Figure 7, SAP05 is highly conserved among different phytoplasma. We have further found that mutation of the vWA domain prevents the interaction with SAP05 and consequent degradation of the SAP05 targets, GATAs and SPLs.
In one embodiment, the method comprises introducing at least one mutation into at least one endogenous RPN10 gene. Preferably, the mutation abolishes or reduces the binding of SAP05 to RPN10. In a further embodiment, the method may involve introducing more two or three mutations into the RPN10 gene.
In the above embodiments an ’endogenous’ nucleic acid or gene may refer to the native or natural sequence in the plant genome. In one embodiment, the endogenous nucleic acid sequence encodes a RPN10 amino acid sequence as defined in SEQ ID NO: 18 or a functional variant or homologue thereof. In a further preferred embodiment, the nucleic acid sequence comprises or consists of a nucleic acid sequence selected from SEQ ID NO: 1 or a functional variant or homologue thereof.
The term “variant” or “functional variant” as used herein with reference to any of the sequences defined herein refers to a variant gene sequence or part of the gene sequence which retains the biological function of the full non-variant sequence. A functional variant also comprises a variant of the gene of interest, which has sequence
alterations that do not affect function, for example in non-conserved residues. Also encompassed is a variant that is substantially identical, i.e. has only some sequence variations, for example in non-conserved residues, compared to the wild type sequences as shown herein and is biologically active. Alterations in a nucleic acid sequence that results in the production of a different amino acid at a given site that does not affect the functional properties of the encoded polypeptide are well known in the art. For example, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the polypeptide molecule would also not be expected to alter the activity of the polypeptide. Each of the proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity of the encoded products.
As used in any aspect of the invention described herein a “variant” or a “functional variant” has at least 25%, 26%, 27%, 28%, 29%, 30%, 31 %, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41 %, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51 %,
52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%,
67%, 68%, 69%, 70%, 71 %, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81 %,
82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%,
97%, 98%, or at least 99% overall sequence identity to the non-variant nucleic acid or amino acid sequence.
The term homolog, as used herein, also designates a RPN10 gene orthologue from other plant species. A homolog may have, in increasing order of preference, at least 50%,
51 %, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%,
66%, 67%, 68%, 69%, 70%, 71 %, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%,
81 %, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%,
96%, 97%, 98%, or at least 99% overall sequence identity to the amino acid represented by SEQ ID NO:18 or to the nucleic acid sequences shown in SEQ ID NOs:1. Functional variants of RPN10 gene homologs as defined above are also within the scope of the invention. In one embodiment, the homolog has an amino acid sequence selected from
SEQ ID Nos 19 to 34 or a variant thereof. In a further embodiment, the homolog has a nucleic acid sequence selected from SEQ ID Nos 2 to 17 or a variant thereof.
As described above, the RPN10 protein is characterised by an N-terminal von Willebrand factor type A domain (vWA). In one embodiment, the amino acid vWA domain comprises or consists of the following amino acid sequence:
SEQ ID NO: 47
MVLEATMICIDNSEWMRNGDYSPSRLQAQTEAVNLLCGAKTQSNPENTVGILTMAGK GVRVLTTPTSDLGKILACMHGLDVGGEINLTAAIQIAQLALKHRQNKNQRQRIIVFAGS PIKYEKKALEIVGKRLKKNSVSLDIVNFGEDDDEEKPQKLEALLTAVNNNDGSHIVHVP SGANALSDVLLSTPVFTGDEGASGY
In one embodiment, the RPN10 homologue comprises a vWA domain as defined in SEQ ID NO:47 or a variant thereof as defined above. As shown in Figure 8, the vWA domain is highly conserved in different plants.
Suitable homologues can be identified by sequence comparisons and identifications of conserved domains as described above. There are predictors in the art that can be used to identify such sequences. The function of the homologue can be identified as described herein and a skilled person would thus be able to confirm the function, for example when overexpressed in a plant.
Hybridization of such sequences may be carried out under stringent conditions. By "stringent conditions" or "stringent hybridization conditions" is intended conditions. Typically, stringent conditions will be those in which the salt concentration is less than about 1.5 M Na ion, typically about 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30°C for short probes (e.g., 10 to 50 nucleotides) and at least about 60°C for long probes (e.g., greater than 50 nucleotides). Duration of hybridization is generally less than about 24 hours, usually about 4 to 12 hours. Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide.
In one embodiment, there is provided a method of increasing resistance of a host to a vector-borne pathogen, as described herein, the method comprising introducing at least one mutation into a RPN10 gene, wherein the RPN10 gene comprises or consists of a. a nucleic acid sequence encoding a polypeptide comprising at least one vWA domain as defined in SEQ ID NO: 47 or a variant thereof; b. a nucleic acid sequence encoding a polypeptide as defined in one of SEQ ID Nos 18 to 34; or c. a nucleic acid sequence as defined in one of SEQ ID Nos 1 to 17; or d. a nucleic acid sequence with at least 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or at least 99% overall sequence identity to either (a) or (c); or e. a nucleic acid sequence encoding a RPN10 polypeptide as defined herein that is capable of hybridising under stringent conditions as defined herein to the nucleic acid sequence of any of (a) to (d).
In one embodiment, the mutation that is introduced into the endogenous RPN10 gene thereof may be selected from the following mutation types
1. a "missense mutation", which is a change in the nucleic acid sequence that results in the substitution of an amino acid for another amino acid;
2. a "nonsense mutation" or "STOP codon mutation", which is a change in the nucleic acid sequence that results in the introduction of a premature STOP codon and, thus, the termination of translation (resulting in a truncated protein); plant genes contain the translation stop codons "TGA" (UGA in RNA), "TAA" (UAA in RNA) and "TAG" (UAG in RNA); thus any nucleotide substitution, insertion, deletion which results in one of these codons to be in the mature mRNA being translated (in the reading frame) will terminate translation.
3. an "insertion mutation" of one or more amino acids, due to one or more codons having been added in the coding sequence of the nucleic acid;
4. a "deletion mutation" of one or more amino acids, due to one or more codons having been deleted in the coding sequence of the nucleic acid;
5. a "frameshift mutation", resulting in the nucleic acid sequence being translated in a different frame downstream of the mutation. A frameshift mutation can have various causes, such as the insertion, deletion or duplication of one or more nucleotides.
6. a “splice site” mutation, which is a mutation that results in the insertion, deletion or substitution of a nucleotide at the site of splicing.
7. an “inversion” mutation, which is a one hundred and eighty rotation of a sequence of nucleic acid.
In one embodiment, the mutation is a loss of function mutation. In a further preferred embodiment, the mutation is a substitution and/or deletion.
In a preferred embodiment, the mutation may be introduced into the N-terminal vWA (von Willebrand factor type A) domain of RPN10. For example, at least one mutation may be introduced into the N-terminal vWA domain as defined in SEQ ID NO:47.
In one embodiment, the mutation is selected from one or both of the following mutations: a substitution at positions 38 and 39 of SEQ ID NO: 18 or a homologous position thereof; and/or a substitution at positions 56 to 58 of SEQ ID NO: 18 or a homologous position thereof.
In a preferred embodiment, the mutation is selected from a GA to HS substitution at positions 38 and 39 of SEQ ID NO: 18 or a homologous position thereof; and/or a GKG to K substitution at positions 56 to 58 of SEQ ID NO: 18 or a homologous position thereof.
In a most preferred embodiment, the mutation is a GA to HS substitution at positions 38 and 39 of SEQ ID NO: 18 or a homologous position thereof.
Homologous positions can be easily determined using techniques in the art. In one example, to identify the homologous positions shown in SEQ ID NO: 19 to 34 and 2 to 17 we first downloaded the homologous nucleotide and aa sequences from NCBI by BLAST using the sequence of AtRPNIO CDNA or aa as the query. Then we used the online too Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) to align either the nucleotide or aa sequences and to identify the homologous positions.
In a further preferred embodiment, the mutation is at the following homologous position is selected from
In one embodiment, the mutation is introduced using targeted genome editing. That is, in one embodiment, the invention relates to a method and plant that has been generated by genetic engineering methods as described above, and does not encompass naturally occurring varieties or generating plants by traditional breeding methods.
Targeted genome modification or targeted genome editing is a genome engineering technique that uses targeted DNA double-strand breaks (DSBs) to stimulate genome editing through homologous recombination (HR)-mediated recombination events.
In a preferred embodiment, the genome editing method that is used according to the various aspects of the invention is CRISPR. Type II CRISPR is one of the most well characterized systems and carries out targeted DNA double-strand breaks in four sequential steps. First, two non-coding RNA, the pre-crRNA array and tracrRNA, are
transcribed from the CRISPR locus. Second, tracrRNA hybridizes to the repeat regions of the pre-crRNA and mediates the processing of pre-crRNA into mature crRNAs containing individual spacer sequences. Third, the mature crRNA:tracrRNA complex directs Cas9 to the target DNA via Watson-Crick base-pairing between the spacer on the crRNA and the protospacer on the target DNA next to the protospacer adjacent motif (PAM), an additional requirement for target recognition. Finally, Cas9 mediates cleavage of target DNA to create a double-stranded break within the protospacer.
One major advantage of the CRISPR-Cas9 system, as compared to conventional gene targeting and other programmable endonucleases is the ease of multiplexing, where multiple genes can be mutated simultaneously simply by using multiple sgRNAs each targeting a different gene. In addition, where two sgRNAs are used flanking a genomic region, the intervening section can be deleted or inverted (Wiles et al., 2015).
Cas9 is thus the hallmark protein of the type II CRISPR-Cas system, and is a large monomeric DNA nuclease guided to a DNA target sequence adjacent to the PAM (protospacer adjacent motif) sequence motif by a complex of two noncoding RNAs: CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA). The Cas9 protein contains two nuclease domains homologous to RuvC and HNH nucleases. The HNH nuclease domain cleaves the complementary DNA strand whereas the RuvC-like domain cleaves the non-complementary strand and, as a result, a blunt cut is introduced in the target DNA. Heterologous expression of Cas9 together with an sgRNA can introduce site-specific double strand breaks (DSBs) into genomic DNA of live cells from various organisms. For applications in eukaryotic organisms, codon optimized versions of Cas9, which is originally from the bacterium Streptococcus pyogenes, have been used.
The single guide RNA (sgRNA) is the second component of the CRISPR/Cas system that forms a complex with the Cas9 nuclease. sgRNA is a synthetic RNA chimera created by fusing crRNA with tracrRNA. The sgRNA guide sequence located at its 5’ end confers DNA target specificity. Therefore, by modifying the guide sequence, it is possible to create sgRNAs with different target specificities. The canonical length of the guide sequence is 20 bp. In plants, sgRNAs have been expressed using plant RNA polymerase III promoters, such as U6 and U3. Accordingly, using techniques known in the art, such
as http://chopchop.cbu.uib.no/ it is possible to design sgRNA molecules that targets a RPN10 gene sequence as described herein.
For example, Figure 9 shows 6 possible CRISPR target sites that can be used for CRISPR followed by homology directed repair to introduce one or more mutations into AtRPNIO.
In another aspect of the invention, there is provided a nucleic acid construct comprising a nucleic acid sequence encoding a sgRNA molecule, wherein the sgRNA molecule targets a nucleic acid sequence in RPN10 selected from SEQ ID NO: 35, 37, 39, 41 , 43 or 45 or a variant thereof. In a further embodiment, the nucleic acid sequence comprises or consists of SEQ ID NO: 36, 38, 40, 42, 44 or 46 or a variant thereof.
By “sgRNA” (single-guide RNA) is meant the combination of tracrRNA and crRNA in a single RNA molecule, preferably also including a linker loop (that links the tracrRNA and crRNA into a single molecule). “sgRNA” may also be referred to as “gRNA" and in the present context, the terms are interchangeable. The sgRNA or gRNA provide both targeting specificity and scaffolding/binding ability for a Cas nuclease. A gRNA may refer to a dual RNA molecule comprising a crRNA molecule and a tracrRNA molecule.
In a further embodiment, the nucleic acid sequence encoding a sgRNA molecule is operable linked to a regulatory sequence, such as a plant promoter. A suitable plant promoter may be a constitutive or strong promoter or may be a tissue-specific promoter. In one embodiment, suitable plant promoters are selected from, but not limited to, oestrum yellow leaf curling virus (CmYLCV) promoter or switchgrass ubiquitin 1 promoter (Pvllbil), wheat U6 RNA polymerase III (Tall6), CaMV35S, wheat U6 or maize ubiquitin (e.g. Ubi1) promoters.
The nucleic acid construct of the present invention may also further comprise a nucleic acid sequence that encodes a CRISPR enzyme. By “CRISPR enzyme” is meant an RNA- guided DNA endonuclease that can associate with the CRISPR system. Specifically, such an enzyme binds to the tracrRNA sequence. In one embodiment, the CRIPSR enzyme is a Cas protein (“CRISPR associated protein), preferably Cas 9 or Cpf1 , more preferably Cas9. The Cas9 enzyme may be modified as described below. In a specific embodiment Cas9 is codon-optimised Cas9. In another embodiment, the CRISPR
enzyme is a protein from the family of Class 2 candidate x proteins, such as C2c1 , C2C2 and/or C2c3. In one embodiment, the Cas protein is from Streptococcus pyogenes. In an alternative embodiment, the Cas protein may be from any one of Staphylococcus aureus, Neisseria meningitides, Streptococcus thermophiles or Treponema denticola. In a preferred embodiment, the CRISPR enzyme is operably linked to a regulatory sequence - either the same or a different regulatory sequence as for the sgRNA sequence. Again, suitable regulatory sequences are described above.
In another aspect of the invention, there is provided a plant or part thereof or at least one isolated plant cell transfected with at least one nucleic acid construct as described herein. Cas9 and sgRNA may be combined or in separate expression vectors (or nucleic acid constructs, such terms are used interchangeably). In other words, in one embodiment, an isolated plant cell is transfected with a single nucleic acid construct comprising both sgRNA and a CRISPR enzyme as described in detail above. In an alternative embodiment, an isolated plant cell is transfected with two nucleic acid constructs, a first nucleic acid construct comprising at least one sgRNA as defined above and a second nucleic acid construct comprising a CRISPR enzyme or a functional variant or homolog thereof. The second nucleic acid construct may be transfected below, after or concurrently with the first nucleic acid construct. The advantage of a separate, second construct comprising a CRISPR enzyme is that the nucleic acid construct encoding at least one sgRNA can be paired with any type of CRISPR enzyme, as described herein, and therefore is not limited to a single CRISPR enzyme function (as would be the case when both the CRISPR enzyme and sgRNA are encoded on the same nucleic acid construct). In one embodiment, the nucleic acid construct comprising a CRISPR enzyme is transfected first and is stably incorporated into the genome, before the second transfection with a nucleic acid construct comprising at least one sgRNA nucleic acid. In an alternative embodiment, a plant or part thereof or at least one isolated plant cell is transfected with mRNA encoding a CRISPR enzyme and co-transfected with at least one nucleic acid construct as defined herein.
In a further aspect of the invention, there is provided a sgRNA molecule expressed from the nucleic acid construct described above.
In a preferred embodiment of any aspect of the invention described herein, sgRNA can be used with a modified Cas9 protein, such as nickase Cas9 or nCas9 or a “dead” Cas9 (dCas9) fused to a “Base Editor” - such as an enzyme, for example a deaminase such
as cytidine deaminase, or TadA (tRNA adenosine deaminase) or ADAR or APOBEC. These enzymes are able to substitute one base for another. As a result no DNA is deleted, but a single substitution is made (Kim et al., 2017; Gaudelli et al. 2017). Alternatively, the method may use sgRNA together with a template or donor DNA constructs, to introduce a targeted SNP or mutation, in particular one of the substitutions described herein, into a RPN10 gene. In this embodiment, the introduction of a template DNA strand, following a sgRNA-mediated snip in the double-stranded DNA, can be used to produce a specific targeted mutation (i.e. a SNP) in the gene using homology directed repair. Using the above methods we can mutate nucleotides GGAGCC (coding amino acids G and A at positions 112 to 117 of SEQ ID NO:1) to either CATTCC or CACTCC
(coding amino acids H and S at positions 38 and 39 of SEQ ID NO: 18) in AtRPNIO.
Once targeted genome editing has been performed, rapid high-throughput screening procedures can be used to analyse amplification products for the presence of a mutation in the RPN10 gene. Once a mutation is identified, the seeds of the M2 plant carrying that mutation are grown into adult M3 plants and screened for the phenotypic characteristics associated with the target gene RPN10. Mutants with mutation in RPN10, and in particular in the N-terminal vWA domain, and as a result, increased resistance to pathogens compared to a control can thus be identified.
Plants obtained or obtainable and seeds obtained or obtainable from such plants by such method which carry a functional mutation in the endogenous RPN10 gene are also within the scope of the invention.
In one embodiment, the progeny plant is stably transformed with the CRISPR constructs, and comprises the exogenous polynucleotide which is heritably maintained in the plant cell. The method may include steps to verify that the construct is stably integrated. The method may also comprise the additional step of collecting seeds from the selected progeny plant.
In a further embodiment, the method may further comprise at least one or more of the steps of assessing the phenotype of the genetically altered plant, specifically, measuring or assessing an increase in resistance to a vector-borne pathogen (such as a bacteria), wherein preferably said increase is relative to a control or wild-type plant.
Also included in the scope of the invention, is the use of the nucleic acid constructs (CRISPR constructs) described above in any of the above-described methods. For example, there is provided the use of the above CRISPR constructs to introduce at least one mutation into RPN10 as described herein. In particular, as described herein, the CRISPR constructs may be used to introduce at least one mutation into the vWA domain, wherein the mutation prevents or reduces binding of SAP05 to RPN10.
Therefore, in a further aspect of the invention, there is provided a method of preventing binding of a pathogen effector molecule to its host target, the method comprising introducing and expressing a CRISPR construct as described above or introducing a sgRNA molecule expressed by the construct into a plant.
In another aspect of the invention there is provided a genetically altered plant, part thereof or plant cell characterised in that the plant has increased resistance to at least one vector-borne pathogen.
In one embodiment, the plant comprises at least one mutation in the RPN10 gene. Preferably, the mutation is a substitution and/or deletion, and even more preferably, the mutation is the N-terminal vWA domain as described above. In a further embodiment, the mutation has been introduced using targeted genome editing, again as described above.
In another aspect of the invention, there is provided a method of making a genetically altered plant, wherein the plant is characterised by increased resistance to a vector borne pathogen, the method comprising introducing at least one mutation into at least one RPN10 gene.
In one embodiment, the method comprises a. selecting a part of the plant; b. transfecting at least one cell of the part of the plant of paragraph (a) with at least one CRISPR construct or sgRNA molecule, wherein the CRISPR construct or sgRNA molecule targets the RPN 10 gene and introduces at least one mutation into the RPN 10 gene as described above; c. regenerating at least one plant derived from the transfected cell or cells;
d. selecting one or more plants obtained according to paragraph (c) that show at least one mutation in the RPN10 gene, preferably in the N-terminal vWA domain of the RPN10 gene .
In one embodiment, the method may comprises obtaining a DNA sample from a transformed plant and carrying out DNA amplification to detect the at least one mutation in the RPN10 gene. In a further embodiment of any of the methods described herein, the method may further comprise at least one or more of the steps of assessing the phenotype of the genetically altered plant, measuring at least one of resistance or increased resistance to a vector-borne pathogen, such as phytoplasma. In other words, the method may involve the step of screening the plants for the desired phenotype.
Transformation methods for generating a genetically altered plant of the invention are known in the art. Thus, according to the various aspects of the invention, a CRISPR construct as defined herein is introduced into a plant and expressed as a transgene. The construct is introduced into said plant through a process called transformation. The terms "introduction" or "transformation" as referred to herein encompass the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer. Plant tissue capable of subsequent clonal propagation, whether by organogenesis or embryogenesis, may be transformed with a genetic construct of the present invention and a whole plant regenerated therefrom. The particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed. Exemplary tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem).
The CRISPR construct may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host genome. The resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art.
Transformation of plants is now a routine technique in many species. Advantageously, any of several transformation methods may be used to introduce a CRISPR construct into a suitable ancestor cell. The methods described for the transformation and regeneration of plants from plant tissues or plant cells may be utilized for transient or for
stable transformation. Transformation methods include the use of liposomes, electroporation, chemicals that increase free DNA uptake, injection of the DNA directly into the plant, particle gun bombardment, transformation using viruses or pollen and microinjection. Methods may be selected from the calcium/polyethylene glycol method for protoplasts, electroporation of protoplasts, microinjection into plant material, DNA or RNA-coated particle bombardment, infection with (non-integrative) viruses and the like. Transgenic plants, including transgenic crop plants, are preferably produced via Agrobacterium tumefaciens mediated transformation.
To select transformed plants, the plant material obtained in the transformation is subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility is growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker.
The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion).
The method may further comprise regenerating a genetically altered plant from the plant or plant cell wherein the genetically altered plant comprises in its genome at least one mutation in a RPN10 gene as described above, and obtaining a progeny plant derived from the transgenic plant, wherein said progeny exhibits at least one mutation in a RPN10 gene as described and shows an increase in resistance to vector-borne pathogens, such as phytoplasma.
In a further embodiment, the methods comprise generating stable T2 plants preferably homozygous for the mutation (that is a mutation in at least one RPN10 gene sequence).
A genetically altered plant of the present invention may also be obtained by transference of any of the sequences of the invention by crossing, e.g., using pollen of the genetically altered plant described herein to pollinate a wild-type or control plant, or pollinating the gynoecia of plants described herein with other pollen that is not genetically altered as described herein. The methods for obtaining the plant of the invention are not exclusively limited to those described in this paragraph; for example, genetic transformation of germ cells from the ear of wheat could also be carried out as mentioned, but without having to regenerate a plant afterwards.
In a further aspect of the invention there is provided a plant obtained or obtainable by the above-described methods.
A plant according to all aspects of the invention described herein may be a monocot or a dicot plant.
In one embodiment, the plant is a crop plant. By crop plant is meant any plant which is grown on a commercial scale for human or animal consumption or use. In another embodiment the plant is Arabidopsis.
In a most preferred embodiment, the plant is a vascular plant. In another embodiment, the plant is a crop plant. In another embodiment, the plant is any plant infected or capable of being infected by phytoplasma.
In one embodiment, the plant may be selected from a brassicas, legumes, cereals, citrus, root vegetables, tuber and rhizome crops, fruits including berries and soft fruits and fruit, nut and seed bearing trees.
In one embodiment, the plant may be selected from Acer negundo (box elder), Achyranthes aspera (devil's horsewhip), Aconitum napellus (aconite monkshood), Adenium obesum, Allium ampeloprasum (wild leek), Allium cepa (onion), Allium sativum (garlic), Alstroemeria (Inca lily), Amaranthus (amaranth), Amaranthus hypochondriacus, Ambrosia artemisiifolia (common ragweed), Ammi majus (Bishop's-weed), Ampelopsis
brevipedunculata (Amur amelopsis), Anemone coronaria (Poppy anemone), Anethum graveolens (dill), Apium graveolens (celery), Asparagus officinalis (asparagus), Avena sativa (oats), Bellis perennis (common daisy), Beta vulgaris (beetroot), Bougainvillea spectabilis (great bougainvillea), Brachyscome multifidi, Brassica napus, Brassica napus var. napus (rape), Brassica oleracea (cabbages, cauliflowers), Brassica oleracea var. capitata (cabbage), Brassica oleracea var. italica (broccoli), Brassica rapa subsp. rapa (turnip), Bromus inermis (Awnless brome), Bunias orientalis (Turkish warty-cabbage), Bupleurum falcatum, Cajanus cajan (pigeon pea), Calendula officinalis (Pot marigold), Callistephus chinensis (China aster), Camelina sativa, Cannabis sativa (hemp), Capsicum annuum (bell pepper), Carica papaya (pawpaw), Carthamus tinctorius (safflower), Catharanthus roseus (Madagascar periwinkle), Celosia argentea (celosia), Celtis australis (European nettle wood), Chrysanthemum coronarium (garland chrysanthemum), Chrysanthemum frutescens (marguerite), Chrysanthemum morifolium (chrysanthemum (florists')), Cirsium arvense (creeping thistle), Citrus maxima (pummelo), Citrus reticulata (mandarin), Citrus sinensis (navel orange), Clarkia unguiculata, Cocos nucifera (coconut), Consolida ambigua (rocket larkspur), Conyza bonariensis (hairy fleabane), Conyza canadensis (Canadian fleabane), Coreopsis lanceolate, Coreopsis tinctoria, Coriandrum sativum (coriander), Cornus racemosa (gray dogwood), Corylus avellana (hazel), Cosmos bipinnatus (garden cosmos), Crotalaria spectabilis (showy rattlepod), Crotalaria tetragona, Croton, Cryptotaenia canadensis (honewort), Cryptotaenia japonica, Cucurbita moschata (pumpkin), Cucurbita pepo (marrow), Cuscuta (dodder), Cyclamen persicum (cyclamens), Cynodon dactylon (Bermuda grass), Cyrtostachys renda, Dahlia, Daucus carota (carrot), Delphinium hybrids (florist's larkspur), Dicentra Formosa, Dicentra spectabilis (bleeding heart), Digitalis lanata (Grecian foxglove), Diplotaxis erucoides, Dysphania ambrosioides (Mexican tea), Echinacea purpurea (purple coneflower), Eclipta prostrata (eclipta), Elaeagnus angustifolia (Russian olive), Elaeis guineensis (African oil palm), Emilia sonchifolia (red tasselflower), Epilobium (willowherbs), Eriobotrya japonica (loquat), Eryngium alpinum, Erysimum linifolium, Eschscholzia californica (California poppy), Etlingera elatior (torch ginger), Eucalyptus, Eucalyptus camaldulensis (red gum), Eupatorium capillifolium (Dog fennel), Euphorbia pulcherrima (poinsettia), Festuca arundinacea (tall fescue), Fortunella japonica (round kumquat), Fragaria ananassa (strawberry), Fraxinus uhdei (tropical ash), Freesia, Gaillardia pulchella (Indian blanket), Gerbera jamesonii (African daisy), Geum coccineum, Gladiolus hybrids (sword lily), Glycine max (soyabean), Gomphocarpus physocarpus (balloon cotton bush),
Gossypium (cotton), Gossypium hirsutum (Bourbon cotton), Guizotia abyssinica (niger), Helianthus debilis, Hibiscus rosa-sinensis (China-rose), Hordeum vulgare (barley), Humulus lupulus (hop), Hyacinthus orientalis (hyacinth), Hydrangea macrophylla (French hydrangea), Impatiens balsamina (garden balsam), Ipomoea obscura, Isopyrum thalictroides, Jatropha curcas (jatropha), Juniperus (junipers), Koelreuteria paniculata (golden rain tree), Lactuca sativa (lettuce), Lactuca serriola (prickly lettuce), Larix (larches), Lepidium draba (hoary cress), Lilium (lily), Limonium sinuatum (sea pink), Lolium multiflorum (Italian ryegrass), Lotus corniculatus (bird's-foot trefoil), Luffa, Luffa aegyptiaca (loofah), Lupinus (lupins), Macadamia integrifolia (macadamia nut), Magnolia, Malus domestica (apple)Malva (mallow), Mangifera indica (mango), Manihot esculenta (cassava), Matricaria perforata (false chamomile), Medicago sativa (lucerne), Melia azedarach (Chinaberry), Melochia corchorifolia (redweed), Mimosa pudica (sensitive plant), Momordica charantia (bitter gourd), Morus bombycis (Japanese mulberry), Musa acuminata (wild banana), Musa balbisiana, Muscari armeniacum, Myriophyllum aquaticum (parrot's feather), Myrtus communis (myrtle), Nasturtium officinale (watercress), Nigella damascena (Love-in-a-mist), Ocimum basilicum (basil), Olea europaea subsp.europaea (European olive), Opuntia ficus-indica (prickly pear), Opuntia sp. (pricklypear), Pachysandra terminalis (Japanese spurge), Papaver rhoeas (common poppy), Parthenium hysterophorus (parthenium weed), Passiflora edulis (passionfruit), Paulownia tomentosa (paulownia), Pelargonium (pelargoniums), Pennisetum glaucum (pearl millet), Petroselinum crispum (parsley), Petunia, Phaseolus vulgaris (common bean), Phlox drummondii (Annual phlox), Phoenix dactylifera (date- palm), Physalis ixocarpa, Piper nigrum (black pepper), Pittosporum undulatum (Australian cheesewood), Plantago (Plantain), Poa pratensis (smooth meadow-grass), Populus (poplars), Populus nigra (black poplar), Portulaca oleracea (purslane), Primula sp. (primrose), Prunus armeniaca (apricot), Prunus avium (sweet cherry), Prunus cerasus (sour cherry), Prunus persica (peach), Prunus persica var. nucipersica (nectarine), Prunus salicina (Japanese plum), Psylliostachys suworowii, Pterocarya stenoptera (Chinese wing nut), Pyrus communis (European pear), Quercus robur (common oak), Ranunculus asiaticus (garden crowfoot), Raphanus raphanistrum (wild radish), Raphanus sativus (radish), Rhododendron (Azalea), Ribes nigrum (blackcurrant), Ribes rubrum (red currant), Rosa multiflora (multiflora rose), Rosa rugosa (rugosa rose), Roystonea regia (cuban royal palm), Rubus (blackberry, raspberry), Rubus fruticosus (blackberry), Rudbeckia hirta, Saccharum, Salix (willows), Salix babylonica (weeping willow), Salix guebriantiana, Santalum album (Indian sandalwood),
Saponaria officinalis (soapwort), Scabiosa atropurpurea (Pincushion), Schizanthus pinnatus, Sechium edule (chayote), Sedum spectabile (showy stonecrop), Senecio jacobaea (common ragwort), Sesamum indicum (sesame), Solanum lycopersicum (tomato), Solanum melongena (aubergine), Solanum tuberosum (potato), Solidago (Goldenrod), Sonchus arvensis (perennial sowthistle), Sonchus asper (spiny sowthistle), Sonchus oleraceus (common sowthistle), Spinacia oleracea (spinach), Spiraea bumalda, Spiraea tomentosa (Hardback), Stellaria media (common chickweed), Streblus asper, Syringa oblate, Syringa reticulate, Syringa vulgaris (lilac), Tagetes erecta (Mexican marigold), Tagetes patula (French marigold), Tanacetum cinerariifolium (Pyrethrum), Tanacetum parthenium (Feverfew), Taraxacum officinale complex (dandelion), Toona ciliata (toon), Trifolium hybridum (alsike clover), Trifolium pratense (red clover), Trifolium repens (white clover), Triticum aestivum (wheat), Ulrnus (elms), Vaccinium (blueberries), Valeriana officinalis (common valerian), Verbascum densiflorum, Vitis vinifera (grapevine), Withania somnifera (poisonous gooseberry), Wodyetia bifurcata (foxtail palm), Xanthoceras sorbifolium, Yucca constricta, Zanthoxylum schinifolium, Zea mays (maize) and Zinnia elegans (zinnia).
In a further embodiment, the plant is selected from rice, maize, wheat, barley, sorghum, potato, tomato, cotton, soybean, Brassicas, such as B.napus, cabbage, lettuce, carrot, coconut, papaya, oil palms, grape, apple, oranges, sugarcane, citrus (such as lime, citrus, orange, grapefruit), egg plant, elm, ash, willow, elm, Dogwood, hydrangea, cyclamen, mulberry, poplar, cactus, anemone, olive, Paulownia species, pecan, walnut, alder, jujube, pigeon pea, hazel, sugar cane, bermuda grass, oat, buckthorn, cirsium, sesame, alfalfa, pea, plantain, birch, cassava, peanut, loofah, cocoa, date or date palm, sweet potato, lettuce, chrysanthemum, pointsettia, sunflower, flox, hortensia, tulips, gladiolus and other bulbs, onion, garlic, cabbage tree, pine, trees, stone fruit trees, palm, carrot, strawberry, blueberry, cranberry, blackberry and other berry plants.
The term "plant" as used herein encompasses whole plants, ancestors and progeny of the plants and plant parts, including seeds, fruit, shoots, stems, leaves, roots (including tubers), flowers, tissues and organs, wherein each of the aforementioned carry at least one of the herein described mutations. The term "plant" also encompasses plant cells, suspension cultures, callus tissue, embryos, meristematic regions, gametophytes, sporophytes, pollen and microspores, again wherein each of the aforementioned comprises the mutations as described herein.
The invention also extends to harvestable parts of a plant of the invention as described herein, but not limited to seeds, leaves, fruits, flowers, stems, roots, rhizomes, tubers and bulbs. The aspects of the invention also extend to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins. In another aspect of the invention, there is provided a product derived from a plant as described herein or from a part thereof.
In a most preferred embodiment, the plant part or harvestable product is a seed or grain. Therefore, in a further aspect of the invention, there is provided a seed or grain produced from a genetically altered plant as described herein. Accordingly, in one aspect of the invention there is provided seed, wherein the seed contains one more of the genetic alterations described herein - specifically, the seed comprises one or more mutations in RPN10. Also provided is progeny plant obtained from the seed as well as seed obtained from that progeny.
In an alternative embodiment, the plant part is pollen, a propagule or progeny of the genetically altered plant described herein. Accordingly, in a further aspect of the invention there is provided pollen, a propagule or progeny produced from a genetically altered plant as described herein.
A control plant as used herein according to all of the aspects of the invention is a plant which has not been modified according to the methods of the invention. Accordingly, in one embodiment, the control plant does not have one of the mutations in RPN10 described herein. In one embodiment, the control plant is a wild type plant. The control plant is typically of the same plant species, preferably having the same genetic background as the modified plant.
While the foregoing disclosure provides a general description of the subject matter encompassed within the scope of the present invention, including methods, as well as the best mode thereof, of making and using this invention, the following examples are provided to further enable those skilled in the art to practice this invention and to provide a complete written description thereof. However, those skilled in the art will appreciate that the specifics of these examples should not be read as limiting on the invention, the scope of which should be apprehended from the claims and equivalents thereof
appended to this disclosure. Various further aspects and embodiments of the present invention will be apparent to those skilled in the art in view of the present disclosure.
"and/or" where used herein is to be taken as specific disclosure of each of the two specified features or components with or without the other. For example "A and/or B" is to be taken as specific disclosure of each of (i) A, (ii) B and (iii) A and B, just as if each is set out individually herein.
Unless context dictates otherwise, the descriptions and definitions of the features set out above are not limited to any particular aspect or embodiment of the invention and apply equally to all aspects and embodiments which are described.
The foregoing application, and all documents and sequence accession numbers cited therein or during their prosecution ("appln cited documents") and all documents cited or referenced in the appln cited documents, and all documents cited or referenced herein ("herein cited documents"), and all documents cited or referenced in herein cited documents, together with any manufacturer's instructions, descriptions, product specifications, and product sheets for any products mentioned herein or in any document incorporated by reference herein, are hereby incorporated herein by reference, and may be employed in the practice of the invention. More specifically, all referenced documents are incorporated by reference to the same extent as if each individual document was specifically and individually indicated to be incorporated by reference.
The invention is now described in the following non-limiting example.
EXAMPLE I: SAP05 alters plant architecture
We previously identified the SAP05 effector of the phytoplasma Aster Yellow strain Witches Broom (AY-WB)12. Here, we observed that Arabidopsis thaliana plants stably expressing the AY-WB SAP05 gene under the control of the Cauliflower mosaic virus (CaMV) 35S ubiquitous promoter showed a range of architectural differences from control plants that express the gene for green fluorescent protein (GFP) (Fig. 1a-c). During vegetative growth, these SAP05 plants displayed accelerated leaf initiations and therefore produced more rosette leaves (Fig. 1a, d). In addition, the leaves of mature rosettes lacked serrated edges (Fig. 1a). Upon entering the reproductive stage, SAP05 plants bolted and flowered earlier (Fig. 1b,e), produced more lateral shoots and
secondary branches and showed reduced height (Fig 1c,f,g). Twenty-six of 32 lines developed abnormal flowers (Fig 1c, inset) with no or fewer-than-normal seeds. Phytoplasmas reside within the cytoplasm of plant phloem sieve cells, where they secrete effectors that unload from the phloem into adjacent plant tissues. To mimic SAP05 release in the phloem, we generated stable transgenic A. thaliana lines expressing SAP05 from the phloem-specific AtSUC2 promoter The AtSUC2::SAP05 plants exhibited similar architectural changes to the 35S::SAP05 plants. Overall, mature 35S::SAP05 and AtSUC2::SAP05 plants appeared stunted and bushy, a phenotype that resembles the witch’s broom symptoms typically observed in phytoplasma-infected plants.
Phytoplasmas often depend on insect vectors for transmission and spread. In addition to inducing developmental phenotypes, phytoplasma virulence factors increase plant susceptibility to their insect vectors. Hence, we investigated whether SAP05 affects A. thaliana susceptibility to the most important insect vector of AY-WB phytoplasma, the leafhopper Macrosteles quadrilineatus. The insects preferred to reproduce on 35S::SAP05 A. thaliana plants as compared to 35S::GFP control plants in both choice and no-choice fecundity tests (Fig. 1 h), suggesting that SAP05 also contributes to the plants’ increased susceptibility to the leafhopper vectors.
EXAMPLE II SAP05 degrades GATAs and SPLs via RPN10
SAP05 interacted with several A. thaliana zinc-finger transcription factors, specifically GATAs and SPLs, in a yeast two-hybrid (Y2H) screen against an A. thaliana seedling library (Fig. 2a). Of the 29 GATA and 16 SPL family members in A. thaliana, 26 GATAs and 12 SPLs were successfully cloned and shown to interact with SAP05 in Y2H assays (Fig 2b), indicating that SAP05 most likely binds all members of both families. SPLs regulate plant developmental phase transitions, and most are developmentally regulated by microRNA156 (miR156), whereas GATA proteins regulate photosynthetic processes, leaf development and flower organ development. In addition, the A. thaliana 26S proteasome subunit RPN10 was identified as a potential SAP05 interactor in the Y2H screen. RPN10 is located within the 19S regulatory particle of the proteasome and serves as one of the main ubiquitin receptors recruiting ubiquitinated proteins for proteasomal degradation.
To investigate whether SAP05 degrades GATA and SPL transcription factors in plant cells, we transiently co-expressed several GATA or SPL genes with SAP05 (or GFP as
control) in A thaliana protoplasts. GATA proteins were absent or less abundant in the presence of SAP05 as compared to GFP (Fig. 2c, left panel). Similarly, the abundances of five SPL proteins were visibly reduced in the presence of SAP05 (Fig. 2c, right panel). Addition of MG132, a potent proteasome inhibitor, inhibited the SAP05-mediated destabilisation of two GATA proteins tested (Figure 2I). Together, these data indicate that SAP05 degrades GATA and SPL transcription factors, likely via the 26S proteasome.
The GATA and SPL transcription factor families evolved independently, though both have zinc-finger (ZnF) DNA-binding domains. The ZnF domain of the GATA family contains one C4-type zinc-binding site of approximately 50 residues and is conserved among plants, animals and fungi, whereas that of SPL proteins is approximately 80 amino acids, contains two zinc-binding sites of the C2HC and the C3H types and is specific to plants (Fig. 2a). Nevertheless, the ZnF domains of SPLs and GATAs are both sufficient to mediate SAP05 binding in Y2H experiments (Fig. 2b).
To investigate the role of RPN10 in the SAP05-mediated destabilisation of plant transcription factors, we made use of the existing and well-described A. thaliana loss-of- function rpn10 mutant line rpn10-2. In the protoplasts of rpn10-2 plants, SAP05 no longer degraded GATA18/HAN or GATA19, whereas when A. thaliana RPN10 was reintroduced into the protoplasts, these plant transcription factors were degraded (Fig. 2f). Therefore, RPN10 is required for the SAP05-mediated degradation of plant targets.
RPN10 is one of the primary ubiquitin receptor proteins in eukaryotes. RPN10 has two main domains, an N-terminal vWA (von Willebrand factor type A) domain required for RPN10 docking to the proteasome and a C-terminal half with ubiquitin-interacting motifs (UIM) involved in binding to ubiquitin chains that are attached to lysine residues of proteins directed to the proteasome for degradation (Fig. 2d). SAP05 interacted with the vWA domain but not the UIM domain of A. thaliana RPN10 (Fig. 2e). GATA18 and GATA19 proteins in which all lysines were replaced by arginines were also degraded in an SAP05-dependent manner (Fig. 2g). Moreover, SPL or GATA zinc-finger domains alone that are sufficient for SAP05 binding were degraded in the presence of SAP05 (Fig. 2h— j). These results indicate that SAP05 directly targets proteins that it interacts with for degradation and that lysine ubiquitination is not required for this degradation. In fact, SAP05 fused to a GFP-nanobody, a single-chain antibody domain that specifically
recognizes GFP, also degraded GFP in A thaliana protoplasts (Fig. 2k). Therefore, the phytoplasma SAP05 has evolved a mechanism to achieve selective protein degradation by hijacking the plant host 26S proteasome component RPN10.
Example III SAP05 degrades GATAs and SPLs in planta
To investigate whether SAP05 degrades GATAs and SPLs in whole plants, we made use of existing A. thaliana lines that ectopically express GATA and SPL protein-coding regions, leading to overexpression (OE) as compared to wild-type plants. These included: (i) the full-length coding region of a Cucumis sativus L. GATA 18 homologue (CsHANI) under the control of the 35S promoter in the A. thaliana han mutant (han-2) background (ii) the full-length coding region of A. thaliana SPL5 under the control of the 35S promoter; and (iii) miR156-resistant forms of SPL11 and SPL13 (rSPL11 and rSPI13, respectively) fused with a p-glucuronidase (GUS) under the control of their native promoter. The CsHAN1-OE produced leaves with more severe serrations than those of the original han-2 line (Fig 3a, b), which is consistent with the described functions of HAN, whereas introduction of SAP05 into this line alleviated the serration phenotype (compare han-2 HAN-OE to han-2 HAN-OE x 35S::SAP05 plants, Fig. 3a, b). Similarly, the reduction in rosette leaf production of OE lines for SPL5, rSPL11 and rSPL13 and the early bolting phenotype of SPL5-OE plants were relieved in the presence of SAP05 (Fig. 3a,c,d). These data provide evidence that SAP05 also degrades GATAs and SPLs in whole plants.
To investigate whether GATAs and SPLs are degraded during phytoplasma infection, we made use of lines that stably produce GUS-fused rSPL11 and rSPL13 proteins driven by their native promoters. Newly emerged or developing leaves of phytoplasma-infected plants had visibly reduced GUS activities compared to un-infected plants (Fig. 3e,f). Therefore, SPL transcription factors are degraded in planta during phytoplasma infection.
Example IV: Insect-guided plant resistance to SAP05
Animals also have GATA transcription factors and RPN10 proteins. GATA transcription factors have multiple roles in humans and animals, including the regulation of processes related to immunity. SAP05 expression has been detected in phytoplasma-colonised insects. To investigate whether phytoplasma SAP05 also interacts with the GATA proteins of the leafhopper vector, we first mined the transcriptome assembly of
M.quadrilineatus for GATA transcription factors and identified six distinct transcripts with typical GATA ZnF domains. None of these ZnF domains interact with SAP05 in Y2H analyses, indicating that SAP05 may not interact with insect vector GATA transcription factors.
We also identified M. quadrilineatus RPN10 (MqRPNIO), which is highly similar in sequence to A. thaliana RPN10 (AtRPNIO) (Fig. 4a and Fig. 6). However, in Y2H assays, SAP05 did not bind MqRPNIO, its vWA domain or a hybrid RPN10 (hRPNIO) consisting of the M. quadrilineatus vWA domain and the A. thaliana C-terminal (UIM) domain (Fig. 4b). Comparison of multiple vWA domains of plant and animal RPN10 homologues revealed differences between the two groups in two regions corresponding to amino acids 39-40 (GA vs. HS) and 56-58 (GKG vs. K) in the vWA domain (Fig. 4a). Changing these residues within the plant RPN10 to those present in the animal homologues, to generate RPN10_39GA40->HS (ml) and RPN10_56GKG58->K (m2), resulted in loss of SAP05 binding in Y2H assays (Fig. 4b). All the RPN10 variants interacted with the A. thaliana RADIATION SENSITIVE23 (RAD23B) protein, a ubiquitin shuttle factor that binds RPN10, indicating that the RPN10 variants are functional in the Y2H assays. SAP05 degradation assays of AtGATA18 in A. thaliana rpn10-2 protoplasts showed that GATA18 was less degraded in the presence of MqRPNIO, hRPNIO and RPN10 ml compared to AtRPNIO (Fig. 4c), indicating that the AtRPNIO vWA domain, and particularly the GA residues that are unique to plant versus animal RPN10 proteins, are involved in the SAP05-mediated degradation of plant GATA18. Therefore, by replacing those residues with those in the same locations in the animal proteins, we were able to engineer A. thaliana RPN10 to become more resistant to SAP05 binding and degradation.
Plant resistance to pathogens may be achieved by knocking out effector targets or susceptibility genes. Knocking out multiple GATA and SPL proteins in plants is tedious and can cause pleiotropic phenotypes. Moreover, RPN10 has an essential function in A. thaliana, and rpn10 null mutants have pleotropic phenotypes, including severe growth defects. However, transforming the A. thaliana RPN10 mutant rpn10-2 with the SAP05 non-interacting allele AtRPNIO ml under the control of the native RPN10 promoter to create rpn10-2 AtRPN10::AtRPN10 ml plants, hereafter called eRPNIO (A. thaliana engineered RPN10) for short, rescued the developmental defects of the rpn10-2 plants, producing a phenotype similar to that erf rpn10-2 complemented with wild-type A. thaliana
RPN10 (rpn10-2 AtRPN10::AtRPN10, hereafter cRPNIO, for RPN10 complementation) (Fig. 6). Introducing the 35S::SAP05 construct into eRPNIO plants generated wild-type- looking plants without obvious development phenotypic abnormalities for all 33 independent transformants, unlike introduction of 35S::SAP05 into cRPNIO plants which yielded typical SAP05 phenotypes in 30 out of 34 independent transformants (Figs. 1a,b and 4d,e). Therefore, the RPN10_39GA40->HS mutation confers resistance to phytoplasma-SAP05-mediated developmental changes in A. thaliana. Moreover, the phytoplasma insect vector M. quadrilineatus did not show a reproduction preference for 35S::SAP05 eRPNIO versus eRPNIO plants, unlike for 35S::SAP05 cRPNIO versus cRPNIO plants (Fig. 4f) and 35S::SAP05 versus GFP plants (Fig. 1 h), indicating that RPN10_39GA40->HS also confers resistance to SAP05-mediated plant susceptibility to the phytoplasma insect vector M. quadrilineatus.
The AY-WB phytoplasma secretes an arsenal of virulence factors, among which only TENGLI, SAP11 , SAP54, and herein SAP05, have been functionally investigated. To investigate the contribution of SAP05 to symptom development due to AY-WB phytoplasma infection in A. thaliana, we infected wild-type, cRPNIO and eRPNIO plants with AY-WB phytoplasma. The infected wild-type and cRPNIO plants produced large quantities of small, deformed leaves and more lateral shoots compared to plants of similar age not infected with phytoplasma (Fig. 4g, h). The symptoms of these infected plants resembled the phenotypes of 35S::SAP05 plants (Fig. 1a-c) and cRPNIO 35S::SAP05 plants (Fig. 4d). By contrast, eRPNIO A. thaliana infected with phytoplasma did not produce severely deformed leaves or more lateral shoots as compared to the non-infected plants (Fig. 4g, h). All AY-WB-infected A. thaliana genotypes produced leaflike flowers that resemble the phyllody symptoms of AY-WB-infected plants, indicating that the engineered RPN10 allele does not interfere with the leaf-like flower phenotype induced by the AY-WB phytoplasma effector SAP54. These data demonstrate that the AY-WB SAP05 effector is largely responsible for the shoot proliferation induction/witches’-broom-like symptoms generated during AY-WB infection in A. thaliana.
Discussion
Multiple pathogen effectors target the host ubiquitin-26S proteasome system. However, effectors described so far mostly interfere with aspects of the ubiquitination machinery, such as ubiquitin and E1 , E2 and E3 ligase activity, or inhibit the general enzymatic
activities of the host 26S proteasome. Here we identified an effector that directly binds a 26S proteasome component leading to the degradation of substrates, without the apparent requirement for ubiquitination. The plant ubiquitin proteasome system tightly regulates GATA and SPL abundance, and SAP05 generates a short cut that does not depend on ubiquitin. To date, effectors that directly link host targets to the proteasome system in a ubiquitin independent manner are not known. Thus, the mode of action we have identified involving SAP05 is potentially significant. Whereas cellular protein levels may be altered by gene knockout and RNA silencing, some systems require the direct targeting of proteins for degradation. In fact, targeted protein degradation has become one of the most promising approaches for drug discovery in targeted therapies. Current approaches to changing protein abundance in cells rely on substrate ubiquitination: for example, the proteolysis-targeting chimera (PROTAC) technique uses small-molecule ligands that create complexes between E3 ligases and targets, a process that can be challenging. Our study of phytoplasma effectors has revealed an alternative approach whereby bridging targets directly onto proteasome subunits, such as RPN10, results in efficient protein degradation.
This strategy of engineering targets to become resistant to effector modulation may be used to engineer resistance to the effectors of other pathogens. However, effectors of more specialised pathogens may not have evolved to avoid modulation of targets within organisms that they do not colonise. Insect-transmitted pathogens have mechanisms to differentially modulate primary host versus insect vector processes: for instance, liberibacters and phytoplasmas differentially regulate effector gene expression depending whether they colonise plants or insect vectors. Here we show evidence that where conserved proteins among divergent organisms are targeted, effectors appear to avoid binding targets in certain hosts. Such effectors may also be present in other multihost pathogen systems, including insect-transmitted pathogens, such as B. burgdorferi, Y. pestis and Liberibacter spp., exposing an Achilles heel of multi-host pathogens that can be exploited to achieve resistance.
Example VI: Material and Method
Plant growth conditions
A. thaliana Columbia-0 ecotype (Col-0) plants were grown in the greenhouse under either long-day (16 h light/8 h dark) or short-day conditions (10 h light/8 h dark) at 22°C. To generate 35S::SAP05 or AtSUC2::SAP05 plants, a codon-optimised SAP05 coding
sequence without the secretory signal peptide was used. Transgenic plants were generated as previously described.
Yeast two-hybrid analysis
The initial Y2H screen of SAP05 against the A. thaliana seedling library was performed by Hybrigenics Services SAS (Paris, France). The coding sequence of SAP05 without the secretory signal peptide was cloned into a pB27 bait plasmid as a C-terminal fusion to the LexA domain). The prey library was constructed from an A. thaliana seedling cDNA library, with pP6 as the prey plasmid. In a second yeast two-hybrid screen, the same SAP05 sequence was cloned into the pDEST32 plasmid and screened against an A. thaliana transcription factor library (pDEST22-TF). The identified interactions were further confirmed using the Matchmaker Gold yeast two-hybrid system (Clontech) or the DUALhybrid system (Dualsystems Biotech).
Protoplast degradation assays
A. thaliana (Col-0) mesophyll protoplast isolation and transformation were carried out according to the methods of Yoo et al.. Briefly, mesophyll protoplasts were isolated from leaves of 4-5-week-old A. thaliana plants grown under short-day conditions. For transfection, 300 pl of fresh protoplast solution (120,000 protoplasts) was transformed with 24 pg of high-quality plasmids (12 pg each for co-transfection) using the PEG- calcium method. Transfected protoplasts were incubated at room temperature (22-25 °C) for 16 h in the dark before harvest. For MG132 treatment, a final concentration of 20 pM was used during the 16-h incubation period. For detection of proteins on western blots, whole protein extracts from protoplasts were separated on NuPAGE 4-12% BisTris Gels (Invitrogen) and transferred to 0.45-pm PVDF membranes (Thermo Scientific) using the Bio-Rad mini-PROTEAN Electrophoresis system. Membranes were blocked by incubation in 5% (w/v) milk power in phosphate-buffered saline and 0.1 % (v/v) Tween- 20 for 2 h at room temperature. Primary antibody incubation was carried out at 4 °C overnight. Antibody to SAP05 from AY-WB phytoplasma were raised to the mature part of the SAP05 protein (residues 33-135), which was produced with a 6XHis-tag into Escherichia coli and purified. The purified protein was used for raising polyclonal antibodies in rabbits (Genscript). Optimal detection of SAP05 in phytoplasma-infected plants occured at a 1 :2,000 dilution of the antibody, and this dilution was used in all western blot experiments for detection of SAP05. The OptimAb HA.11 monoclonal antibody (Eurogentec) was used to detect hemagglutinin (HA)-fusion proteins at the concentration of 0.5 pg/ml. Rabbit polyclonal anti-GFP antibody (Santa Cruz
Biotechnology) was used at a 1 :10,000 dilution. Protein loading was visualised using Amido black staining solution (Sigma).
GUS staining
GUS staining of healthy or phytoplasma-infected plants at 4 weeks after phytoplasma inoculation was performed as described previously.
Insect fecundity assay
The aster leafhopper M. quadrilineatus was reared on oats under long-day conditions at 22 °C. A. thaliana plants used for insect fecundity assays were grown on insecticide-free F2 compost soil (Levington) in 8 x 8 cm pots under short-day conditions for 4 weeks. For choice fecundity assay, three control plants and three experiment plants, placed in an alternating manner, were bagged together in a perforated bag. Twenty leafhoppers (10 females and 10 males) were released into the bag for 5 d and removed. The plants were then bagged individually and the nymphs that developed on each plant were scored 2-3 weeks after leafhopper removal. The experiments were repeated at least three times. For no-choice fecundity assays, the plants were bagged individually from the beginning. Ten leafhoppers (six females and four males) were kept on each plant for 5 d and removed. The number of nymphs produced on each plant was scored 2-3 weeks after leafhopper removal. For each genotype, at least three plants were used in no-choice fecundity assays.
Phytoplasma inoculation
M. quadrilineatus colonies carrying the AY-WB phytoplasma were reared on infected lettuce and china aster under long-day conditions at 24 °C. For A. thaliana inoculation, one leaf from a 4-week-old plant grown under short-day conditions was exposed to two or three leafhoppers from this colony in a clip cage for 2 d. The leaf and the clip cage were then removed to get rid of the insects. The plants were then transfer to either short- day or long-day conditions for recording of disease symptoms.
Phylogenetic analysis
Sequences were aligned with MUSCLE (v3.8.31) configured for highest accuracy. Phylogenetic trees were reconstructed using the maximum-likelihood method implemented in the PhyML program (v3.1/3,0 aLRT). Graphical representation and editing of the phylogenetic trees were performed with TreeDyn (v198.3).
Statistical Analysis
Statistical analysis was performed in Prism 7. /_2 test was used to analyse choice fecundity assay data. One-way ANOVA was used to analyse no-choice fecundity assay
data with more than 2 two experimental groups, and two-tailed unpaired Student’s t-test was used for other data analysis.
References
1 Jiang, Y., Zhang, C. X., Chen, R. & He, S. Y. Challenging battles of plants with phloem-feeding insects and prokaryotic pathogens. Proc Natl Acad Sci U S A 116, 23390-23397 (2019).
2 Eigenbrode, S. D., Bosque-Perez, N. A. & Davis, T. S. Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions. Annu. Rev. Entomol. 63, 169-191 (2018).
3 Bean, A. G. et al. Studying immunity to zoonotic diseases in the natural host - keeping it real. Nat. Rev. Immunol. 13, 851-861 (2013).
4 Tan, M. W. Cross-species infections and their analysis. Annu. Rev. Microbiol. 56, 539-565 (2002).
5 Madison-Antenucci, S., Kramer, L. D., Gebhardt, L. L. & Kauffman, E. Emerging Tick-Borne Diseases. Clin Microbiol Rev 33 (2020).
6 Hinnebusch, B. J., Jarrett, C. O. & Bland, D. M. "Fleaing" the Plague: Adaptations of Yersinia pestis to Its Insect Vector That Lead to Transmission. Annu Rev Microbiol 71 , 215-232 (2017).
7 Kumari, S. et al. Global Status of Phytoplasma Diseases in Vegetable Crops. Frontiers in microbiology 10, 1349-1349 (2019).
8 Sicard, A. et al. Xylella fastidiosa: Insights into an Emerging Plant Pathogen. Annu Rev Phytopathol 56, 181-202 (2018).
9 Wang, N. et al. The Candidatus Liberibacter-Host Interface: Insights into Pathogenesis Mechanisms and Disease Control. Annu Rev Phytopathol 55, 451-482 (2017).
10 Lee, I. M., Davis, R. E. & Gundersen-Rindal, D. E. Phytoplasma: phytopathogenic mollicutes. Annu Rev Microbiol 54, 221-255 (2000).
11 Strauss, E. Microbiology. Phytoplasma research begins to bloom. Science 325, (2009).
12 Bai, X. et al. AY-WB phytoplasma secretes a protein that targets plant cell nuclei. Mol Plant Microbe Interact 22, 18-30 (2009).
13 MacLean, A. M. et al. Phytoplasma Effector SAP54 Hijacks Plant Reproduction by Degrading MADS-box Proteins and Promotes Insect Colonization in a RAD23-Dependent Manner. PLoS Biol. 12 (2014).
14 Sugio, A., Kingdom, H. N., MacLean, A. M., Grieve, V. M. & Hogenhout, S. A. Phytoplasma protein effector SAP11 enhances insect vector reproduction by manipulating plant development and defense hormone biosynthesis. Proc Natl Acad Sc/ U S A 108, E1254-1263 (2011).
15 MacLean, A. M. et al. Phytoplasma effector SAP54 induces indeterminate leaflike flower development in Arabidopsis plants. Plant Physiol 157, 831-841 (2011).
16 Hoshi, A. et al. A unique virulence factor for proliferation and dwarfism in plants identified from a phytopathogenic bacterium. Proceedings of the National Academy of Sciences of the United States of America 106, 6416-6421 (2009).
17 Maejima, K. et al. Recognition of floral homeotic MADS domain transcription factors by a phytoplasmal effector, phyllogen, induces phyllody. Plant J 78, 541- 554 (2014).
18 Tomkins, M., Kliot, A., Maree, A. F. & Hogenhout, S. A. A multi-layered mechanistic modelling approach to understand how effector genes extend beyond phytoplasma to modulate plant hosts, insect vectors and the environment. Curr Opin Plant Biol 44, 39-48 (2018).
19 Sugio, A. et al. Diverse targets of phytoplasma effectors: from plant development to defense against insects. Annu Rev Phytopathol 49, 175-195 (2011).
20 Mathieu, J., Warthmann, N., Kuttner, F. & Schmid, M. Export of FT protein from phloem companion cells is sufficient for floral induction in Arabidopsis. CurrBiol 17, 1055-1060 (2007).
21 Frost, K. E., Willis, D. K. & Groves, R. L. Detection and variability of aster yellows phytoplasma titer in its insect vector, Macrosteles quadrilineatus (Hemiptera: Cicadellidae). J Econ Entomol 104, 1800-1815 (2011).
22 Xu, M. et al. Developmental Functions of miR156-Regulated SQUAMOSA PROMOTER BINDING PROTEIN-LIKE (SPL) Genes in Arabidopsis thaliana. PLoS Genet 12, e1006263 (2016).
23 Ranftl, Q. L., Bastakis, E., Klermund, C. & Schwechheimer, C. LLM-Domain Containing B-GATA Factors Control Different Aspects of Cytokinin-Regulated Development in Arabidopsis thaliana. Plant Physiol 170, 2295-2311 (2016).
24 Ding, L. et al. HANABA TARANU regulates the shoot apical meristem and leaf development in cucumber (Cucumis sativus L.). J Exp Bot GG, 7075-7087 (2015).
25 Zhang, X. et al. Transcription repressor HANABA TARANU controls flower development by integrating the actions of multiple hormones, floral organ specification genes, and GATA3 family genes in Arabidopsis. Plant Cell 25, 83- 101 (2013).
26 Szlanka, T. et al. Deletion of proteasomal subunit S5a/Rpn10/p54 causes lethality, multiple mitotic defects and overexpression of proteasomal genes in Drosophila melanogaster. J Cell Sci 116, 1023-1033 (2003).
27 Lin, Y. L. et al. The defective proteasome but not substrate recognition function is responsible for the null phenotypes of the Arabidopsis proteasome subunit RPN10. Plant Cell 23, 2754-2773 (2011).
28 Smalle, J. et al. The pleiotropic role of the 26S proteasome subunit RPN10 in Arabidopsis growth and development supports a substrate-specific function in abscisic acid signaling. Plant Cell 15, 965-980 (2003).
29 Rothbauer, U. et al. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods 3, 887-889 (2006).
30 Prakash, S., Tian, L., Ratliff, K. S., Lehotzky, R. E. & Matouschek, A. An unstructured initiation site is required for efficient proteasome-mediated degradation. Nat Struct Mol Biol 11 , 830-837 (2004).
31 Fishbain, S. et al. Sequence composition of disordered regions fine-tunes protein half-life. Nat Struct Mol Biol 22, 214-221 (2015).
32 Wu, G. & Poethig, R. S. Temporal regulation of shoot development in Arabidopsis thaliana by miR156 and its target SPL3. Development 133, 3539- 3547 (2006).
33 Shapira, M. et al. A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci U S A 103, 14086- 14091 (2006).
34 Oshima, K. et al. Dramatic transcriptional changes in an intracellular parasite enable host switching between plant and insect. PLoS One 6, e23242 (2011).
35 Drurey, C. et al. Chemosensory proteins in the CSP4 clade evolved as plant immunity suppressors before two suborders of plant-feeding hemipteran insects diverged. bioRxiv, 173278 (2019).
36 Farmer, L. M. et al. The RAD23 family provides an essential connection between the 26S proteasome and ubiquitylated proteins in Arabidopsis. The Plant cell 22, 124-142 (2010).
37 van Schie, C. C. & Takken, F. L. Susceptibility genes 101 : how to be a good host. Annu Rev Phytopathol 52, 551-581 (2014).
38 Ribet, D. & Cossart, P. Ubiquitin, SUMO, and NEDD8: Key Targets of Bacterial Pathogens. Trends Cell Biol 28, 926-940 (2018).
39 Lin, Y. H. & Machner, M. P. Exploitation of the host cell ubiquitin machinery by microbial effector proteins. J Cell Sci 130, 1985-1996 (2017).
40 Cui, J. et al. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329, 1215-1218 (2010).
41 Sanada, T. et al. The Shigella flexneri effector Ospl deamidates LIBC13 to dampen the inflammatory response. Nature 483, 623-626 (2012).
42 Abramovitch, R. B., Janjusevic, R., Stebbins, C. E. & Martin, G. B. Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity. Proc Natl Acad Sci U S A 103, 2851-2856 (2006).
43 Tzfira, T., Vaidya, M. & Citovsky, V. Involvement of targeted proteolysis in plant genetic transformation by Agrobacterium. Nature 431 , 87-92 (2004).
44 Qiu, J. Z. et al. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors. Nature 533, 120-124 (2016).
45 llstun, S., Bartetzko, V. & Bornke, F. The Xanthomonas campestris type III effector XopJ targets the host cell proteasome to suppress salicylic-acid mediated plant defence. PLoS Pathog 9, e1003427 (2013).
46 Groll, M. et al. A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism. Nature 452, 755-758 (2008).
47 Chamberlain, P. P. & Hamann, L. G. Development of targeted protein degradation therapeutics. Nat Chem Biol 15, 937-944 (2019).
48 Schapira, M., Calabrese, M. F., Bullock, A. N. & Crews, C. M. Targeted protein degradation: expanding the toolbox. Nat. Rev. Drug Discov. 18, 949-963 (2019).
49 Yan, Q. et al. Global gene expression changes in Candidatus Liberibacter asiaticus during the transmission in distinct hosts between plant and insect. Molecular plant pathology 14, 391-404 (2013).
50 Zhang, L. et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF- kappaB activation. Nature 481 , 204-208 (2011).
51 Zhang, Y., Higashide, W. M., McCormick, B. A., Chen, J. & Zhou, D. The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase. Mol Microbiol 62, 786-793 (2006).
52 Pruneda, J. N. et al. The Molecular Basis for Ubiquitin and Ubiquitin-like Specificities in Bacterial Effector Proteases. Mol Cell 63, 261-276 (2016).
53 Ustun, S. & Bornke, F. The Xanthomonas campestris type III effector XopJ proteolytical ly degrades proteasome subunit RPT6. Plant Physiol 168, 107-119 (2015).
54 Pruneda-Paz, J. L. et al. A genome-scale resource for the functional characterization of Arabidopsis transcription factors. Cell Rep 8, 622-632 (2014).
55 Yoo, S. D., Cho, Y. H. & Sheen, J. Arabidopsis mesophyll protoplasts: a versatile cell system for transient gene expression analysis. Nat Protoc 2, 1565- 1572 (2007).
SEQUENCE LISTING
• RPN 10 cDNA sequences
Underlined bases are mutation/substitution positions in the cDNA sequence that lead to a 39-40 GA to HS mutation in the amino acid sequence of AtRPNIO or a homologous mutation at a homologous position in a homologous sequence (homologous mutations are underlined).
SEQ ID NO: 1 >NM_120024.3:140-1300 Arabidopsis thaliana regulatory particle non- ATPase 10 (RPN10), cDNA ATGGTTCTCGAGGCGACTATGATATGTATCGACAACTCCGAGTGGATGCGAAACG GAGATTACTCTCCGTCTAGGTTACAGGCGCAAACGGAAGCTGTTAATCTTCTTTGC GGAGCCAAAACCCAGTCGAATCCGGAGAATACGGTGGGGATTTTGACAATGGCT GGCAAAGGAGTTAGAGTATTGACTACTCCTACCTCTGATCTTGGCAAAATTCTGGC CTGTATGCACGGCCTTGATGTGGGAGGAGAGATCAACTTAACCGCAGCTATCCAG ATCGCCCAGCTAGCTCTTAAGCATCGCCAAAACAAGAATCAACGCCAAAGGATTA TTGTTTTTGCTGGAAGTCCAATCAAGTACGAGAAGAAGGCCCTAGAGATAGTTGG AAAAAGGCTGAAGAAGAATAGTGTCTCTCTTGATATTGTCAATTTCGGGGAGGATG ATGATGAGGAAAAGCCTCAGAAACTCGAGGCGCTCCTTACAGCTGTGAATAACAA TGACGGTAGCCACATTGTTCATGTTCCTTCTGGAGCCAATGCTCTCTCAGATGTGC TTCTCAGCACACCTGTATTCACGGGTGATGAGGGTGCAAGTGGCTATGTTTCTGC GGCAGCTGCTGCAGCGGCCGCAGGTGGGGACTTCGACTTTGGTGTGGACCCAAA TATCGATCCAGAACTTGCTCTTGCCCTTCGGGTCTCCATGGAGGAGGAGAGAGCA AGACAAGAAGCTGCTGCCAAGAAGGCGGCCGATGAGGCAGGTCAGAAAGACAAA GATGGGGACACAGCTTCCGCCTCACAGGAGACAGTTGCTAGGACAACTGACAAG AACGCTGAACCAATGGATGAGGACAGTGCGTTGCTAGATCAGGCAATTGCTATGT CTGTTGGTGATGTGAATATGTCAGAAGCGGCTGATGAGGACCAGGATCTGGCTTT AGCTCTGCAAATGTCAATGAGTGGGGAAGAGTCAAGTGAAGCTACAGGTGCTGGA AACAACCTCTTGGGAAATCAAGCCTTCATATCGTCTGTTCTCTCATCGCTTCCTGG GGTGGATCCAAATGATCCGGCAGTTAAAGAACTACTAGCGTCTCTGCCAGACGAG TCAAAGCGTACCGAGGAGGAAGAGAGTAGTAGCAAAAAAGGCGAGGATGAGAAG AAGTGA
SEQ ID NO: 2>Brassica_napus_BnaA06g37370D
ATGATATGCATCGACAACTCAGAGTGGATGAGAAACGGAGATTACTCACCCTCTA GGTTGCAGGCTCAAACCGAAGCTGTCAATCTTCTCTGCGGTGCCAAAACTCAGTC GAATCCAGAGAACACGGTAGGGATCTTGACAATGGCGGGCAAAGGAGTTAGAGT TTTGACGACGCCTACCTCTGATCTTGGCAAAATTTTGGCCTGTATGCACGGGCTC GATGTGGGAGGAGAGATTAACTTAACGGCAGCCATCCAGATTGCCCAGCTTGCTC TTAAGCATCGCCAAAACAAGAATCAACGCCAACGGATTATTGTTTTCGCTGGAAGC CCAATCAAGTATGAAAAGAAGGCCTTGGAGGTTGTTGGCAAAAGGCTCAAAAAGA ACAGTGTCTCTCTTGACGTTGTCAATTTTGGTGATGATGACGATCAGGATAAGCCT CTCAAACTGGAGGCCCTCCTTTCTTCTGTCAATAACAACGATGGTAGCCACATTGT TCATGTTCCTTCTGGTCCCAACGCCCTCTCTGATGTCCTTCTCAGCACACCTGTAT
TCACTGGTGATGAGGGTGCAAGTGGGTATGTTTCTGCCGCAGCTGCTGCTGCTG
CTGCCGGTGGTGACTTTGACTTTGGTGTTGATCCAAATATCGATCCAGAGCTTGCT
CTCGCCCTTCGGGTCTCCATGGAAGAGGAGAGAGCAAGGCAAGAGGCTGCTGCT
AAGAAGGCAGCTGATGAGGCAGGTCAGAAAGACCAAGATGGGGCTTCAGCTTCT
GCTTCGCAGGAGACGGTTGCTAGGACAACTGAGAAGAACGCTGAACCAATGGAT
GAGGACAACGCATTGCTAAATCAGGCAATTGCTATGTCCGTTGGTGATGTAAACAT
GTCAGAAGCGGCAGATGAGGACCAGGATTTGGCTTTAGCTCTGCAAATGTCAATG
AGTGGGGAGGAAGCTACGGGTGCTGGAAACCTCTTAGGAGATCAAGCTTTCATAT
CATCTGTTCTCTCATCCCTTCCAGGGGTGGATCCAAATGATCCAGCGGTTCAAGC
GCTGCTAGCGTCTCTGCCAGACGAATCAAAGCGTAACGAGGAGGAAGAGAGTAG
TAGCAAAGGTGAGGATGAGAAGAAGTGA
SEQ ID NO: 3>Brassica_napus_BnaC07g47640D
ATGATATGCATCGACAACTCCGAGTGGATGAGAAACGGAGATTACTCACCCTCTA
GGTTACAAGCTCAAACCGAAGCTGTCAATCTTCTCTGCGGTGCCAAAACCCAGTC
GAATCCAGAGAACACGGTGGGGATCTTGACAATGGCAGGGAAAGGAGTTAGAGT
TTTGACGACGCCTACCTCTGATCTTGGCAAGATTCTGGCCTGTATGCACGGCCTC
GATGTTGGAGGAGAGATTAACTTAACGGCAGCCATCCAGATTGCTCAGCTTGCTC
TTAAGCATCGCCAAAACAAGAATCAACGCCAACGGATTATTGTTTTCGCTGGAAGC
CCAATCAAGTATGAAAAGAAGGCCTTGGAGGTTGTTGGCAAAAGGCTCAAAAAGA
ATAGTGTCTCTCTTGACATTGTCAATTTTGGTGAAGATGACGATCAGGATAAGCCT
CTGAAACTGGAGGCCCTCCTTTCTGCTGTCAATAACAACGATGGTAGCCACATTG
TTCATGTTCCTTCTGCTGCCAATGCTCTCTCCGATGTCCTCCTCAGCACACCTGTA
TTCACTGGTGATGAGGGTGCAGCTGGGTATGTTTCTGCTGCAGCTGCAGCCGGT
GGTGACTTTGACTTTGGTGTTGATCCAAATATCGATCCAGAGCTTGCTCTTGCCCT
TCGGGTCTCCATGGAGGAGGAGAGAGCAAGGCAAGAGGCTGCTGCTAAGAAGGC
AGCTGATGAGGCAGGTCAGAAAGACCAAGATGGGGCTTCTGCTTCGCAGGAGAC
GGTTGCTAGGACAACTGAGAAGAACGCTGAACCAATGGATGAGGACAACGCATTG
CTAAATCAGGCAATTGCTATGTCCGTAGGTGATGTAAACATGTCAGAAGCGGCGA
ATGAGGACCAGGACTTGGCTTTAGCTCTTCAAATGTCAATGAGTGGGGAGGAGTC
AAATGAAGCTATGGGTGCTGGAAACCTCTTAGGAGATCAAGCTTTCATATCATCTG
TTCTCTCATCGCTTCCAGGGGTGGATCCAAATGATCCAGCGGTTCAAGCGCTGCT
AGCGTCTCTGCCAGACGAATCAAAGCGTAACGAGGAGGAAGAGAGTAGTAGCAA
AGGTGAGGATGAGAAGAAGTGA
SEQ ID NO: 4>Brassica_napus_BnaA08g16980D
ATGATTTGCATCGACAACTCCGAGTGGATGCGAAACGGAGATTACTCTCCCTCTA
GGCTACAGGCTCAAACCGAAGCTGTTAATCTTCTCTGTGGGGCCAAAACCCAGTC
GAATCCGGAGAATACAGTGGGGATCTTGACAATGGCTGGGAAAGGAGTTAGAGTT
TTGACAACTCCTACCTCTGATCTTGGCAAAATCTTGGCGTGTATGCATGGACTTGA
GGTGGGAGGGGAGATTAACTTAACGGCTGCGATACAGATTGCTCAGCTAGCTCTT
AAGCATCGTCAAAACAAGAATCAACGCCAAAGGATTATTGTTTTTGCTGGAAGCCC
AATCAAGTATGAAAAGAAGGCCTTGGAGGTTGTTGGGAAAAGGCTCAAGAAGAAT
AGTGTCTCTCTTGACATTGTCAATTTTGGAGATGATGATGATGAGGAAAAACCTCA
GAAACTTGAGGCCCTCCTTGCAGCTGTCAATAACAATGACGGAAGCCACATTGTT
CATGTTCCTTCTGGGGCCAATGCTCTCTCTGATGTGCTTCTCAGCACACCTGTATT
CACGGGTGATGAGGGTGCAAGTGGGTATGTTTCTGCGGCAGCTGCTGCAGCTGC
AGCGGGTGGTGACTTTGACTTTGGTGTGGATCCAAATATCGACCCAGAACTTGCT
CTTGCCCTTCGAGTCTCCATGGAGGAGGAGAGAGCAAGGCAAGAGGCTGCTGCT
AAGAAGGCAGCCGATGAGGCAGGTCAGAAAGACAAAGACGGGGATACAGCTTCG
GCCTCACAGGAGACGGTTGCTAGGACAACCGAGAAGAACGCTGAACCAATGGAT
GAGGACAACGCATTGCTAGACCAGGCAATTGCTATGTCCGTAGGTGATGTAAACA
TGTCAGAAGCGGCGGATGAGGACCAGGATTTGGCTTTAGCGCTGCAAATGTCAAT
GAGTGGGGAAGAGTCAGGTGAAGCTACGGGTGCTGGAAACCTCTTAGGAGATCA
AGCTTTCATATCATCTGTTCTCTCATCGCTTCCAGGGGTGGATCCAAATGATCCAG
CGGTTCAAGCGCTGCTAGCGTCTCTGCCAGACGAATCAAAGCGTAACGAGGAAG
AGAGTAACAGCAAAGGTGAGGATGAGAAGAAGTGA
SEQ ID NO: 5>Brassica_napus_BnaC03g60090D
ATGATTTGCATCGACAACTCCGAGTGGATGCGAAACGGAGATTACTCTCCCTCTA
GGTTACAGGCTCAAACCGAAGCTGTTAATCTTCTCTGTGGGGCCAAAACCCAGTC
GAATCCGGAGAACACGGTGGGGATCTTGACAATGGCAGGGAAAGGAGTTAGAGT
GTTGACAACTCCTACCTCTGATCTTGGCAAAATCTTGGCCTGTATGCACGGTCTCG
ATGTGGGAGGAGAGATTAACTTAACAGCTGCGATACAGATTGCTCAGCTAGCTCT
TAAGCATCGTCAAAACAAGAATCAACGCCAAAGGATTATTGTTTTTGCTGGAAGCC
CAATCAAGTATGAAAAGAAGGCCTTGGAGGTTGTTGGCAAAAGGCTCAAGAAGAA
TAGTGTCTCTCTTGACATTGTCAATTTTGGAGATGATGACGATGAGGAAAAGCCTC
AGAAACTTGAGGCCCTCCTTGCAGCTGTCAATAACAATGACGGAAGCCACATTGT
TCATGTTCCTTCTGGAGCCAATGCTCTCTCTGATGTGCTTCTCAGCACACCTGTAT
TCACTGGTGATGAGGGTGCAAGTGGGTATGTTTCTGCGGCAGCAGCTGCAGCTG
CAGCAGGTGGTGACTTTGACTTTGGTGTGGATCCAAATATCGACCCAGAACTTGC
TCTTGCCCTTCGAGTCTCCATGGAGGAGGAGAGAGCAAGGCAAGAGGCTGCTGC
TAAGAAGGCAGCGGATGAGGCAGGTCAGAAAGACAAAGACGGGGATACAGCTTC
GGCCTCACAGGAGACGGTTGCTAGGACAACTGAGAAGAACGCTGAACCAATGGA
TGAGGACAACGCATTGCTAGACCAGGCAATTGCTATGTCCGTAGGTGATGTAAAC
ATGTCAGAAGCGGCGGATGAGGACCAGGATTTGGCTTTAGCGCTGCAAATGTCAA
TGAGTGGGGAAGAGTCAGGTGAAGCTACGGGTGCTGGAAACCTCTTAGGAGATC
AAGCTTTCATATCATCTGTTCTCTCGTCGCTTCCAGGGGTGGATCCTAATGATCCA
GCGGTTCAAGCGCTGCTAGCGTCTCTGCCAGACGAATCAAAGCGTAACGAGGAA
GAGAGTAACAGCAAAGGTGAGGATGAGAAGAAGTGA
SEQ ID NO: 6>XM_002264522.3 Vitis vinifera 26S proteasome non-ATPase regulatory subunit 4 homolog (LOG 100257366)
ATGGTGCTCGAGGCGACTATGATCTGTATCGACAATTCCGAATGGATGCGAAATG
GCGATTATTCTCCCACTAGATTTCAGGCTCAAGCCGACGCCGTTAATCTTATCTGT
GGAGCTAAGACTCAGTCCAATCCAGAAAATACTGTGGGAGTTCTTACAATGGCAG
GCAAAGGGGTCCGAGTTTTGGTCACTCCCACAAGCGATCTCGGCAAGATCTTGGC
GTGCATGCACGGTTTAGAGGTGGGTGGTGAGATGAACTTAGCCGCAGGTATCCA
AGTGGCTCAATTGGCTCTTAAGCATCGACAAAACAAAAAGCAGCAACAAAGGATC
ATTGTCTTTGCTGGAAGTCCTGTAAAGTATGACAAGAAGGTATTAGAGATGATTGG
AAGAAAGCTAAAAAAGAATAGTGTGGCCATTGATATTGTGGATTTTGGTGAGGATG ATGATGGGAAGCCAGAGAAACTTGAGGCCCTTCTTGGTTCTGTAAACAACAATGA TAGTAGCCACATAGTTCATGTTCCTGCTGGTCCAAATGCTCTTTCTGACGTGCTTA
TAAGTACACCCATCTTCACAGGGGATGGGGAAGGTGGAAGTGGTTTTGCAGCAG
CTGCCGCCGCAGCAGCAGCTGGTGGTGTGGCTGGTTTTGATTTTGGTGTGGATC
CAAACTTAGATCCTGAACTGGCTCTTGCTCTTAGAGTTTCAATGGAAGAAGAGAGA
GCGAGACAAGAAGCTGCTGCTAAAAAGGCTGCGGAGGAGGCTTCCAGACAGGAA
AAGGAAGGGGAACAGCAATCTAGTTCTCAAGATGCAACTATGACTGAGCACGCCA
ATGTTGCAGCTTCTGATGCTGATAAGAAAAGTGATCTAATGGATGATGAGAATGCT
TTGCTACAGCAGGCCCTTGCAATGTCTATGGATGACCCTGCCACTAGCCTTGCCA
TGAGAGACACAGATATGTCTGAGGCAGCTGCAGATGATCAGGACTTGGCTCTTGC
TCTTCAATTATCTGTGCAGGACACTGGAAAAGATTCAACCAGTCAGACCGACATGA GTAAATTGTTGACAGATCAGACTTTTGTGTCCTCTATCCTTGCATCTCTTCCAGGA GTTGACCCCAATGATCCTTCAGTCAAAGATTTGCTAGCATCCATGCAAAATGAGTC
AGAGTCCCAGCAGAAGAAGAATGAGGACAAGGCACCAGATGAGGAAGACAAGTG A
SEQ ID NO: 7>XM_003520152.4 Glycine max 26S proteasome non-ATPase regulatory subunit 4 homolog (LOG 100780583)
ATGGTGCTCGAGGCGACTATGATCTGTATTGACAATTCGGAATGGATGCGTAACG
GGGATTACTCTCCTTCTCGATTTCAAGCCCAAACAGACGCCGTCAATCTTATTTGC
GGTGCTAAAACCCAGTCTAATCCAGAAAATACGGTGGGAGTTCTCACGATGGCGG
GGAAGGGCGTTCGTGTTTTGGTGACCCCTACCAGTGATCTGGGCAAGATCTTAGC
TTGCATGCATGGACTAGAAATAGGCGGTGAGATGAATCTAGCTGCTGGCATTCAG
GTTGCACAATTGGCTCTTAAGCATCGGCAGAACAAGAAGCAGCAGCAAAGGATTA
TTGTCTTTGCTGGAGGTCCTGTTAAGCATGAGAAGAAAATGTTGGAGATGATTGG
GAGAAAATTGAAAAAGAATAGTGTAGCTCTTGACATTGTCAATTTTGGTGAAGAAG
ATGAGGGGAAGACAGAGAAGTTGGAGGCACTCCTTTCAGCTGTTAACAATAATGA
TACCAGCCACATTGTTCATGTTCCATCTGGTCCAAACGCTCTTTCTGATGTACTAA
TAAGTACTCCTATTTTTACTGGTGATGGGGAAGGTGGAAGTGGTTTTGCAGCAGC
TGCTGCTGCAGCAGCAGCAGGCGGTGTATCTGGATTTGAGTTTGGTGTTGATCCA
AACTTGGACCCTGAACTGGCTCTTGCTCTAAGAGTTTCAATGGAAGAAGAGAGAG
CCAGACAAGAAGCAGCTGCCAAAAAGGCATCAGAGGATGCTTCCAAACAGGAGA
AAGATGGTGAGCAGCAAGCTAGCCCACAGGATACAACAATGACTGAGGGTGCCA
GTGCAGCAGCTTCTGAAGCCGAGACTAAGAGAACTGATTTGACGGACGATGAGAA
TGCTCTTCTACAGCAGGCCCTTGCAATGTCAATGGATGATCCCACAATTAACCATG
AAGTGAGAGATACAGATATGTCTGAAGCAGCTGCTGAAGATCCCGAGTTGGCTCT
AGCTCTCCAATTGTCAGTAGAAGACAGCTCAAAGGACTCGGCAAGCCAGTCTGAC
GTGAGTAAACTGTTGGCAGATCAGTCCTTTGTATCTTCTATCCTTGCATCGCTTCC TGGGGTTGACCCAAATGACCCATCTGTCAAAGATTTGCTGGCTTCCATGCAAAATC AGTCTGAGCCACAGCAGAAGAATGAAGACAAGCCACCAAATGAAGAGGAGAAAAA
ATAA
SEQ ID NO: 8 >XM_015776829.2 Oryza sativa Japonica Group 26S proteasome non- ATPase regulatory subunit 4 homolog (LOC4332222)
ATGGTGCTCGAGGCGACGATGATCTGCATAGACAACTCGGAGTGGATGCGGAAC
GGCGACTACTCGCCGTCGCGATTCCAGGCTCAGGCCGACGCCGTCAACCTCATC
TGTGGCGCCAAGACCCAGTCCAACCCGGAGAACACGGTGGGCGTCATGACGATG
GCCGGAAAGGGCGTGCGCGTGCTCGTCACTCCCACCAGCGACCTCGGCAAGATC
CTCGCTTGTATGCACGGACTTGAAGTTGGTGCTGAAGCAAATTTGGCTGCAGCAA
TTCAGGTTGCTCAGCTGGCTCTGAAGCATCGCCAGAATAAGAGGCAGCAACAGC
GGATTATAGCTTTTATTGGAAGCCCTGTGAAATACGACAAGAAAGTTTTGGAAACA
ATCGGGAAAAAGCTGAAGAAGAATAATGTGGCTCTTGACATCGTTGACTTTGGTG
AAACCGATGATGATAAGCCTGAGAAACTGGAAGCGCTAATCTCTGCTGTGAACAG
TAGTGATAGCAGCCACATCGTTCATGTCCCTCCCGGTGAAAATGCCCTTTCCGAT
GTGCTTATAAGTACTCCTATCTTCACTGGTGAAGAAGGTGGAAGCGGTTTTGCTG
CTTCTGCAGCAGCAGCAGCAGCTACTGGTGCAGCTGGATTTGAATTTGATGTGGA
CCCAAATGTAGATCCAGAATTGGCACTCGCCCTGCGGTTGTCCATGGAAGAAGAG
CGAGCAAGGCAAGAGGCTATTGCGAAGAAGGCCGCAGAAGAATCTTCTGGTGCT
GAAAATAAGGACCATGCCTCAAGCTCAAACGCTGATTCTGTTATGGCAGAAGCGG
AACCTGCCTCAAATGCTGCTGATGATAAAAAAGATCAGCCGAAGGAAGATGATGA
TGCTCAGCTACTACAACAGGCTCTTGCAATGTCAATGGAGGAGGGTTCTTCAGGG
GCTGCAGCGGCTGATGCTGCTATGGCAGAGGCTGCTGTAGATGACCAGGACTTG
GCACTAGCTCTTCAAATGTCTGTCCAGGACGCAGGCGGGTCTAGTCAGTCTGATA
TGAGCAAGGTGTTTGAAGACAGATCATTTGTTACATCCATCCTTAACTCTCTCCCT
GGTGTTGACCCCAATGACCCCTCTGTGAAAGATTTGCTGGCATCATTGCATGGGC
AGGGCGAGCAAGAGAAGAAGGAAGACAAATCAGACAAGCCAGAAGATGAGAAGA
AATAA
SEQ ID NO: 9>XM_026020592.1 Oryza sativa Japonica Group 26S proteasome non-
ATPase regulatory subunit 4 homolog (LOC4348083)
ATGGTGCTCGAGCTCGAGGCGACGGTGATATGCGTGGACGACTCCGAGTGGATG
CGGAACGGCGACTACCCGCCGACGCGGCTCCAGGCGCAGGAGGACGCCGCCAA
CCTCGTCGTCGGCACTAAAATGACGTCGAACCCGGAGAACACGGTCGGGGTGCT
GGCCATGGCTGGGGACAGAGTGCGCGTGCTCCTCGCGCCCACCAGCGACCCCG
TCAAGTTCCTCGCCTGCATGCACGGGCTGGAAGCTAGTGGTGAAGCAAATTTGAC
TGCTACTCTAAATATTGCTGAACTGGTACTTAAAAATCGTCCCGACAAAAGACTGA
GTCAGAGGATAGTTGTTTTTGTTGGCAGCCCTGTAAAAGATGAAAAGTTAGAGACA
ATTGGAAAAAAGCTGAAGAAGTATAATGTTTCTCTTGATGTTGTTGAATTTGGCGA
ATCTGACGATGAAAAGCCTGAGAAACTAGAAGCTCTTGTTGCTGCAGTTGGTGGC
AGCAGCCACATAGTTCACATCCCACCTGGGGAAGATCTTCGTGCCGTCCTTGCCA
ATACACCGATAATTACTGGAGATGAAGGAGGGGGTGCTGCAGCCGGTGGAGCAT
CTAGATATGAATACAATGTTGACCCAAATGTGGATCCAGAGTTTGCAGAAGCACTT
CGTTTATCAGAGATAGCAAGGCAAGAAGCTGCAGCCGATGGAGCATCTAGATATG
AATACAGTGTTGACCCAAATGCGGATCCAGAGTTAGCAGAAACATTTCGTTTGGCT
GCAGGGGAACCTTCAACCTCAAACACTGATACTGTTCTCTTGGAATCTGACTCAGA
CACTTATGTTCCTTTTCATGAGTTCATACAAAATAATCCTTTTGTGACTGGAGCGGA
ATCTGCCTCAGATAGACCTGCTGACGATGAGAGGGCAACGGAAGAAGGGTTCCG
TATGATACGAGAAGCTCTTGCAAGGTCTGCAAATGCAGCACATGCTGAAATATCA
GGCAATTCCTCATCTGGGCAGGAGTTGGAATTAGGTTAA
SEQ ID NO: 10>XM_010318126.3 Solanum lycopersicum 26S proteasome non- ATPase regulatory subunit 4 homolog (LOC101263071)
ATGGTGCTCGAGGCGACAATGATCTGCATCGACAATTCGGAGTGGATGAGAAACG
GTGATTACTCGCCCAATAGGTTCCAAGCTCTAGCAGACGCTGTTAATCTAATCTGT
GGTGCCAAAACCCAGTCTAATCCCGAGAATACAGTTGGAATTTTGACGATGGCTG
GTAAAGGGGTTCGAGTGTTAGTCACTCCGACCAGCGATCTTGGAAAAATTTTAGC TTGTATGCACGGATTGGAGATAGGCGGTGAGATGAATTTGGCTGCTGGAATCCAG
GTAGCCCAGTTGGCTTTGAAGCACCGACAAAACAAGAAGCAACAACAAAGGATTA TTGTTTTTGCTGGCAGCCCTGTTAAATATGACAAGAAGGTCTTGGAGATGATTGGG
AGAAAGTTGAAGAAGAATAGTGTAGCTCTTGATGTGGTTAATTTTGGTGAAGATGA
TGAAGGGAAAGCTGAGAAGCTAGAGGCACTAGTTGCTGCGCTTAATACCAACGAC
AGTAGTCACATCATTCATATTCCTCCTGGTCCTAATGCTCTCTCTGATGTTCTCATA
AGTACTCCTATTTTCACTGGTGATGGAGAAGGTGGCAGTGGATTTGCTGCTGCTG
CTGCAGCGGCTGCTGCTGGTGGAGTGTCTGGATATGATTTTGGTGTAGATCCTAA
TTTGGATCCAGAACTTGCTCTCGCACTCCGAGTTTCAATGGAGGAAGAAAGGGCG
AGGCAGGAAGCAGCTGCAAAGAAGGCTGCAGAAGAAGCTGGTAACCAAGAGAAA
GGAGAAAATCAGTCTACTTCTCAGGATGTTGCTATGGCTGAAAATGTCAATGCAG
GAACTTCTGAGCCTGAAAGCAAAGCAACTGACCTAATGGATGATGAGAATGCCTT
GTTACAGCAAGCCCTTGCAATGTCGATGGATGACTCGTCCTCCAATGTTGCTACA
CGAGACACTGACATGTCAGAAGCGGCTTCTGAAGATCAAGACTTGGCACTTGCTC
TTCAACTGTCTGTGCAAGACAGTACAAATGATCAGTCAAATCCGACAGATATGAGT
AAGCTGTTGGCAGATCAATCATTTGTGTCATCAATCCTTGCCTCACTTCCAGGTGT TGATCCAAACGATCCTTCTGTCAAAGATTTGCTTGCTTCCATGCAAGGGCAGTCCG
AGCAGAAGAAGGATGAGGACAATGATAAGGAACAGAAAGAGGACAAGAAGTAA
SEQ ID NO: 11>XM_006422562.2 Citrus Clementina 26S proteasome non-ATPase regulatory subunit 4 homolog (LOC18035426)
ATGGTTCTCGAGGCGACTATGATATGCATTGACAATTCGGAATGGATGCGAAACG
GCGATTACTCTCCGTCACGATTACGAGCTCAAGCGGACGCCGTTAGTCTTATTTG
TGGAGCCAAAACACAATCGAACCCGGAGAATACCGTGGGGATATTGACGATGGG
TGGCAAAGGGGTTCGTGTTTTGACTACTCCTACAACTGATCTTGGGAAAATTTTAG
CTTGCATGCATGAACTTGATATTGGGGGTGAGATGAACATAGCGGCAGGAATCCA
GGTTGCTCAGTTGGCTCTTAAGCATCGGCAGAACAAAAACCAGCGTCAAAGGATT
ATAGTTTTTGCTGGAAGTCCTGTTAAGTATGATAGGAAGGTAATGGAGATGATTGG
GAAGAAATTGAAGAAGAACAGTGTGGCTATTGATATTGTTAATTTTGGTGAAGATG
ATGATGGGAAGCCAGAGAAATTGGAAGCACTTCTTGCTGCAGTTAATAACAATGAT
AGTAGTCATCTAGTTCATGTTCCTACTGGTCCAAATGCTCTTTCTGATGTACTTATA
AGCTCACCTGTATTCACTGCTGATGGTGAAGGAGGAAGTGGCTTTGCTGCAGCAG CGGCGGCAGCTGCAGCTGGTGGAGTTTCTGACTTCGATTTTGGTGTGGACCCCA
ACATTGACCCTGAACTGGCTCTTGCCCTTAGGGTTTCCATGGAAGAGGAGAGAGC
AAGGCAAGAAGCTGCTGCCAAAAGGGCTGCTGATGAAGCTTCCAGACAAGGGAA
AGAGGAGGAGCCATCATCCAACTCACAGGATGCAACGATGACTGACAATACTAAC
AATACAGCAGCAGAAACAACTGAGAAAACTGCTGATCCAATGGATGAAGAGAAAT CTTTGCTAGAGAGGGCTTTTGCAATGTCCATGGGTACTTCTGTATCTGATACTTCC
ATGGCTGATGCTGATACGTCAAAAGCGACTGATGAGGATAAGGAGTTGGCCTTGG
CTCTCCAAATGTCCATGCAGGATGATACAAAAGATCCATCAAACCAATCAGATATG
AGCAAGGTGCTAGGGGATCAGTCATTTGTGTCATCCATCCTTACATCACTTCCAG
GAGTTGACCCAAATGATCCATCGGTGAAAGATCTGATTGCATCTCTTCAAGGTCAA
CCTGAGTCATCTGAACAGAAGAAGAAAGAAGATGAACCCCCAAAGGATGATAAGT
GA
SEQ ID NO: 12>XM_008374684.3 Malus domestica 26S proteasome non-ATPase regulatory subunit 4 homolog (LOG 103436261)
ATGGTTCTCGAGGCGACTATGATCTGCGTCGACAATTCCGAATGGATGCGAAACG
GCGATTACTCTCCCTCCCGATTGCAGGCTCAAGCTGACGCCATTAATCTCATCTGT
GGTGCCAAAACCCAGGCTAATCCGGAGAATACAGTTGGGGTATTGACAATGGCG
GGCAAAGGGGTGCGGGTTTTGGCTACTCCAACCTCTGATCTTGGCAGGATTTTGG
CTTGCATGCATGGTCTGGAGATGGGAGGTGAGATGAACATAGCAGCTGCAATCCA
GGTAGCACAGCTGGCTCTTAAGCATCGTCAAAACAAAAATCAACAACAGCGGATT
ATTGTTTTTGCTGGAAGTCCTGTTAAATTTGAAAAGAAGTTGTTGGAATCGATAGG
GAAGAAATTGAAAAAGAACAGTGTTGCTCTTGACATTGTTGATTTTGGTGAAGAGG
ATGATGGGAAGCCAGAGAAGCTGGAGGCCCTTCTGTCTGCTGTTAATAATAATGA
AAGCAGTCATATAGTACATGTCCCTCCTGGTCCAAATGCTCTCTCGGATGTTCTTA
TAAGTACACCTGTATTTACTGGTGACGGAGAAGGAGGAAGTGGTTTTGCAGTGGC
GGCGGCAGCAGCAACTGCTGCTGCTAATGGTGGCTCTGGGTATGACTTTGGAGT
TGATCCCAACATTGATCCTGAGCTGGCTCTCGCCCTTAGAGTTTCTATGGAAGAG
GAAAGGGCTAGGCAAGAAGCTGCTGCCAAAAGAGCTTCTGAAGAAGCTGGTGGG
AAAGGAGGGGAACCGTCATCCAAATCAGAAGATGCAACCATGACAGATCAAGCTA
ATGTTTCTTCTCCCAATGAGGATAAGAAACATACTGATAATATGGTTGATGAGAAT
GACTTGCTGAAGGAGGCTCTTGCAATGTCAATGAACGTCTCTGGAACTGGTCATT
CAGCAGGTGATACTGAGATGTCCGAAGCAACTAGTGCGGATCAGGAGTTGGCATT
AGCTCTTCAAATGTCGATGCAGGAAAGTGCAGGAGAGCCATCCTCCCAGAGCGAT
GCGAGCAAGGTGTTGGAGGATCAGTCTTTTATATCATCTATCCTTGAATCTCTTCC
AGGAGTTGACCCCAACGATCCTTCAGTGAAAGATCTTCTTGCATCTCTGAAGAATC
AGTCTGAGCAGAAGGACAAAGAAGAACCATCGAACAAGGACAAATGA
SEQ ID NO: 13>XM_006340687.2 Solanum tuberosum 26S proteasome non-ATPase regulatory subunit 4 homolog (LOC102594714)
ATGGTGCTCGAGGCGACAATGATCTGCATCGACAATTCGGAGTGGATGCGAAAC
GGTGATTACTCGCCCAATAGGTTCCAAGCTCTAGCAGACGCTGTTAATCTAATCTG
TGGTGCCAAAACCCAGTCTAATCCCGAGAATACAGTTGGAATTTTGACGATGGCT
GGTAAAGGGGTTCGAGTGTTAGTCACTCCGACTAGCGATCTTGGAAAAATCTTAG
CTTGTATGCACGGATTGGAGATAGGCGGTGAGATGAATTTGGCTGCTGGAATCCA
GGTAGCCCAGTTGGCATTGAAGCACCGACAAAACAAGAAGCAACAACAAAGGATC
ATTGTTTTTGCTGGCAGCCCTGTTAAATATGACAAGAAGGTCTTGGAGATGATTGG
GAGAAAGTTGAAGAAGAATAGTGTAGCACTTGATGTGGTTAATTTTGGTGAAGATG
ATGAAGGGAAAGCTGAGAAGCTAGAGGCACTAGTTGCTGCGCTTAATACCAATGA
CAGTAGTCACATCATTCATATTCCTCCTGGTCCTAATGCTCTCTCTGATGTTCTCAT
AAGTACTCCTATTTTCACTGGTGATGGTGAAGGTGGCAGTGGATTTGCTGCTGCT
GCTGCAGCGGCTGCTGCTGGTGGAGTGTCTGGATATGATTTTGGTGTAGATCCTA
ATTTGGATCCGGAACTTGCTCTCGCACTCCGAGTTTCAATGGAGGAAGAAAGGGC
GAGGCAGGAAGCAGCCGCAAAAAAGGCTGCAGAAGAAGCTGGTAACCAAGAGAA
AGGAGAAAATCAGTCTACTTCCCAGGACGTTGCTATGGCTGAAAATGTCAATGCA
GGAACTTCTGAGCCCGAAAGCAAAGCTACCGACCTAATGGATGATGAGAATGCCT
TGTTACAGCAAGCCCTTGCAATGTCGATGGACGACTCGTCCTCCAATGTTGCTAC
ACGAGACACTGACATGTCAGAAGCAGCTTCTGAAGATCAAGACTTGGCACTTGCT
CTTCAACTGTCTGTGCAAGACAGTACAAATGATCAGTCAAATCAGACAGATATGAG
TAAGCTGTTGGCAGATCAATCATTTGTGTCATCAATCCTTGCCTCACTTCCAGGTG
TTGATCCAAACGATCCTTCCGTTAAAGATTTGCTTGCTTCCATGCAAGGCCAGTCT
GAGCAGAAGAAGGATGAGGACAATGATAAGGAACAGAAAGAGGAAAAGAAGTAA
SEQ ID NO: 14>XM_006343297.2 Solanum tuberosum 26S proteasome non-ATPase regulatory subunit 4 homolog (LOG 102584699)
ATGGTGGAGGAGGCTGTAATGATCTGTATTGATAATTCTGAATGGATGCGTAATG
GTGATTACTCGCGCAACCGGTTTGATGCACAATATTCGGCTTTTACTTCGATTTGT
GGTTTCAAACACCTGGCAAACCCTGAGAGTACAGTCGGAGCATTAACCATGGCTG
GCAAAGGAGTTCGTGTATTAATCACTCCAACCAATGACTTTGGAGAAATGTTATCT
TGCATTAACGGATTAAATATCGGTGGTGAGATGAATTTGGCTGCTGGACTCCAGG
TGGCACAGTTGGCTCTGAAGCATCGGCAAAACAAAAAGCAGCATCAAAAGATCAT
TCTTTTTGCTGGCAGCCCTGTTAAAGAAGACAAGAGGGTCTTGGAGATGATTGGA
AGAAAGTTGAATAAGCATAGAGTAGCTCTTGATGTTATTAATTTTGGTCAAGAAGAT
AACAGGAAGGCTGAGAAGCTGGAGGCATTAGTTGCTGCAGTTAACAACAATGATA
ACAGTCACATCATTTATATTCCTCCTGGGGCTAGGGATCTTTCTGATGTGCTAGGG
AGGAATCCTATCTTTACTAGAGATGTTGACTCTAGAAAGAGATTTGCTGCGGTTGC
TTCTGGTGCAGGGTCTGGCTATGATTTTGGTGTTGATCCTAACTTGGATCCTGAGA
TTGCTCTGGCACTTCGAGTTTCAATGGAGGAGGAAAGGGATAGACAAGCAGCAGC
AGCAAAGAAGGCTGCACAAGAAGCTGCAAAACAAGAAAAAGGAGAAATGCAGTCA
ACTTCCCAGGATGTTACAATGACTGAAAATGTCAGTGCTCGAAAGTCTGAAACTAA
AAACAAGGCAGCTGATCTACTGGATAATGATCATTCCCTGTTACAACAAGCACTTG
CAATGTCGAGGGATGATTCTTCCTCCAACACTGCTACAAGAGACACAGACATGTC
AGAAGCAGATTTTGAAGATCGGGAGTTGCTACTAGATCTTCTTTTATTCATACAGG
ACAATTCAAAAGATGAGACAAATGTCACTAAATTGTTGGCAAACCAATCACTCGTG
CCATCAATTCTTGCTTCAATTCTAGGTGTTGATCCGAATGACCCTTCAATTGAAGTT
TTACTTGCTTCTATGCAAAGTCAGTCTGAGAATGACGAGAACAAGGAACAACGAG
AGGACAAGGAACAGAAAGAAGACAAGAAGTGA
SEQ ID NO: 15> TraesCS4B02G227200.2 4B [Triticum aestivum]
ATGGTGCTCGAGTCGACGATGATCTGCATAGACAACTCGGAGTGGATGCGGAAC
GGCGACTACTCGCCGTCCCGCTTCCAGGCGCAGGCCGACGCCGTCAACCTCATC
TGCGGCGCCAAGACCCAGTCGAACCCGGAGAATACGGTGGGCGTCATGACGATG
GCCGGCAAGGGCGTGCGCGTGCTTGTCACTCCCACCAGCGACCTCGGCAAGATC
CTCGCCTGTATGCACGGGCTGGAAGTTGGAGCTGAAGCAAACTTGGCCGCAGCT
ATTCAGGTTGCTCAGCTGGCGCTAAAGCATCGCCAGAATAAGAGGCAACAGCAGA
GAATTATTGTTTTCATTGGAAGCCCTGTGACATACGACAAGAAGGTCTTGGAGACA
ATAGGGAAGAAGCTGAAGAAGAATAATGTTGCCCTTGACGTTGTTGATTTTGGTGA
AACTGATGATGAAAAGCCTGAGAAACTGGAAGCGCTGATCGCTGCTGTGAACAGC
AGTGATAGCAGCCACATCGTCCATGTCCCTCCGGGTGACCATGCCCTTTCTGATG
TTCTTATAAGCACTCCTATCTTTACTGGTGAAGAAGGTGGAAGTGGCTTTGCTGCT
TCTGCAGCAGCTGCTGCAGCCACCGGAGCTACCGGATATGATTTTGGTGTGGAC
CCAAATGTGGATCCAGAGTTGGCACTTGCCCTACGGTTGTCTATGGAGGAAGAGC
GAGCTAGGCAAGAGGCTATCGCGAAAAAGGCTGCAGAAGACAACAAGGATCATG
CCTCGAGCTCTACTGATGCTATTATGGCTGAAGCGGAACTTACCTTAAATGCTCCT
GCTGATGTTGACGCAGATCTACTGAAGTGTAACCCACAGGATGATGATGATGCTC
AGCTACTACAGCAAGCACTCGCTATGTCAATGGATGAGGGTGCTTCAGGATCTGC
AGCTGTGGCTGATGCTGCTATGGCAGAAGCTGCTGCAGATGACCAGGATTTGGC
ATTGGCTCTTCAAATGTCTGTCCAGGACGCAGAGGTGGCTGGTCAATCTGATATG
AGCAAAGTGTTTGAGGACAGGTCATTTGTGACATCCATCCTTAATTCGCTTCCTGG
TGTTGACCCCAATGACCCATCTGTGAAAGATCTACTGGCTTCTTTGCATGGCCAAG
GAGAGGAGGAGAAGAAAGATAAGGAGGACAAGCCAGACAAGCCTGAAGATGGGA
AGAACTAA
SEQ ID NO: 16>TraesCS4A02G0713004A [Triticum aestivum]
ATGGTGCTCGAGTCGACGATGATCTGCATAGACAACTCGGAGTGGATGCGGAAC
GGCGACTACTCGCCGTCCCGCTTCCAGGCGCAGGCCGACGCCGTCAACCTCATC
TGCGGCGCCAAGACCCAGTCGAACCCGGAGAATACGGTGGGCGTCATGACGATG
GCCGGCAAGGGCGTGCGCGTGCTTGTCACCCCCACCAGCGACCTCGGCAAGAT
CCTCGCCTGTATGCACGGGCTGGAAGTTGGAGCTGAAGCAAACTTGGCCGCGGC
TATTCAGGTTGCTCAGCTGGCGCTAAAGCATCGCCAGAATAAGAGGCAACAGCAG
AGAATTATTGTTTTCATTGGAAGCCCTGTGACATACGACAAGAAGGTCTTGGAGAC
AATAGGGAAGAAGCTGAAGAAGAATAATGTTGCCCTTGACGTTGTTGATTTTGGTG
AAACTGATGATGAAAAGCCTGAGAAACTGGAAGCGCTGATCGCTGCTGTGAACAG
CAGTGATAGCAGCCACATCGTCCACGTCCCTCCGGGTGACCATGCCCTTTCTGAT
GTTCTTATAAGCACTCCTATCTTTACTGGCGAAGAAGGTGGAAGTGGCTTTGCTGC
TTCTGCAGCAGCTGCTGCAGCCACCGGAGCTACTGGATATGATTTTGGCGTGGAC
CCAAATGTGGACCCAGAGTTGGCACTTGCCCTACGGTTGTCTATGGAGGAAGAGC
GAGCTAGGCAAGAGGCTATCGCGAAAAAGGCTGCAGAAGACAACAAGGATCAGC
CCTCAAGCTCTACCGATGCTATTATGGCTGAAGCGGAACTTACCTTAAATGCTCCT
GCTGATGTTGACGCAGATCTACTCAAGGATGATGATGATGCTCAGCTACTACAGC
AAGCACTTGCTATGTCAATGGATGAGGGTGCTTCAGGAGCTGCAGCCGTGGCTG
ATGCTGCTATGGCAGAAGCTGCTGCAGATGACCAGGATTTGGCATTGGCTCTTCA
AATGTCTGTCCAGGACGCTGAGGCGGCTGGTCAATCTGATATGAGCAAAGTGTTT
GAAGACAGATCATTTGTGACATCCATCCTTAATTCGCTTCCTGGTGTTGACCCCAA
TGACCCATCTGTGAAAGATCTACTGGCATCTTTGCATGGCCAAGGAGAGCAGGAG
GAGAAGAAAGATAAGGAGGACAAGCCAGACATTTCTGAAGATGGGAAGAACTGA
SEQ ID NO: 17 >TraesCS4D02G2279004D [Triticum aestivum]
ATGGTGCTCGAGTCGACGATGATCTGCATAGACAACTCGGAGTGGATGCGGAAC
GGCGACTACTCGCCGTCCCGCTTCCAGGCGCAGGCCGACGCCGTCAACCTCATC
TGCGGCGCCAAGACCCAGTCGAACCCGGAGAATACGGTGGGCGTCATGACGATG
GCCGGCAAGGGCGTGCGCGTGCTTGTCACTCCCACCAGCGACCTCGGCAAGATC CTCGCCTGTATGCACGGGCTGGAAGTTGGAGCTGAAGCAAACTTGGCCGCAGCT ATTCAGGTTGCTCAGCTGGCGCTAAAGCATCGCCAGAATAAGAGGCAACAGCAGA GAATTATTGTTTTCATTGGAAGCCCTGTGACATACGACAAGAAGGTTTTGGAGACA ATAGGGAAGAAGCTGAAGAAGAATAATGTTGCCCTTGACGTTGTTGATTTTGGTGA AACTGATGATGAAAAGCCCGAGAAACTGGAAGCGCTGATCGCTGCTGTGAACAGC AGTGATAGCAGCCACATCGTCCATGTCCCTCCGGGTGATCATGCCCTTTCTGATG TTCTTATAAGCACTCCTATCTTTACTGGTGAAGAAGGTGGAAGTGGCTTTGCTGCT TCTGCAGCAGCTGCTGCAGCCACCGGAGCTACTGGATATGATTTTGGCGTGGAC CCAAATGTGGATCCAGAGTTGGCACTTGCCCTACGGTTGTCTATGGAGGAAGAAC GAGCTAGGCAAGAAGCTATCGCGAAGAAGGCTGCAGAAGACAACAAGGATCAGG CCTCAAGCTCTACTGATGCTATTATGGCTGAAGCAGAACTTACCTTAAATGCTCCT GCTGATGTTGACGCAGATCTACTGAAGGATGATGATGATGCTCAGCTACTACAGC AAGCACTCGCTATGTCAATGGATGAGGGTGCTTCAGGAGCTGCAGCCGTGGCTG ATGCTGCTATGGCAGAAGCTGCTGCAGATGACCAGGATTTGGCATTGGCTCTTCA AATGTCTGTCCAGGATGCAGAGGCGGCTGGTCAATCTGATATGAGCAAAGTGTTT GAAGACAGATCATTTGTGACATCCATCCTTAATTCGCTTCCTGGTGTTGACCCCAA TGACCCATCTGTGAAAGATCTACTGGCATCTTTGCATGGCCAAGGAGAGCAGGAG GAGAAGAAAGATACGGAGGACAAGCCAGACAAGCCTGAAGATGGGAAGAACTGA
Protein
Underlined bases are mutation/substitution positions in the amino acid sequence that lead to a 38-39 GA to HS mutation in the amino acid sequence of AtRPNIO or a homologous mutation at a homologous position in a homologous sequence.
SEQ ID NO: 18>NP_195575.1 regulatory particle non-ATPase 10 [Arabidopsis thaliana] MVLEATMICIDNSEWMRNGDYSPSRLQAQTEAVNLLCGAKTQSNPENTVGILTMAGK
GVRVLTTPTSDLGKILACMHGLDVGGEINLTAAIQIAQLALKHRQNKNQRQRIIVFAGS PIKYEKKALEIVGKRLKKNSVSLDIVNFGEDDDEEKPQKLEALLTAVNNNDGSHIVHVP SGANALSDVLLSTPVFTGDEGASGYVSAAAAAAAAGGDFDFGVDPNIDPELALALRVS MEEERARQEAAAKKAADEAGQKDKDGDTASASQETVARTTDKNAEPMDEDSALLDQ AIAMSVGDVNMSEAADEDQDLALALQMSMSGEESSEATGAGNNLLGNQAFISSVLSS LPGVDPNDPAVKELLASLPDESKRTEEEESSSKKGEDEKK
SEQ ID NO: 19>Brassica_napus_BnaA06g37370D
MICIDNSEWMRNGDYSPSRLQAQTEAVNLLCGAKTQSNPENTVGILTMAGKGVRVLT TPTSDLGKILACMHGLDVGGEINLTAAIQIAQLALKHRQNKNQRQRIIVFAGSPIKYEKK
ALEWGKRLKKNSVSLDWNFGDDDDQDKPLKLEALLSSVNNNDGSHIVHVPSGPNA
LSDVLLSTPVFTGDEGASGYVSAAAAAAAAGGDFDFGVDPNIDPELALALRVSMEEE RARQEAAAKKAADEAGQKDQDGASASASQETVARTTEKNAEPMDEDNALLNQAIAM SVGDVNMSEAADEDQDLALALQMSMSGEEATGAGNLLGDQAFISSVLSSLPGVDPN DPAVQALLASLPDESKRNEEEESSSKGEDEKK
SEQ ID NO: 20>Brassica_napus_BnaC07g47640D
MICIDNSEWMRNGDYSPSRLQAQTEAVNLLCGAKTQSNPENTVGILTMAGKGVRVLT
TPTSDLGKILACMHGLDVGGEINLTAAIQIAQLALKHRQNKNQRQRIIVFAGSPIKYEKK
ALEVVGKRLKKNSVSLDIVNFGEDDDQDKPLKLEALLSAVNNNDGSHIVHVPSAANAL
SDVLLSTPVFTGDEGAAGYVSAAAAAGGDFDFGVDPNIDPELALALRVSMEEERARQ
EAAAKKAADEAGQKDQDGASASQETVARTTEKNAEPMDEDNALLNQAIAMSVGDVN
MSEAANEDQDLALALQMSMSGEESNEAMGAGNLLGDQAFISSVLSSLPGVDPNDPA
VQALLASLPDESKRNEEEESSSKGEDEKK
SEQ ID NO: 21>Brassica_napus_BnaA08g16980D
MICIDNSEWMRNGDYSPSRLQAQTEAVNLLCGAKTQSNPENTVGILTMAGKGVRVLT
TPTSDLGKILACMHGLEVGGEINLTAAIQIAQLALKHRQNKNQRQRIIVFAGSPIKYEKK
ALEWGKRLKKNSVSLDIVNFGDDDDEEKPQKLEALLAAVNNNDGSHIVHVPSGANAL
SDVLLSTPVFTGDEGASGYVSAAAAAAAAGGDFDFGVDPNIDPELALALRVSMEEER
ARQEAAAKKAADEAGQKDKDGDTASASQETVARTTEKNAEPMDEDNALLDQAIAMS
VGDVNMSEAADEDQDLALALQMSMSGEESGEATGAGNLLGDQAFISSVLSSLPGVD
PNDPAVQALLASLPDESKRNEEESNSKGEDEKK
SEQ ID NO: 22>Brassica_napus_BnaC03g60090D
MICIDNSEWMRNGDYSPSRLQAQTEAVNLLCGAKTQSNPENTVGILTMAGKGVRVLT
TPTSDLGKILACMHGLDVGGEINLTAAIQIAQLALKHRQNKNQRQRIIVFAGSPIKYEKK
ALEWGKRLKKNSVSLDIVNFGDDDDEEKPQKLEALLAAVNNNDGSHIVHVPSGANAL
SDVLLSTPVFTGDEGASGYVSAAAAAAAAGGDFDFGVDPNIDPELALALRVSMEEER
ARQEAAAKKAADEAGQKDKDGDTASASQETVARTTEKNAEPMDEDNALLDQAIAMS
VGDVNMSEAADEDQDLALALQMSMSGEESGEATGAGNLLGDQAFISSVLSSLPGVD
PNDPAVQALLASLPDESKRNEEESNSKGEDEKK
SEQ ID NO: 23>XP_002264558.1 PREDICTED: 26S proteasome non-ATPase regulatory subunit 4 homolog [Vitis vinifera]
MVLEATMICIDNSEWMRNGDYSPTRFQAQADAVNLICGAKTQSNPENTVGVLTMAGK
GVRVLVTPTSDLGKILACMHGLEVGGEMNLAAGIQVAQLALKHRQNKKQQQRIIVFAG
SPVKYDKKVLEMIGRKLKKNSVAIDIVDFGEDDDGKPEKLEALLGSVNNNDSSHIVHVP
AGPNALSDVLISTPIFTGDGEGGSGFAAAAAAAAAGGVAGFDFGVDPNLDPELALALR
VSMEEERARQEAAAKKAAEEASRQEKEGEQQSSSQDATMTEHANVAASDADKKSDL
MDDENALLQQALAMSMDDPATSLAMRDTDMSEAAADDQDLALALQLSVQDTGKDST
SQTDMSKLLTDQTFVSSILASLPGVDPNDPSVKDLLASMQNESESQQKKNEDKAPDE
EDK
SEQ ID NO: 24>XP_003520200.1 26S proteasome non-ATPase regulatory subunit 4 homolog [Glycine max]
MVLEATMICIDNSEWMRNGDYSPSRFQAQTDAVNLICGAKTQSNPENTVGVLTMAGK
GVRVLVTPTSDLGKILACMHGLEIGGEMNLAAGIQVAQLALKHRQNKKQQQRIIVFAG
GPVKHEKKMLEMIGRKLKKNSVALDIVNFGEEDEGKTEKLEALLSAVNNNDTSHIVHV
PSGPNALSDVLISTPIFTGDGEGGSGFAAAAAAAAAGGVSGFEFGVDPNLDPELALAL
RVSMEEERARQEAAAKKASEDASKQEKDGEQQASPQDTTMTEGASAAASEAETKRT DLTDDENALLQQALAMSMDDPTINHEVRDTDMSEAAAEDPELALALQLSVEDSSKDS ASQSDVSKLLADQSFVSSILASLPGVDPNDPSVKDLLASMQNQSEPQQKNEDKPPNE EEKK
SEQ ID NO: 25>XP_015632315.1 26S proteasome non-ATPase regulatory subunit 4 homolog [Oryza sativa Japonica Group]
MVLEATMICIDNSEWMRNGDYSPSRFQAQADAVNLICGAKTQSNPENTVGVMTMAG KGVRVLVTPTSDLGKILACMHGLEVGAEANLAAAIQVAQLALKHRQNKRQQQRIIAFIG SPVKYDKKVLETIGKKLKKNNVALDIVDFGETDDDKPEKLEALISAVNSSDSSHIVHVPP GENALSDVLISTPIFTGEEGGSGFAASAAAAAATGAAGFEFDVDPNVDPELALALRLS
MEEERARQEAIAKKAAEESSGAENKDHASSSNADSVMAEAEPASNAADDKKDQPKE DDDAQLLQQALAMSMEEGSSGAAAADAAMAEAAVDDQDLALALQMSVQDAGGSSQ SDMSKVFEDRSFVTSILNSLPGVDPNDPSVKDLLASLHGQGEQEKKEDKSDKPEDEK K
SEQ ID NO: 26 >XP_025876377.1 26S proteasome non-ATPase regulatory subunit 4 homolog [Oryza sativa Japonica Group] MVLELEATVICVDDSEWMRNGDYPPTRLQAQEDAANLWGTKMTSNPENTVGVLAM AGDRVRVLLAPTSDPVKFLACMHGLEASGEANLTATLNIAELVLKNRPDKRLSQRIVVF
VGSPVKDEKLETIGKKLKKYNVSLDWEFGESDDEKPEKLEALVAAVGGSSHIVHIPPG
EDLRAVLANTPIITGDEGGGAAAGGASRYEYNVDPNVDPEFAEALRLSEIARQEAAAD GASRYEYSVDPNADPELAETFRLAAGEPSTSNTDTVLLESDSDTYVPFHEFIQNNPFV TGAESASDRPADDERATEEGFRMIREALARSANAAHAEISGNSSSGQELELG
SEQ ID NO: 27 >XP_010316428.1 26S proteasome non-ATPase regulatory subunit 4 homolog isoform X1 [Solanum lycopersicum]
MVLEATMICIDNSEWMRNGDYSPNRFQALADAVNLICGAKTQSNPENTVGILTMAGK GVRVLVTPTSDLGKILACMHGLEIGGEMNLAAGIQVAQLALKHRQNKKQQQRIIVFAG SPVKYDKKVLEMIGRKLKKNSVALDVVNFGEDDEGKAEKLEALVAALNTNDSSHIIHIP PGPNALSDVLISTPIFTGDGEGGSGFAAAAAAAAAGGVSGYDFGVDPNLDPELALALR
VSMEEERARQEAAAKKAAEEAGNQEKGENQSTSQDVAMAENVNAGTSEPESKATDL MDDENALLQQALAMSMDDSSSNVATRDTDMSEAASEDQDLALALQLSVQDSTNDQS NPTDMSKLLADQSFVSSILASLPGVDPNDPSVKDLLASMQGQSEQKKDEDNDKEQKE DKK
SEQ ID NO: 28 >XP_006422625.1 26S proteasome non-ATPase regulatory subunit 4 homolog isoform X1 [Citrus Clementina]
MVLEATMICIDNSEWMRNGDYSPSRLRAQADAVSLICGAKTQSNPENTVGILTMGGK GVRVLTTPTTDLGKILACMHELDIGGEMNIAAGIQVAQLALKHRQNKNQRQRIIVFAGS PVKYDRKVMEMIGKKLKKNSVAIDIVNFGEDDDGKPEKLEALLAAVNNNDSSHLVHVP TGPNALSDVLISSPVFTADGEGGSGFAAAAAAAAAGGVSDFDFGVDPNIDPELALALR
VSMEEERARQEAAAKRAADEASRQGKEEEPSSNSQDATMTDNTNNTAAETTEKTAD PMDEEKSLLERAFAMSMGTSVSDTSMADADTSKATDEDKELALALQMSMQDDTKDP SNQSDMSKVLGDQSFVSSILTSLPGVDPNDPSVKDLIASLQGQPESSEQKKKEDEPP KDDK
SEQ ID NO: 29 >XP_008372906.2 26S proteasome non-ATPase regulatory subunit 4 homolog isoform X1 [Malus domestica]
MVLEATMICVDNSEWMRNGDYSPSRLQAQADAINLICGAKTQANPENTVGVLTMAGK
GVRVLATPTSDLGRILACMHGLEMGGEMNIAAAIQVAQLALKHRQNKNQQQRIIVFAG
SPVKFEKKLLESIGKKLKKNSVALDIVDFGEEDDGKPEKLEALLSAVNNNESSHIVHVP
PGPNALSDVLISTPVFTGDGEGGSGFAVAAAAATAAANGGSGYDFGVDPNIDPELAL
ALRVSMEEERARQEAAAKRASEEAGGKGGEPSSKSEDATMTDQANVSSPNEDKKHT
DNMVDENDLLKEALAMSMNVSGTGHSAGDTEMSEATSADQELALALQMSMQESAG
EPSSQSDASKVLEDQSFISSILESLPGVDPNDPSVKDLLASLKNQSEQKDKEEPSNKD K
SEQ ID NO: 30 >XP_006340749.1 26S proteasome non-ATPase regulatory subunit 4 homolog isoform X1 [Solanum tuberosum]
MVLEATMICIDNSEWMRNGDYSPNRFQALADAVNLICGAKTQSNPENTVGILTMAGK
GVRVLVTPTSDLGKILACMHGLEIGGEMNLAAGIQVAQLALKHRQNKKQQQRIIVFAG
SPVKYDKKVLEMIGRKLKKNSVALDVVNFGEDDEGKAEKLEALVAALNTNDSSHIIHIP
PGPNALSDVLISTPIFTGDGEGGSGFAAAAAAAAAGGVSGYDFGVDPNLDPELALALR
VSMEEERARQEAAAKKAAEEAGNQEKGENQSTSQDVAMAENVNAGTSEPESKATDL
MDDENALLQQALAMSMDDSSSNVATRDTDMSEAASEDQDLALALQLSVQDSTNDQS
NQTDMSKLLADQSFVSSILASLPGVDPNDPSVKDLLASMQGQSEQKKDEDNDKEQK
EEKK
SEQ ID NO: 31>XP_006343359.1 26S proteasome non-ATPase regulatory subunit 4 homolog isoform X2 [Solanum tuberosum]
MVEEAVMICIDNSEWMRNGDYSRNRFDAQYSAFTSICGFKHLANPESTVGALTMAGK
GVRVLITPTNDFGEMLSCINGLNIGGEMNLAAGLQVAQLALKHRQNKKQHQKIILFAGS
PVKEDKRVLEMIGRKLNKHRVALDVINFGQEDNRKAEKLEALVAAVNNNDNSHIIYIPP
GARDLSDVLGRNPIFTRDVDSRKRFAAVASGAGSGYDFGVDPNLDPEIALALRVSME
EERDRQAAAAKKAAQEAAKQEKGEMQSTSQDVTMTENVSARKSETKNKAADLLDND
HSLLQQALAMSRDDSSSNTATRDTDMSEADFEDRELLLDLLLFIQDNSKDETNVTKLL
ANQSLVPSILASILGVDPNDPSIEVLLASMQSQSENDENKEQREDKEQKEDKK
SEQ ID NO: 32> TraesCS4B02G227200.2 4B [Triticum aestivum]
MVLESTMICIDNSEWMRNGDYSPSRFQAQADAVNLICGAKTQSNPENTVGVMTMAG
KGVRVLVTPTSDLGKILACMHGLEVGAEANLAAAIQVAQLALKHRQNKRQQQRIIVFIG
SPVTYDKKVLETIGKKLKKNNVALDVVDFGETDDEKPEKLEALIAAVNSSDSSHIVHVP
PGDHALSDVLISTPIFTGEEGGSGFAASAAAAAATGATGYDFGVDPNVDPELALALRL
SMEEERARQEAIAKKAAEDNKDHASSSTDAIMAEAELTLNAPADVDADLLKCNPQDD
DDAQLLQQALAMSMDEGASGSAAVADAAMAEAAADDQDLALALQMSVQDAEVAGQ
SDMSKVFEDRSFVTSILNSLPGVDPNDPSVKDLLASLHGQGEEEKKDKEDKPDKPED
GKN
SEQ ID NO: 33>TraesCS4A02G0713004A [Triticum aestivum]
MVLESTMICIDNSEWMRNGDYSPSRFQAQADAVNLICGAKTQSNPENTVGVMTMAG
KGVRVLVTPTSDLGKILACMHGLEVGAEANLAAAIQVAQLALKHRQNKRQQQRIIVFIG
SPVTYDKKVLETIGKKLKKNNVALDVVDFGETDDEKPEKLEALIAAVNSSDSSHIVHVP
PGDHALSDVLISTPIFTGEEGGSGFAASAAAAAATGATGYDFGVDPNVDPELALALRL
SMEEERARQEAIAKKAAEDNKDQPSSSTDAIMAEAELTLNAPADVDADLLKDDDDAQ
LLQQALAMSMDEGASGAAAVADAAMAEAAADDQDLALALQMSVQDAEAAGQSDMS
KVFEDRSFVTSILNSLPGVDPNDPSVKDLLASLHGQGEQEEKKDKEDKPDISEDGKN
SEQ ID NO: 34 >TraesCS4D02G2279004D [Triticum aestivum]
MVLESTMICIDNSEWMRNGDYSPSRFQAQADAVNLICGAKTQSNPENTVGVMTMAG
KGVRVLVTPTSDLGKILACMHGLEVGAEANLAAAIQVAQLALKHRQNKRQQQRIIVFIG
SPVTYDKKVLETIGKKLKKNNVALDVVDFGETDDEKPEKLEALIAAVNSSDSSHIVHVP
PGDHALSDVLISTPIFTGEEGGSGFAASAAAAAATGATGYDFGVDPNVDPELALALRL
SMEEERARQEAIAKKAAEDNKDQASSSTDAIMAEAELTLNAPADVDADLLKDDDDAQ
LLQQALAMSMDEGASGAAAVADAAMAEAAADDQDLALALQMSVQDAEAAGQSDMS
KVFEDRSFVTSILNSLPGVDPNDPSVKDLLASLHGQGEQEEKKDTEDKPDKPEDGKN
SEQ ID NO: 35 Target_2: CGAATCCGGAGAATACGGTGGGG
SEQ ID NO: 36: Protospacer sequence: CGAATCCGGAGAATACGGTG
SEQ ID NO: 37 Target_4: TATGTATCGACAACTCCGAGTGG
SEQ ID NO: 38 Protospacer sequence: TATGTATCGACAACTCCGAG
SEQ ID NO: 39 Target_9: TATCGACACGATGGTTCTCGAGG
SEQ ID NO: 40 Protospacer sequence: TATCGACACGATGGTTCTCG
SEQ ID NO: 41 Target_11: CTGGGCGATCTGGATAGCTGCGG
SEQ ID NO: 42: Protospacer sequence: CTGGGCGATCTGGATAGCTG
SEQ ID NO: 43 Target_15: ATCTCCGTTTCGCATCCACTCGG
SEQ ID NO: 44 Protospacer sequence: ATCTCCGTTTCGCATCCACT
SEQ ID NO: 45 Target_21: TTTTCAGGCCTTGATGTGGGAGG
SEQ ID NO: 46 Protospacer sequence: TTTTCAGGCCTTGATGTGGG
SEQ ID NO: 48 SAP05 amino acid sequence >SAP05_AYWB
MFKIKNNLLKSKIFVFILLGLFVIINNHQAMAAPNEEFVGDMRIVNVNLSNIDILKKHETFK KYFDFTLTGPRYNGNIAEFAMIWKIKNPPLNLLGVFFDDGTRDDEDDKYILEELKQIGN GAKNMYIFWQYEQK SEQ ID NO: 49 SAP05 cDNA sequence >SAP05_AYWB
ATGTTTAAAATCAAAAATAATTTATTAAAATCAAAAATATTTGTATTTATTTTATTAGG ATTATTTGTAATTATCAATAATCATCAAGCAATGGCTGCCCCTAATGAAGAGTTTGT TGGCGACATGAGAATAGTTAATGTAAATTTATCAAATATTGATATTCTTAAAAAACA
TGAAACATTTAAAAAATATTTTGATTTTACACTAACTGGTCCTCGTTATAATGGAAA CATAGCAGAATTTGCAATGATATGGAAAATTAAAAATCCGCCTCTTAATTTATTAGG
TGTTTTTTTTGATGATGGCACCAGAGATGATGAAGATGATAAATATATTTTAGAAGA ATTAAAACAAATAGGCAATGGAGCCAAAAATATGTATATTTTTTGGCAATATGAACA AAAATAA
Claims
1 . A method of providing resistance or increasing resistance of a host to a vector- borne pathogen, the method comprising: a. identifying at least one host protein that is the target of at least one pathogen effector; b. identifying at least one homologue of the host target protein in the vector; c. comparing the nucleic acid or protein sequence of the host target and vector homologue and identifying one or more differences in the nucleic acid or protein sequence between the host and vector nucleic acid or protein sequence; and d. introducing said one or more differences in nucleic acid or protein sequence into the host target protein; wherein introduction of one or more of the differences increases resistance to the vector-borne pathogen.
2. A genetically altered plant, part thereof or plant cell, wherein the plant comprises at least one mutation in at least one RPN10 gene.
3. The genetically altered plant of claim 2, wherein the mutation is a loss of function mutation.
4. The genetically altered plant of claim 2, wherein the mutation is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof.
5. The genetically altered plant of claim 4, wherein the mutation is at position 38 and 39 of SEQ I D NO: 18 or at a homologous position in a homologous sequence.
6. The genetically altered plant of any of claims 2 to 5, wherein the mutation is a substitution.
7. The genetically altered plant, wherein the mutation is introduced using targeted genome editing.
8. The genetically altered plant of any of claims 2 to 7, wherein the plant is a monocot or dicot.
9. The genetically altered plant of claim 8, wherein the plant is selected from rice, maize, wheat, barley, sorghum, potato, tomato, cotton, soybean, Brassica napus, cabbage, lettuce, carrot, asters, coconut, grape, apple, oranges and sugarcane.
10. The genetically altered plant of any of claims 2 to 9, wherein the plant part is a seed.
11 . A seed obtained or obtainable from the plant of any of claims 2 to 10.
12. A method of increasing resistance of a plant to vector-borne pathogen, the method comprising introducing at least one mutation into at least one RPN10 gene.
13. The method of claim 12, wherein the method further increases the resistance of the plant to the vector.
14. A method of producing a plant with increased resistance to a vector borne pathogen, the method comprising introducing at least one mutation into at least one RPN10 gene.
15. The method of any of claims 12 to 14, wherein the vector-borne pathogen is a bacteria, preferably a phytoplasma.
16. The method of any of claims 12 to 15, wherein the mutation is a loss of function mutation.
17. The method of any of claims 12 to 15, wherein the mutation is a mutation is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the sequence of the vWA domain comprises or consists of SEQ ID NO:47 or a homologue or variant thereof.
18. The method of any of claims 12 to 17, wherein the mutation is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence.
19. The method of any of claims 12 to 18, wherein the mutation is a substitution.
20. The method of any of claims 12 to 19, wherein the mutation is introduced using targeted genome editing.
21 . The method of any of claims 12 to 20, wherein the plant is a monocot or dicot.
22. The method of claim 21 , wherein the plant is selected from brassicas, legumes, cereals, citrus, root vegetables, tuber and rhizome crops, fruits including berries and soft fruits and fruit, nut and seed bearing trees.
23. A method for identifying and/or selecting a plant that will have increased resistance to phytoplasma infection, the method comprising detecting in the plant or plant germplasm at least one polymorphism in the RPN10 gene.
24. The method of claim 23, wherein preferably, the polymorphism prevents binding of a phytoplasma effector protein, wherein preferably the phytoplasma effector protein is SAP05.
25. The method of claims 23 or 24, wherein the mutation is in the N-terminal vWA (von Willebrand factor type A) domain of RPN10, wherein preferably the
sequence of the vWA domain comprises or consists of SEQ ID NO: 47 or a homologue or variant thereof. The method of any of claims 23 to 25, wherein the mutation is at position 38 and 39 of SEQ ID NO: 18 or at a homologous position in a homologous sequence.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LULU102305 | 2020-12-18 | ||
LU102305 | 2020-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022129579A1 true WO2022129579A1 (en) | 2022-06-23 |
Family
ID=74181252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/086603 WO2022129579A1 (en) | 2020-12-18 | 2021-12-17 | Modulating plant responses to activities of pathogen virulence factors |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022129579A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116410988A (en) * | 2023-04-28 | 2023-07-11 | 西南大学 | Method for improving citrus yellow dragon disease resistance by utilizing citrus RUB2 to regulate citrus ubiquitination pathway |
CN117106078A (en) * | 2023-07-18 | 2023-11-24 | 华南农业大学 | Rice phytoplasma aurantia antigen membrane protein polyclonal antibody and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019108619A1 (en) * | 2017-11-28 | 2019-06-06 | Two Blades Foundation | Methods and compositions for enhancing the disease resistance of plants |
-
2021
- 2021-12-17 WO PCT/EP2021/086603 patent/WO2022129579A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019108619A1 (en) * | 2017-11-28 | 2019-06-06 | Two Blades Foundation | Methods and compositions for enhancing the disease resistance of plants |
Non-Patent Citations (60)
Title |
---|
ABRAMOVITCH, R. B.JANJUSEVIC, R.STEBBINS, C. E.MARTIN, G. B.: "Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity", PROC NATL ACAD SCI USA, vol. 103, 2006, pages 2851 - 2856 |
ANONYMOUS: "AYWB_032 - SVM_signal domain-containing protein - Aster yellows witches'-broom phytoplasma (strain AYWB) - AYWB_032 gene & protein", 7 February 2006 (2006-02-07), pages 1 - 4, XP055838933, Retrieved from the Internet <URL:https://www.uniprot.org/uniprot/Q2NK94> [retrieved on 20210908] * |
BAI, X. ET AL.: "AY-WB phytoplasma secretes a protein that targets plant cell nuclei", MOL PLANT MICROBE INTERACT, vol. 22, 2009, pages 18 - 30 |
BEAN, A. G.: "Studying immunity to zoonotic diseases in the natural host - keeping it real", NAT. REV. IMMUNOL., vol. 13, 2013, pages 851 - 861, XP037065596, DOI: 10.1038/nri3551 |
CHAMBERLAIN, P. P.HAMANN, L. G.: "Development of targeted protein degradation therapeutics", NAT CHEM BIOL, vol. 15, 2019, pages 937 - 944, XP036888691, DOI: 10.1038/s41589-019-0362-y |
CUI, J. ET AL.: "Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family", SCIENCE, vol. 329, 2010, pages 1215 - 1218 |
DING, L. ET AL.: "HANABA TARANU regulates the shoot apical meristem and leaf development in cucumber (Cucumis sativus L.", J EXP BOT, vol. 66, 2015, pages 7075 - 7087 |
DRUREY, C. ET AL.: "Chemosensory proteins in the CSP4 clade evolved as plant immunity suppressors before two suborders of plant-feeding hemipteran insects diverged", BIORXIV, 2019, pages 173278 |
EIGENBRODE, S. D.BOSQUE-PEREZ, N. A.DAVIS, T. S.: "Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions", ANNU. REV. ENTOMOL., vol. 63, 2018, pages 169 - 191 |
FARMER, L. M. ET AL.: "The RAD23 family provides an essential connection between the 26S proteasome and ubiquitylated proteins in Arabidopsis", THE PLANT CELL, vol. 22, 2010, pages 124 - 142 |
FISHBAIN, S. ET AL.: "Sequence composition of disordered regions fine-tunes protein half-life", NAT STRUCT MOL BIOL, vol. 22, 2015, pages 214 - 221 |
FROST, K. E.WILLIS, D. K.GROVES, R. L.: "Detection and variability of aster yellows phytoplasma titer in its insect vector, Macrosteles quadrilineatus (Hemiptera: Cicadellidae", J ECON ENTOMOL, vol. 104, 2011, pages 1800 - 1815 |
GROLL, M.: "A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism", NATURE, vol. 452, 2008, pages 755 - 758 |
HINNEBUSCH, B. J.JARRETT, C. O.BLAND, D. M.: "Fleaing'' the Plague: Adaptations of Yersinia pestis to Its Insect Vector That Lead to Transmission", ANNU REV MICROBIOL, vol. 71, 2017, pages 215 - 232 |
HOSHI, A. ET AL.: "A unique virulence factor for proliferation and dwarfism in plants identified from a phytopathogenic bacterium", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 106, 2009, pages 6416 - 6421, XP002660928, DOI: 10.1073/pnas.0813038106 |
HUANG W ET AL: "IS-MPMI XVIII Congress Abstracts of Poster Presentations Abstracts submitted for presentation at IS-MPMI XVIII Congress in", 14 July 2019 (2019-07-14), pages 1 - 212, XP055838703, Retrieved from the Internet <URL:https://apsjournals.apsnet.org/doi/pdf/10.1094/MPMI-32-10-S1.1> [retrieved on 20210907] * |
HUANG WEIJIE ET AL: "Bacterial Vector-Borne Plant Diseases: Unanswered Questions and Future Directions", MOLECULAR PLANT, vol. 13, no. 10, 1 October 2020 (2020-10-01), pages 1379 - 1393, XP055839433, ISSN: 1674-2052, DOI: 10.1016/j.molp.2020.08.010 * |
JIANG, Y.ZHANG, C. X.CHEN, R.HE, S. Y.: "Challenging battles of plants with phloem-feeding insects and prokaryotic pathogens", PROC NATL ACAD SCI U S A, vol. 116, 2019, pages 23390 - 23397 |
KUMARI, S.: "Global Status of Phytoplasma Diseases in Vegetable Crops", FRONTIERS IN MICROBIOLOGY, vol. 10, 2019, pages 1349 - 1349 |
LEE, I. M.DAVIS, R. E.GUNDERSEN-RINDAL, D. E.: "Phytoplasma: phytopathogenic mollicutes", ANNU REV MICROBIOL, vol. 54, 2000, pages 221 - 255, XP002609131 |
LIN, Y. H.MACHNER, M. P.: "Exploitation of the host cell ubiquitin machinery by microbial effector proteins", J CELL SCI, vol. 130, 2017, pages 1985 - 1996 |
LIN, Y. L. ET AL.: "The defective proteasome but not substrate recognition function is responsible for the null phenotypes of the Arabidopsis proteasome subunit RPN10", PLANT CELL, vol. 23, 2011, pages 2754 - 2773, XP055839558, DOI: 10.1105/tpc.111.086702 |
MACLEAN, A. M. ET AL.: "Phytoplasma Effector SAP54 Hijacks Plant Reproduction by Degrading MADS-box Proteins and Promotes Insect Colonization in a RAD23-Dependent Manner", PLOS BIOL., vol. 12, 2014, XP055841192, DOI: 10.1371/journal.pbio.1001835 |
MACLEAN, A. M. ET AL.: "Phytoplasma effector SAP54 induces indeterminate leaf-like flower development in Arabidopsis plants", PLANT PHYSIOL, vol. 157, 2011, pages 831 - 841 |
MADISON-ANTENUCCI, S.KRAMER, L. D.GEBHARDT, L. L.KAUFFMAN, E.: "Emerging Tick-Borne Diseases", CLIN MICROBIOL REV, vol. 33, 2020 |
MAEJIMA, K. ET AL.: "Recognition of floral homeotic MADS domain transcription factors by a phytoplasmal effector, phyllogen, induces phyllody", PLANT J, vol. 78, 2014, pages 541 - 554 |
MATHIEU, J.WARTHMANN, N.KUTTNER, F.SCHMID, M.: "Export of FT protein from phloem companion cells is sufficient for floral induction in Arabidopsis", CURR BIOL, vol. 17, 2007, pages 1055 - 1060, XP026574775, DOI: 10.1016/j.cub.2007.05.009 |
OSHIMA, K. ET AL.: "Dramatic transcriptional changes in an intracellular parasite enable host switching between plant and insect", PLOS ONE, vol. 6, 2011, pages e23242 |
PRAKASH, S.TIAN, L.RATLIFF, K. S.LEHOTZKY, R. E.MATOUSCHEK, A.: "An unstructured initiation site is required for efficient proteasome-mediated degradation", NAT STRUCT MOL BIOL, vol. 11, 2004, pages 830 - 837 |
PRUNEDA, J. N. ET AL.: "The Molecular Basis for Ubiquitin and Ubiquitin-like Specificities in Bacterial Effector Proteases", MOL CELL, vol. 63, 2016, pages 261 - 276, XP029653540, DOI: 10.1016/j.molcel.2016.06.015 |
PRUNEDA-PAZ, J. L. ET AL.: "A genome-scale resource for the functional characterization of Arabidopsis transcription factors", CELL REP, vol. 8, 2014, pages 622 - 632 |
QIU, J. Z.: "Ubiquitination independent of E1 and E2 enzymes by bacterial effectors", NATURE, vol. 533, 2016, pages 120 - 124, XP055341933, DOI: 10.1038/nature17657 |
RANFTL, Q. L.BASTAKIS, E.KLERMUND, C.SCHWECHHEIMER, C.: "LLM-Domain Containing B-GATA Factors Control Different Aspects of Cytokinin-Regulated Development in Arabidopsis thaliana", PLANT PHYSIOL, vol. 170, 2016, pages 2295 - 2311 |
RIBET, D.COSSART, P.: "Ubiquitin, SUMO, and NEDD8: Key Targets of Bacterial Pathogens", TRENDS CELL BIOL, vol. 28, 2018, pages 926 - 940, XP085508909, DOI: 10.1016/j.tcb.2018.07.005 |
ROTHBAUER, U. ET AL.: "Targeting and tracing antigens in live cells with fluorescent nanobodies", NAT METHODS, vol. 3, 2006, pages 887 - 889, XP002553544, DOI: 10.1038/nmeth953 |
SAMBROOK ET AL.: "Molecular Cloning: A Library Manual", 1989, COLD SPRING HARBOR LABORATORY PRESS |
SANADA, T.: "The Shigella flexneri effector Ospl deamidates UBC13 to dampen the inflammatory response", NATURE, vol. 483, 2012, pages 623 - 626 |
SCHAPIRA, M.CALABRESE, M. F.BULLOCK, A. N.CREWS, C. M.: "Targeted protein degradation: expanding the toolbox", NAT. REV. DRUG DISCOV., vol. 18, 2019, pages 949 - 963, XP036929738, DOI: 10.1038/s41573-019-0047-y |
SHAPIRA, M. ET AL.: "A conserved role for a GATA transcription factor in regulating epithelial innate immune responses", PROC NATL ACAD SCI U S A, vol. 103, 2006, pages 14086 - 14091 |
SICARD, A.: "Xylella fastidiosa: Insights into an Emerging Plant Pathogen", ANNU REV PHYTOPATHOL, vol. 56, 2018, pages 181 - 202 |
SMALLE JAN ET AL: "The Pleiotropic Role of the 26S Proteasome Subunit RPN10 in Arabidopsis Growth and Development Supports a Substrate-Specific Function in Abscisic Acid Signaling", vol. 15, no. 4, 1 April 2003 (2003-04-01), US, pages 965 - 980, XP055839428, ISSN: 1040-4651, Retrieved from the Internet <URL:https://academic.oup.com/plcell/article-pdf/15/4/965/35428432/plcell_v15_4_965.pdf> DOI: 10.1105/tpc.009217 * |
SMALLE, J. ET AL.: "The pleiotropic role of the 26S proteasome subunit RPN10 in Arabidopsis growth and development supports a substrate-specific function in abscisic acid signaling", PLANT CELL, vol. 15, 2003, pages 965 - 980, XP055839428, DOI: 10.1105/tpc.009217 |
STRAUSS, E.: "Microbiology. Phytoplasma research begins to bloom", SCIENCE, vol. 325, 2009 |
SUGIO, A. ET AL.: "Diverse targets of phytoplasma effectors: from plant development to defense against insects", ANNU REV PHYTOPATHOL, vol. 49, 2011, pages 175 - 195 |
SUGIO, A.KINGDOM, H. N.MACLEAN, A. M.GRIEVE, V. M.HOGENHOUT, S. A.: "Phytoplasma protein effector SAP11 enhances insect vector reproduction by manipulating plant development and defense hormone biosynthesis", PROC NATL ACAD SCI U S A, vol. 108, 2011, pages E1254 - 1263 |
SZLANKA, T. ET AL.: "Deletion of proteasomal subunit S5a/Rpn10/p54 causes lethality, multiple mitotic defects and overexpression of proteasomal genes in Drosophila melanogaster", J CELL SCI, vol. 116, 2003, pages 1023 - 1033 |
TAN, M. W.: "Cross-species infections and their analysis", ANNU. REV. MICROBIOL., vol. 56, 2002, pages 539 - 565 |
TOMKINS, M.KLIOT, A.MAREE, A. F.HOGENHOUT, S. A.: "A multi-layered mechanistic modelling approach to understand how effector genes extend beyond phytoplasma to modulate plant hosts, insect vectors and the environment", CURR OPIN PLANT BIOL, vol. 44, 2018, pages 39 - 48, XP085443152, DOI: 10.1016/j.pbi.2018.02.002 |
TZFIRA, T.VAIDYA, M.CITOVSKY, V.: "Involvement of targeted proteolysis in plant genetic transformation by Agrobacterium", NATURE, vol. 431, 2004, pages 87 - 92 |
USTUN, S.BARTETZKO, V.BORNKE, F.: "The Xanthomonas campestris type III effector XopJ targets the host cell proteasome to suppress salicylic-acid mediated plant defence", PLOS PATHOG, vol. 9, 2013, pages e1003427 |
USTUN, S.BORNKE, F.: "The Xanthomonas campestris type III effector XopJ proteolytically degrades proteasome subunit RPT6", PLANT PHYSIOL, vol. 168, 2015, pages 107 - 119 |
VAN SCHIE, C. C.TAKKEN, F. L.: "Susceptibility genes 101: how to be a good host", ANNU REV PHYTOPATHOL, vol. 52, 2014, pages 551 - 581 |
WANG, N. ET AL.: "The Candidatus Liberibacter-Host Interface: Insights into Pathogenesis Mechanisms and Disease Control", ANNU REV PHYTOPATHOL, vol. 55, 2017, pages 451 - 482 |
WU, G.POETHIG, R. S.: "Temporal regulation of shoot development in Arabidopsis thaliana by miR156 and its target SPL3", DEVELOPMENT, vol. 133, 2006, pages 3539 - 3547, XP008126489, DOI: 10.1242/dev.02521 |
XU, M. ET AL.: "Developmental Functions of miR156-Regulated SQUAMOSA PROMOTER BINDING PROTEIN-LIKE (SPL) Genes in Arabidopsis thaliana", PLOS GENET, vol. 12, 2016, pages e1006263 |
YAN, Q. ET AL.: "Global gene expression changes in Candidatus Liberibacter asiaticus during the transmission in distinct hosts between plant and insect", MOLECULAR PLANT PATHOLOGY, vol. 14, 2013, pages 391 - 404 |
YOO, S. D.CHO, Y. H.SHEEN, J.: "Arabidopsis mesophyll protoplasts: a versatile cell system for transient gene expression analysis", NAT PROTOC, vol. 2, 2007, pages 1565 - 1572, XP002621444, DOI: 10.1038/NPROT.2007.199 |
ZHANG, L. ET AL.: "Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappaB activation", NATURE, vol. 481, 2011, pages 204 - 208 |
ZHANG, X. ET AL.: "Transcription repressor HANABA TARANU controls flower development by integrating the actions of multiple hormones, floral organ specification genes, and GATA3 family genes in Arabidopsis", PLANT CELL, vol. 25, 2013, pages 83 - 101 |
ZHANG, Y.HIGASHIDE, W. M.MCCORMICK, B. A.CHEN, J.ZHOU, D.: "The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase", MOL MICROBIOL, vol. 62, 2006, pages 786 - 793 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116410988A (en) * | 2023-04-28 | 2023-07-11 | 西南大学 | Method for improving citrus yellow dragon disease resistance by utilizing citrus RUB2 to regulate citrus ubiquitination pathway |
CN116410988B (en) * | 2023-04-28 | 2023-12-22 | 西南大学 | Method for improving citrus yellow dragon disease resistance by utilizing citrus RUB2 to regulate citrus ubiquitination pathway |
CN117106078A (en) * | 2023-07-18 | 2023-11-24 | 华南农业大学 | Rice phytoplasma aurantia antigen membrane protein polyclonal antibody and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110494039B (en) | Method for modifying resistance spectrum of spinach to downy mildew | |
US11299746B2 (en) | Disease resistant pepper plants | |
US8637735B2 (en) | Method for improving stress resistance in plants and materials therefor | |
EP3889266A1 (en) | Method for generating new mutations in organisms, and application thereof | |
US20220112512A1 (en) | Wheat stem rust resistance genes and methods of use | |
JP2010538670A (en) | Plant having enhanced yield-related trait and method for producing the same | |
WO2022129579A1 (en) | Modulating plant responses to activities of pathogen virulence factors | |
CN111818794A (en) | Method for increasing nutrient utilization efficiency | |
WO2016100624A1 (en) | Compositions and methods for improving abiotic stress tolerance | |
US20220064665A1 (en) | Methods of genetically altering a plant nin-gene to be responsive to cytokinin | |
US20230323384A1 (en) | Plants having a modified lazy protein | |
CN104080915B (en) | Methods using acyl-coenzyme A-binding proteins to enhance drought tolerance in genetically modified plants | |
AU2014336957B2 (en) | Method for modulating plant growth | |
CN113924367A (en) | Method for improving rice grain yield | |
CA3124395A1 (en) | Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides | |
WO2022129557A1 (en) | Methods of altering plant architecture | |
WO2018078390A1 (en) | Compositions and methods for enhancing abiotic stress tolerance | |
US20160272995A1 (en) | Manipulation of plasmodesmal connectivity to improve plant yield and fitness | |
US10968463B2 (en) | Methods of using acyl-coenzymea-binding proteins to enhance tolerance to necrotrophic fungal pathogens in genetically modified plants | |
TWI840629B (en) | A method for generating a mutant gene | |
WO2024084025A1 (en) | Rna transfection in plant cells with modified rna | |
WO2023118136A1 (en) | Improved screening method for genome edited events | |
AU2022422286A1 (en) | Improved screening method for genome edited events | |
WO2022235606A1 (en) | Nucleic acid molecules for conferring insecticidal properties in plants | |
Pozueta-Romero | Tools of genetic engineering in plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21824605 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21824605 Country of ref document: EP Kind code of ref document: A1 |